The Development and Exploration of a Twelve-Factor Model of Motivations for Using Substances by Altenberger, Taylor
The University of Southern Mississippi 
The Aquila Digital Community 
Master's Theses 
Spring 2020 
The Development and Exploration of a Twelve-Factor Model of 
Motivations for Using Substances 
Taylor Altenberger 
Follow this and additional works at: https://aquila.usm.edu/masters_theses 
 Part of the Clinical Psychology Commons 
THE DEVELOPMENT AND EXPLORATION OF A TWELVE-FACTOR MODEL OF 
MOTIVATIONS FOR USING SUBSTANCES 
 
 
by 
 
Taylor Altenberger 
A Thesis 
Submitted to the Graduate School, 
the College of Education and Human Sciences 
and the School of Psychology 
at The University of Southern Mississippi 
in Partial Fulfillment of the Requirements 
for the Degree of Master of Arts 
Approved by: 
 
Dr. Randy Arnau, Committee Chair 
Dr. Bradley Green 
Dr. Richard Mohn 
 
 
 
 
 
 
 
____________________ ____________________ ____________________ 
Dr. Randy Arnau 
Committee Chair 
Dr. Sara Jordan 
Director of School 
Dr. Karen S. Coats 
Dean of the Graduate School 
 
May 2020
 
ii 
ABSTRACT 
The existing literature suggests inconsistent and limited application of various 
salient motives to use substances across substance classes and has been further limited by 
only measuring substance use motives by the frequency at which one uses for a given 
reason. The purpose of this study was the development and initial validation of the 
Motivations for Substance Use Questionnaire (MUSQ). The MUSQ was intended to be a 
more comprehensive measure identifying motives to use that have been selectively 
included in some measures and expanding the breadth of substances addressed. We also 
aimed to index and test cognitive aspects of the motives (i.e., wanting, and liking and 
satisfaction) for use-related patterns.  
Factor analysis (n = 367) indicated that the MUSQ was characterized by 12 
factors: Reduce Anxiety/Unpleasant Arousal, Conformity, Effects of Other Substances, 
Relative Low Risk, Positive Social Interactions, Rebellion, Altered 
Perceptions/Experiential Processes, Performance/Arousal Enhancement, Increase 
Positive Affect, Manage Negative Social Interactions, Reduce Negative Affect, and 
Substitution. Regressions supported the predictability of wanting, but not liking and 
satisfaction, for severity and change variables. Canonical correlations were conducted to 
assess incremental validity of the MUSQ but were limited due to small effects and 
sample sizes. ANOVAs suggested salient motives differed by drug of choice. This 
measure may direct motivational interviewing dialogue by supporting change talk and 
may expand the current understanding of substance use motivation.  
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1 
 – INTRODUCTION  
Substance Use Disorders (SUDs) are a substantial economic and emotional 
burden on those afflicted and their support system. The prevalence of SUDs in the United 
States is rather high, with 3.9 and 9.9 percent of individuals meeting DSM-5 SUD 
diagnostic criteria for past year and lifetime diagnoses (Grant et al., 2016). High 
comorbidity of SUDs with mood, anxiety, and personality disorders demonstrates a 
complex expression of problems at the individual and societal level. SUDs cost the 
individual substantial time devoted to obtaining, using, and recovering from the 
substance and loss of relationships while costing the nation billions of dollars annually 
related to legal and health care costs, as well as reductions in work productivity (National 
Drug Intelligence Center, 2011). Because of the disabling impact of SUDs, as well as the 
diversity of reasons individuals begin and continue to use, it is necessary to understand 
individuals’ motivations to use substances and how they vary by substance type, 
experience with use, and severity of use as it progresses from the beginning stages of 
initial substance use to dependence. Such fine-grained understanding is necessary to 
adjust treatment interventions to individual needs (i.e. motives to use) and guide 
prevention efforts to address all likely etiological pathways to addiction. A novel method 
of measuring these motives for substance use appears warranted. There were three 
distinct, but related, theoretical bases that influenced the development of this study and, 
more specifically, a comprehensive questionnaire assessing motives for substance use: 
Addiction Syndrome Model, Transtheoretical Model for Stages of Change, and 
Motivational Enhancement Model.  
 
 
2 
Addiction Syndrome Model  
First, according to the Addiction Syndrome Model, the expression of various 
SUDs (e.g., Alcohol Use Disorder, Stimulant Use Disorder, Cannabis Use Disorder) 
manifests in both general and unique ways. That is, some aspects of SUDs are similar 
across substances (e.g., biopsychosocial vulnerabilities) and others are unique to a 
substance, or group of substances (e.g., consequences of use and motivations to use). A 
crucial component of the precursors to an addiction syndrome is that the individual must 
(a) be exposed to the substance and (b) interact with the substance (Shaffer et al., 2004). 
For some individuals, a combination of vulnerabilities and exposure to an object of 
addiction manifests in an addiction syndrome. An addiction syndrome is characterized by 
some unique consequences of a particular object of addiction (e.g., irritation or deviation 
of the nasal septum for substances used intranasally; “blackouts” related to alcohol and 
benzodiazepine use); however, the addiction syndrome shares several common 
presentations among the various objects of addiction, some of which include: shifts in 
social networks, deviant behavior, relapse, comorbid psychopathology, neurological 
alterations, and object substitution. Likewise, motivations to engage in substance use may 
be conceptualized as intervening variables that explain addiction-related behaviors in 
specific or general patterns in relation to objects of addiction. For example, it is likely 
that people use a variety of substances to cope with negative emotions (Baker, Piper, 
McCarthy, Majeskie, & Fiore, 2004); however, individuals are likely to specifically use 
opioids rather than stimulants to relieve pain (Blevins, Lash, & Abrantes, 2018). In 
development of the present measure, we aim to capture both the global and unique 
motivations to use.  
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Transtheoretical Model for Stages of Change 
The second theoretical model that informed the current study was the 
Transtheoretical Model for Stages of Change (Prochaska, DiClemente, & Norcross, 
1992) and subsequently the third, Motivational Interviewing (MI; Miller, 1983) 
specifically related to Motivational Enhancement Therapy (MET; Miller, Zweben, 
DiClemente, & Rychtarik, 1992). The Stages of Change model delineates five 
distinguishable stages of orientation to change that can characterize a given individual’s 
readiness to change a problematic behavior. The stages define a linear progression, 
beginning with precontemplation (no desire or not recognizing a need to change 
substance using behavior), and progressing to contemplation (thinking about change and 
recognizing a need to change), preparation (combining intention with some behavioral 
action for change), action (modifying substance using behavior), and maintenance 
(actively supporting the behavior change through continued prevention efforts). 
However, more often than not individuals struggling with a SUD progress through the 
stages in a recycling nature via relapse, learning from past attempts, and modifying the 
course of action in the next attempt at change. The Stages of Change is a general model 
that applies across all SUDs and thus could be construed as a general feature in terms of 
the Addiction Syndrome Model. In contrast, the relevance of a specific motive to use or 
not use may vary in regard to a given user’s status within the Stages of Change model 
(i.e., their current stage). The relevance of a specific motive may also vary by the 
substance that is the object of addiction, the severity of the SUD, the user’s sociocultural 
values, or the salience of environmental circumstances. Individuals come to treatment at 
different stages of change, and it is necessary to recognize where they are at in their 
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desire and intention to change, as well as what motivational factors are impeding or 
promoting change to provide the most effective, individualized treatment plan, such as 
with Motivational Interviewing (MI) in Motivational Enhancement Therapy. The motives 
for substance use questionnaire in the current study will capture facets of motives to use 
and not use and is expected to provide information that maps on to the Stages of Change.  
Motivational Enhancement Model 
MI is an effective therapeutic approach to stimulating behavioral change (Miller, 
1983). In congruence with other client-centered approaches to treatment, the fundamental 
philosophy of MI posits that the client is the expert to their own challenges and 
motivations related to substance use whereas the therapist’s role is to offer support and 
empathy, while encouraging motivation to change (Lundahl & Burke, 2009). The MI 
style respects that clients can identify why they want to use and, at the same time, 
identify reasons they do not want to use. The often-internal battle of “I want to change 
because a, b, c but I don’t want to change because x, y, z” “is both the source of 
immobilization and mobilization” to change maladaptive behavior (Rollnick & Allison, 
2004, p. 108). Motivational Enhancement Therapy (MET) utilizes MI techniques, 
incorporating personalized feedback into a brief manualized format (Ball et al., 2007; 
Miller, Zweben, DiClemente, & Rychtarik, 1992; Project MATCH Research Group, 
1993; Stephens, Babor, Kadden, & Miller 2002). Feedback has the potential to establish 
discrepancy between the client’s desire to use and not use, as well as between their use 
patterns and normative data. The realized discrepancy, and attending cognitive 
dissonance, can prompt consideration for change. Therefore, gathering pertinent data on 
motives to use, or not use substances, prior to initiating therapy, may help guide in-
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session discourse, and even allow therapy application to be more efficient. We will 
capture reasons to use and not use, as well as discrepancies in these motives, with the 
piloted questionnaire.  
Using the Addiction Syndrome Model, the Stages of Change Model, and the 
Motivational Enhancement Model as complementary components of a larger substance 
use disorder framework, one begins to understand just how complex the SUDs are. 
Arguably, the greatest complexity is in the numerous motivations to use, as is reflected in 
the extensive literature on the subject. Therapeutic approaches involving stages of change 
and motivational enhancement cannot be implemented effectively without identifying the 
motives for using, and the motives for stopping use, for the given individual in treatment. 
Given the complexity of the subject, a brief review of the literature on motivations for use 
was in order. 
Measuring Substance Use Motives 
 When assessing motivation for substance use, the literature points to somewhat 
overlapping concepts: situational contexts (i.e., cues or triggers) and cognitive 
motivations (i.e., self-identifiable reasons for using). Situational contexts may be 
recognized as circumstances in which a substance-using individual experiences an urge to 
use. The Inventory of Drinking Situations (Annis, 1982; IDS) and Drinking Context 
Scale (DCS; O’Hare 1997), for example, record the frequency in which one drinks 
alcohol in several contexts (e.g., When there were fights at home; When it’s semester 
break; When I’m at a restaurant ordering a meal). Although these measures include 
items that relate more so to cognitive motivation (e.g., When I’m having trouble relaxing 
or winding down) and the contexts nevertheless provide important data regarding 
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antecedents to use, knowledge of significant contexts does not necessarily identify the 
underlying motivation at play. Upon further examination of the first example, one cannot 
decipher from the context of fighting at home whether the individual who drinks in this 
context drinks to escape conflict with others, cope with anxiety, cope with depression, or 
to become more assertive. Although these contextual measures have been cited in the 
literature describing measures of motivations to use (e.g., Kuntsche, Knibbe, Gmel, & 
Engels, 2005), we focused from this point on measures designed to solely address 
cognitive motivations. What follows is a review of the empirical literature of published 
substance use motive measures. We begin by discussing the factor structures of available 
scales. We highlight factors that are common across different substance classes, as well 
as scale content that has thus far been uniquely tied to specific substances. We encourage 
readers to view our supplemental file for a succinct review of the existing substance use 
motives literature. Following the in-depth review, we underscore both salient item 
content addressed in published scales and motives assessed in studies of motives (i.e., 
without the utilization of published measures) to form the foundation of the hypothesized 
factor structure in the development of the MUSQ for the present study (see Table 1 for 
existing motive content falling within our hypothesized factor structure).     
Table 1  
Factors Identified in the Literature Under Hypothesized Factors & Non-Factors 
Affect Reduction/Negative Arousal (ARNA) 
ACOPE Coping with anxiety 
AFEP Anger/frustration/get away from problems or troubles 
ANF Because of anger or frustration 
CHMD* Changing mood 
COPE* Coping 
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Table 1 Continued 
DCOPE Coping with depression 
EMES Emotional escape 
ESCP Escape drinking 
FRGT To forget your worries 
LONE Loneliness 
LSE Low self-esteem 
NAF Negative affect 
NP Negative/personal 
OCC Keep me occupied 
PD Personal deficiency 
PPSY Personal psychological 
PSM Pathological/self-medication 
RLX Relaxation 
SFMED* Self-medication 
STRSS Handle stress 
SUP Suppression 
TENR Tension reduction 
UPEM Unpleasant emotions 
Affect Enhancement/Positive Arousal (AEPA) 
ALRT To become alert 
BOR Boredom 
BOR/ENR Relieve boredom/get energy 
CEL Celebration 
CHMD*  
EMEN Emotional Enhancement 
ENH Enhancement 
ENJ Enjoyment 
ENR To get more energy 
GOOD  To feel good 
PEM Pleasant emotions 
PEP Peps me up 
PLS Pleasure 
POSAF Increase positive affect 
PSYEF* Psychoactive effects 
SOC/EN* Social/enhancement 
SOC/RC* Social/recreation 
SOC/CEL* Social/celebratory 
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Table 1 Continued 
Social/Relational (SR) 
ACPT Peer acceptance 
ASRT Assertiveness power 
BEL Belonging 
CNFL Conflict with others 
CONV Convivial 
DOM Dominance power 
EMEQ Emotional equivalence with others 
FAM Family drinking 
GTFI To have a good time with others/fit in 
IMEN Image enhancement 
INH Disinhibition 
PARTY Party  
PRIM Private intimate 
PSOC Positive social 
PTWO Pleasant times with others 
SAPRTY* Stay awake to party 
SOC Social 
SOC/CEL*  
SOC/EN*  
SOC/RC*  
SOCAX Social anxiety 
SOCCOM Social comradery 
SOCF Social facilitation 
SOCINH Overcoming social inhibitions 
SOCINT Social interaction 
SOCPO To be sociable/polite 
Altered Perceptions/Experiential Processes (APEP) 
ACTEN Activity enhancement 
ALTP Altered perceptions 
CREAT Creativity  
CUR Curiosity 
EXPAN Expansion (of the mind) 
EXPER Experimentation 
FACT* Facilitate activity 
FDEN Food enhancement  
INUN To seek insights and understanding 
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Table 1 Continued 
VARY Desire for variety 
Relative Low Risk (RLR) 
ANON Concerns about anonymity/data transfer 
AVDET Avoiding detection 
LEGAL It is legal 
NGTST Get high without having a positive drug test 
PSYEF*  
PURE Greater purity 
RLR Relative low risk/safer than other drugs 
SOCACC Socially more acceptable 
TOLPREF* Better tolerability/preferred to heroin 
Functional/Self-Medication (FSM) 
ACADM Academic outcomes 
BODEN Body enhancement 
BRVAG Become brave/aggressive 
CNC Concentration 
COPE*  
COUGH To control coughing 
FACSX Facilitation of sex 
FACT*  
GW Gain weight 
ILL Illness 
LW Lose weight 
MED Medical use 
NRWL Weight lifting no longer yielded results 
NSPS Non-sexual physical sensation 
PAIN Pain 
PAIN/SLP Pain/sleep 
PERF Performance 
PHDIS Physical discomfort 
PHEF Physical effects 
SAPRTY*  
SFMED*  
SLFMNG* Prefers self-managed substitution/detox 
SLP Sleep 
SPS Sexual physical sensation 
SPTEN Enhance sport 
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Table 1 Continued 
STAWK Stay awake 
STRONG Become stronger 
STUD Study 
THERAP Therapeutic 
WITH Withdrawal 
WITHC Withdrawal/craving 
Substitution (SUB) 
NHA No (good quality) heroin available 
NPMED Does not get preferred opioid substitution treatment medication 
NSDOS Insufficient substitution dosage 
REDSTP To reduce/stop using non-prescription opioids/heroin/other drugs 
SLFMNG*  
SUB To substitute non-prescription opioids/heroin 
TOLPREF*  
Effects of Other Substances (EOS) 
ALU Alcohol use 
CNTR Counteract effects of other drugs 
DEEF Decrease effects of other substances 
INEF Increase effects of other substances 
MNGE Manage effects of other drugs 
OSU Other substance use 
Conformity/Rebellion (CR) 
CNFO Conformity 
COMP To comply with others 
OTH Others also smoke 
REBEL Rebellion 
SOCPR Social pressure to use 
Contextual/Situational (Non-Factor) 
ACCESS Easier to obtain than non-prescription opioids/heroin 
AVAIL Availability  
CHPX Prescription fee too high 
CTH Lower price than heroin 
DKDR Did not know that it was available from doctors 
DWT Difficulties with office hours/transportation efforts 
FINAN Financial reasons 
INSR No health insurance 
LAEA Limited access to cannabis/ease of access to synthetic cannabinoids 
 
11 
Table 1 Continued 
 
Gaps in the Measures of Substance Use Motivations 
Incomplete Coverage of Substances within Measures  
Several questionnaires have been designed for evaluation of motives to use one 
particular class of substances. The most common are those for alcohol use, followed by 
marijuana, and some specific to prescription medications. In addition, a few measures of 
substance use motivations examine motives in relation to several substances, but either 
omit substances of high prevalence use (e.g., marijuana) or aggregate substances that 
really do not belong together into the same class. 
 One of the earliest measures of alcohol motives, the Definitions of Alcohol Scale 
(DAS) identified two factors: social/celebratory (i.e., external/positive) and 
personal/deficiency (i.e., internal/negative) (Mulford & Miller, 1960). Subsequent 
MV Motor vehicle 
NAT No access to opioid substitution treatment 
NTHP No take-home prescription 
POSREV Positive reviews from others 
PRPCRM In preparation for a crime 
PRSN Was in prison 
PWR Problems/non-compliance with treatment regulations 
SEXAS Facilitate sexual assault 
TPC Testing personal control 
UT* Urges/temptations to use 
Unclear or Vague (Non-Factor) 
GTTH To get through the day 
HIGH Get high 
TSTGD Because it tastes good 
Addiction as a Motive (Non-Factor) 
ADD Addicted 
HAB Habit 
UT*  
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measures of drinking motives followed a similar theoretical structure, albeit assigning 
different factor names, and many expanded the range of motives. For example, the 
Reasons for Drinking Questionnaire (RDQ) factors were identified as positive 
reinforcement (social) and negative reinforcement (coping) (Farber, Khavari, & 
Douglass, 1980). Examination of motivation factors from the Drinking Motives 
Questionnaire (Cooper, Russell, Skinner, & Windle, 1992; DMQ) has yielded a three-
factor model (coping, social rewards, and affective enhancement), four-factor model 
(adding a conformity motive; Cooper, 1994), and a five-factor model differentiating 
coping with depression and coping with anxiety within college student (Grant, Stewart, 
O'Connor, Blackwell, & Conrod, 2007) and adolescent populations ( MacLean & Lecci, 
2000).  
Again, we see overlap in the content but inconsistency in factor naming across 
measures. Cronin’s (1997) content in the factors of the Reasons for Drinking Scale (RDS) 
(tension reduction, social comradery, enhancement) parallel the DMQ (1992) three-
factor model (coping, social rewards, and affective enhancement). Similarly, the DMQ 
(1994) four-factor model (coping, social rewards, affective enhancement, and conformity) 
and Carpenter and Hasin’s (1998) Reasons for Drinking Scale (RDS) (negative affect, 
social facilitation, enjoyment, and social pressure to use) display similar content. 
The drinking motive literature formed the basis for most subsequent motive 
measures extending beyond alcohol use. Simons, Correia, Carey, and Borsari (1998) 
developed the Marijuana Motives Questionnaire (MMQ) using college populations by 
modifying the DMQ and expanding the four-factor model to include a fifth factor, 
expansion (“of the mind”; e.g., I use marijuana so I can be more creative and original; I 
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use marijuana to be more open to experiences). The DMQ and MMQ address both 
positive and negative valence (i.e., attractiveness or averseness) and internal (i.e., coping, 
enhancement, expansion) and external (i.e., social, conformity) forces driving motives. 
Comparisons between marijuana and alcohol use motives using the DMQ and MMQ 
revealed significant differences in the degree of frequency of motives for each substance 
such that endorsement of marijuana frequency motives were higher than the frequency of 
alcohol motives, albeit in the same ranking order (Tkalić, Sučić, & Dević, 2013). In a 
subsequent study, Simons, Correia, and Carey (2000) demonstrated that social and 
conformity motives significantly predicted alcohol use, but not marijuana use, while 
expansion of the mind motives did not influence the prediction of alcohol use. The 
formation and validation of this fifth factor supports differential characteristics of 
motives between alcohol and marijuana use, lending to the notion that motives for using 
vary by substance type.  
More recent measures of motives for specific classes of drugs have expanded or 
collapsed factors on the DMQ and MMQ. The Opioid Prescription Medication Motives 
Questionnaire (OPMMQ) measures individuals’ motives to misuse (one’s own 
prescription) or illegally use prescription opioids (those that one does not have a 
prescription for), such as oxycodone and methadone. The OPMMQ retains the three-
factor DMQ structure and includes a fourth factor, pain (i.e., management of physical 
pain) (Jones, Spradlin, Robinson, & Tragesser, 2014). Likewise, the Prescription 
Stimulant Motives Scale (PSMS) measures individuals’ motives for illicit use and misuse 
of prescription stimulants, such as methylphenidate and amphetamines. The PSMS 
preserves the five-factor MMQ, but incorporates a sixth factor, academic outcomes (i.e., 
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to perform better in school; to study) and a seventh factor, lose weight (Blevins, 
Stephens, & Abrantes, 2016). On the other hand, the Non-Medical Prescription Drug 
Motives Questionnaire (NMPDMQ), which similarly measures illicit use and misuse of 
prescription stimulants, collapses the DMQ’s core content in the social and enhancement 
factors into a single factor (i.e., social/recreation), retains the conformity factor, 
establishes a fourth factor (i.e., performance) that parallels the PSMS’s academic 
outcomes with less specificity to school (e.g., to be more efficient; to help you stay 
organized), and combines coping with physiological discomfort (e.g., to manage pain; to 
help you sleep) and mental distress into a fifth factor (i.e., self-medication; Milner, 2015).   
The Comprehensive Marijuana Motives Questionnaire (CMMQ), developed 
specifically for marijuana use motives from open-ended participant responses, taps 
several factors for marijuana use motives: reduced inhibition related to alcohol use, 
enjoyment, conformity, coping, experimentation, boredom, celebration, altered 
perceptions, social anxiety, sleep, relative low risk (e.g., because it is safer than other 
drugs), and availability (e.g., because it is there; Lee, Neighbors, Hendershot, & 
Grossbard, 2009). Here, we see the familiar coping (i.e., coping, boredom), enhancement 
(enjoyment), social (i.e., social anxiety, celebration), and conformity motive content 
similar to that of the DMQ parsed apart, as well as shared content with the MMQ. 
Specifically, the CMMQ dissected the MMQ’s expansion factor content into 
experimentation and altered perceptions. The CMMQ included a component of physical 
discomfort in its sleep factor and introduced the relative low risk, reduced inhibition 
related to alcohol use, and availability motives for the first time in a psychometrically 
examined measure.  
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Although relatively comprehensive in capturing motives for use, the motives 
addressed with the Clinical Substance Use Motives Questionnaire (discussed below) were 
not assessed for marijuana use, despite marijuana’s high prevalence rates (Blevins, Lash, 
& Abrantes, 2018). The Reasons for Using Drugs Survey (discussed below) also 
compared motives by substance type, but combined several qualitatively different 
substances (i.e., PCP, heroin, amphetamines, psychedelics, sedatives, and codeine) as an 
“other drugs” comparison group, which limited the extent to which one can conceptualize 
motivations for these distinct substances (Novacek, Raskin, & Hogan, 1991). Indeed, 
psychedelics such as LSD and mushrooms are likely to be related to using to be more 
creative, and to a greater extent than use of sedatives. Overall, there is greater 
development of motive factors on a limited number of substances (i.e., alcohol, 
marijuana, and prescription medications), but to the degree that multiple substances are 
examined in relation to motives, they are compressed into categories of heterogeneous 
substances that limits interpretation or are limited in substances considered.  
Incomplete or Inconsistent Coverage of Motives within Measures 
Existing psychometrically examined measures do not address the breadth of 
motivations and substance types necessary to be applicable to the general substance using 
population. In fact, one of the more comprehensive studies of frequency of substance use 
motives by substance type dates back to 1986, in which high school seniors self-reported 
their motives for use of alcohol, amphetamines, barbiturates, cocaine, heroin, LSD, 
marijuana, tranquilizers, and other opioids (Johnston & O’Malley, 1986). The thirteen 
items, while wide-ranging in motive content, were not factor analyzed nor 
psychometrically evaluated, and not all items were asked in regard to each type of 
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substance. For example, the motive “to get to sleep” was a motive option for alcohol, 
barbiturates, tranquilizers, and other opioids, but not for marijuana (although sleep was a 
motive factor for the CMMQ) and “to relieve physical pain” was only available as a 
motive option for barbiturates, tranquilizers, and other opioids (but not for marijuana or 
heroin). In addition, barbiturates, as measured in Johnston and O’Malley’s (1986) study, 
have been widely replaced in accessibility with benzodiazepines since the late 1950s 
(López-Muñoz, Ucha-Udabe, & Alamo, 2005), pointing to the utility of developing a 
contemporary measure.   
The Reasons for Using Drugs Survey (RUDS) also explored motives across 
several substances: nicotine, alcohol, marijuana, and “other drugs,” which combined 
amphetamines, codeine, heroin, inhalants, PCP, and psychedelics into a single category 
(Novacek, Raskin, & Hogan, 1991). This study revealed a five-factor structure with 
content similar to the five-factor MMQ such that a belonging factor (i.e., “conformity”), 
coping factor, pleasure factor (i.e., “enhancement”) and creativity factor (i.e., 
“expansion”) were present, with an aggression factor instead of a “social” factor. Here, 
the coping factor included coping with both emotional problems and physical problems 
(e.g., to lose weight; for physical pain). Although most content in the creativity factor 
was similar to the expansion factor in the MMQ, one item (i.e., to help me do my 
schoolwork better) was reflected in the academic (PSMS) and performance (NMPDMQ) 
factors in measures of prescription stimulant motives. Aggression as a motive has been 
examined in the anabolic steroid use literature (Petersson, Bengtsson, Voltaire-Carlsson, 
& Thiblin, 2010), but in the context of using to feel brave and physically aggressive 
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rather than using for self-destruction and to emotionally hurt others as described in the 
RUDS measure.   
Several studies have used the scale name “Drug Use Motives Questionnaire” 
(DUMQ) to describe a substance use motive measure that applies to all substances of use; 
however, such studies have only used the three-factor and four-factor items of the DMQ 
and simply changed the instructions to indicate all substance use, instead of alcohol use 
(Mueser, Nishith, Tracy, DeGirolamo, & Molinaro, 1995; Scott, Hides, Allen, & 
Lubman, 2013), or used a variation of the DMQ and added an illness factor (i.e., related 
to coping with psychological symptoms such as psychosis and suicidality, or side effects 
of psychotropic medication) (Spencer, Castle, & Michie, 2002; Thornton, Baker, 
Johnson, Kay-Lambkin, & Lewin, 2012).  
Recently, the Clinical Substance Use Motives Questionnaire (CSUMQ) was 
developed to address motives for alcohol, cocaine and other stimulants, and opioid use 
(Blevins, Lash, & Abrantes, 2018). The CSUMQ yields an eight-factor structure. Similar 
to the five-factor DMQ, the CSUMQ differentiates coping with anxiety and coping with 
depression into two separate factors. Unlike the DMQ, social and enhancement content 
are combined into one factor (social/enhancement) and a single item reflects conformity 
within the social/enhancement factor (i.e., because it is what most of my friends do when 
we get together). Other factors derived from this measure include boredom/energy, 
pain/sleep, loneliness, other substance use, and withdrawal. The CSUMQ’s other 
substance use factor combines the content from the CMMQ’s reduced inhibition related 
to alcohol use (but generalizes to being under the influence of “another substance”) and 
content related to managing the effects of other substances, which was considered in 
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Johnston and O’Malleys (1986) early study and in studies of nicotine use motives 
(Pederson, Bull, Ashley, & MacDonald, 1996), synthetic cannabinoid use motives 
(Bonar, Ashrafioun, & Ilgen, 2014), and several opioid use motive analyses (Boyd, 
McCabe, Cranford, & Young, 2006; McCabe, Cranford, Boyd, & Teter, 2007; Teter, 
McCabe, Cranford Boyd, & Guthrie, 2005; Teter, McCabe, LaGrange, Cranford & Boyd, 
2006). This measure was the first psychometrically evaluated measure, to the author’s 
knowledge, to include using to relieve withdrawal symptoms as a motive.  
Incomplete Application of Motives within Measures 
Thus far, we have illustrated the inconsistencies in factor labeling and content 
grouping among existing motive measures. As previously mentioned, many of the 
psychometrically evaluated motive measures in the literature do not address relevant 
motivations that are likely applicable to the specific substance measured or miss the 
opportunity to evaluate additional substances that are expected to be used for the 
motivations measured.  
Altered Perceptions and Experiential Processes Motive Inconsistencies. Content 
related to altered perceptions and experiential processes motives have been considered in 
factor analyzed measures of motives for prescription stimulants (Blevins, Stephens, & 
Abrantes, 2017) and marijuana (Lee, Neighbors, Hendershot, & Grossbard, 2009; Lee, 
Neighbors, & Woods, 2007; Simons, Correia, Carey, & Borsari, 1998). Unfortunately, 
the CSUMQ, which aimed to address motives for use of multiple substance classes failed 
to consider these motives. While the multi-substance RUDS included content related to 
experiential processes, it lacked motives related to altered perceptions (Novacek, Raskin, 
& Hogan, 1991). In addition, the MMQ’s expansion factor for marijuana use includes 
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content addressed by the RUDS’s creativity factor as well as content in the CMMQ’s 
altered perceptions factor. Based on the literature, it seems likely that a comprehensive 
factor of altered perceptions and experiential processes would likely extend to other 
hallucinogenic “mind opening” substance use.  
Coping and Self-Medication Motive Inconsistencies. Coping and variants of self-
medication, as factors, have been inconsistently applied to coping with emotional pain, 
bodily discomfort and discontent, or both (e.g., Spencer, Castle, & Michie, 2002). Both 
emotional and physical/physiological discomfort and discontent should be addressed but 
would likely load on separate factors.  
Affective Coping Motive Inconsistencies. Coping with emotional pain, commonly 
considered in the context of feelings of depression and anxiety, has always been 
considered as a fundamental motive for users of a variety of substances. That is one 
reason why we often see the spiraling nature of addiction in which either using the 
substance or emotional pain comes first and each influence and perpetuate the other. 
Although one may consider using to cope with negative emotions as a self-medication 
motive, this motive is likely differentiated from those related to relieving physical and 
physiological discomfort and discontent by labeling the hypothesized factor for emotional 
coping content, affect reduction/negative arousal. Many labels have been used to 
describe this factor in the literature (e.g., unpleasant emotions; emotional escape) and 
several have included more nuanced facets of negative emotions (e.g., loneliness; low 
self-esteem; coping with anxiety; coping with depression) that likely aggregate as facets 
of a single factor. 
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Functional or Self-Medication Motive Inconsistencies. Motives related to using 
substances to alleviate or self-medicate physical and physiological discomfort or 
discontent, on the other hand, would likely load onto a functional/self-medication factor. 
Indeed, several factors emerging on the OPMMQ, PSMS, and NMPDMQ measures 
appear to cluster into a functional/self-medication factor, in that using a substance for its 
inherit effects or as a self-administered treatment of symptoms would encompass these 
motives. Self-medication was recognized as a motive factor in the NMPDMQ but 
included items related to both coping with negative emotions (i.e., because it helps you 
when you feel depressed or nervous) and managing physical problems (i.e. pain and 
sleep) (Milner, 2015). Performance (i.e. to help focus; to perform better on schoolwork 
or on tests), too, was parsed out as a separate factor; however, we hypothesized that these 
motives would group under a functional/self-medication factor. Although these motive 
measures were designed to assess prescription drug use, many functional/self-medication 
motives may be pertinent to their non-prescription drug counterparts (e.g., 
methamphetamine may similarly be used to help focus as Adderall, and alcohol may be 
used to help with falling sleep).  
Affect Enhancement Motive Inconsistencies. Emotional enhancement motive 
content has surfaced in many of the existing measures through a single enhancement 
factor, sharing content similar to other measures’ pleasure and enjoyment factors, and in 
combination with other social and relational content such as in the social/enhancement 
and social/recreation factors. Emotional enhancement motive content has also been 
lumped with coping with negative emotions content in a study comparing motives for 
cannabis, alcohol, cocaine, LSD, ecstasy, and amphetamine use (Boys, Marsden, & 
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Strang, 2001). Based on the literature, emotional enhancement content in the present 
measure would likely load onto a factor of affect enhancement/positive arousal.  
Arousal Motive Inconsistencies. One domain of motive content, effects on arousal 
(e.g., to get energy; to increase alertness; to relieve boredom; to relax; to relieve tension), 
has been commonly considered within motives but inconsistently loaded onto coping, 
enhancement, and performance factors, or has been parsed into its own factor. Although 
the development of the present measure was exploratory in nature, we hypothesized that 
arousal motives would load onto both affect reduction/negative arousal and affect 
enhancement/positive arousal due to the large association between arousal and emotion 
(Scherer, 2005). That is, using substances to increase arousal and stimulation was 
hypothesized to load onto affect enhancement/positive arousal, whereas using to decrease 
arousal and stimulation was hypothesized to load onto affect reduction/negative arousal.  
Social Interaction Motive Inconsistencies. Nearly all studies of substance use 
motivations have measured social and relational motives. Many, such as the four- and 
five-factor DMQ, MMQ, PSMS, NMPDMQ, and CMMQ, considered enhancing social 
experience motives (e.g., to have a good time with others; to feel more confident around 
others; to celebrate with others) separately from motives to use to conform to others 
(e.g., to be cool; did not want to be the only one not doing it; felt pressure from others to 
do it).  One study examining the prevalence of synthetic cannabinoid use motives, 
however, addressed these motivations in a double-loaded item: To have a good time with 
friends or to fit in (Bonar, Ashrafioun, Ilgen, 2014). A qualitative study of club drug use 
motives revealed a social interaction theme and the researchers considered this theme to 
encompass both social facilitation and social acceptance motives (Jerome, Halkitis, & 
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Siconolfi, 2009). A social/relational motive factor would likely emerge from the data and 
would contain facets of motives influenced by relationships, including social facilitation 
and social enhancement.  
Social Adherence Motive Inconsistencies. Content related to using to rebel against 
the law, society, and social norms has rarely been examined in the literature. Indeed, the 
pilot study for the CMMQ revealed rebellion as a self-identified motivation, but the 
content did not hold in the follow-up study used to factor analyze the original participant 
self-identified salient content (Lee, Neighbors, Hendershot, & Grossbard, 2009). This 
content may load onto a bipolar dimensional conformity/rebellion factor, such that 
motives would range from using to follow the crowd (whether an adaptive or maladaptive 
social circle) to using to deliberately challenge expectation of society at large or proximal 
others. Conformity and rebellion content would likely be more salient for those in the 
early stages of substance use than for those with more severe substance use disorders, as 
conformity motive endorsement has demonstrated a negative correlation with alcohol use 
frequency and quantity among adolescents (Cooper, 1994); on the other hand, those who 
endorse more rebellion motives may have more substance use problems, as those who use 
alcohol to rebel may do so with a socially aggressive conviction according to Alexander 
(1967). 
Relative Low Risk Motive Inconsistencies. Relative low risk has been identified as 
a motive for synthetic cannabinoid use (Bonar, Ashrafioun, Ilgen, 2014; Loeffler, 
Delaney, & Hann, 2016), kratom use (a currently-legal gas station- and internet-sold 
substance with both stimulant and opioid-like effects) (Smith & Lawson, 2017), non-
prescribed opioid substitution use (e.g., methadone; Schulte et al., 2013) and several 
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studies of prescription medication misuse (e.g., Boyd, McCabe, Cranford, & Young, 
2006; McCabe, Cranford, Boyd, & Teter, 2007; Teter, McCabe, Cranford, Boyd, & 
Guthrie, 2005). Surprisingly, a relative low risk factor has emerged only in a 
psychometrically evaluated measure for cannabis use (CMMQ) but was not considered in 
measures designed to evaluate prescription medication motives (i.e., OPMMQ, PSMS, 
NMPDMQ). Thus, some substances that may be legal in some contexts (i.e., marijuana, 
alcohol, prescription medications) or perceived to be more socially acceptable may be 
perceived as “safer” than other drugs or easier to hide from detection by others (e.g., in 
the case of a urine drug screen for synthetic cannabinoids) and this may be a motivation 
for their use. In addition, content related to relative low risk may include using substances 
because they are viewed as “purer” without unknown contaminants used to cut the 
product or using a regulated substance because its contents are legitimized. Lastly, using 
a substance because it causes less side effects, has less health risks, or because one has a 
better tolerance to the substance at hand compared to another also relates to relative low 
risk motives. This motive may be under-valued in present psychometrically evaluated 
measures and may be a relevant motive for several substances, including those that may 
be medically prescribed, legal to use, or culturally accepted.  
Substitution Motive Inconsistencies. Johnston and O’Malley (1986) were among 
the first to identify the motive to use for substance substitution. Again, only asking 
participants a limited range of motives per substance, the motive “as a substitute for 
heroin” was asked only in reference to using “other opiates” (Johnston & O’Malley, 
1986, p. 41). Similarly, Schulte and colleagues (2013) found that common motives for 
use of non-prescribed opioid substitution treatments (e.g., methadone) included to use 
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something that has better quality than the available heroin, to use one’s preferred opioid 
substitution treatment medication, and to obtain sufficient substitution medication 
dosage. Substitution motives have also been identified in the synthetic cannabinoid 
(Loeffler, Delaney, & Hann, 2016) and kratom use (Smith & Lawson, 2017) literature. In 
Loeffler and colleagues’ review of motives for synthetic cannabinoid use, using to reduce 
use of marijuana was cited as a significant motive. Kratom, on the other hand, was found 
to be significantly related to the motive of using to substitute heroin or other opioid use. 
Arguably, substituting one substance for another may be a motivation for use of all 
substances for both those attempting to quit or reduce use of one substance, or to get the 
same effects as another substance when it is not available.   
Effects of Other Substances Motive Inconsistencies. A common, yet inconsistently 
addressed motive domain in the literature involves the effects of other substances. The 
CMMQ includes an alcohol use motive factor, which includes content related to using 
because one is under the influence of alcohol and did not make the decision to use with a 
sober mind (Lee, Neighbors, Hendershot, & Grossbard, 2009). This content was also 
salient in the nicotine use motives literature (i.e., smoking because drinking; Pederson, 
Bull, Ashley & MacDonald, 1996). Other motives concerning the effects of other 
substances have related to managing the effects of other substances. Examining motives 
for cannabis, alcohol, cocaine, LSD, ecstasy, and amphetamine use, Boys, Marsden, and 
Strang (2001) included content related to using a substance to enhance the effects of other 
substances and help manage the “after effects” (i.e., the “come down”) from other 
substances in a manage effects of other substances subscale (although the total scale was 
not factor analyzed to create this subscale). Looking at synthetic cannabinoid motives, 
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Bonar, Ashrafioun, and Ilgen (2014) found that 32 percent of inpatient rehabilitation 
patients identified using to increase or decrease the effects of some other drugs as a 
motive for their use. Johnston and O’Malley’s (1986) early study split this content into an 
item measuring using to increase effects of other substances and an item measuring using 
to decrease effects of other substances. Several studies in the prescription misuse motive 
literature identified using to counteract the effects of other substances as a motive (Boyd, 
McCabe, Cranford, & Young, 2006; Teter, McCabe, Cranford, Boyd, & Guthrie, 2005; 
Teter, McCabe, LaGrange, Cranford, & Boyd, 2006). An other substance use factor 
emerged in the factor analyzation of the CSUMQ’s factor structure, encompassing both 
motives to use because one is under the influence of another substance and to counteract 
the effects of other substances (Blevins, Lash, & Abrantes, 2018). Compared to the 
CMMQ, the CSUMQ is more comprehensive in its measure of specific motives related to 
the effects of other substances, both in its generalization of using because one is under the 
influence of another substance (as opposed to the influence of only alcohol) and its 
inclusion of using to counteract the effects of other substances; however, a general effects 
of other substance factor would likely emerge by including more nuanced items such as 
in Johnston and O’Malley’s (1986) and Boys, Marsden, and Strang’s (2001) studies (e.g., 
to reduce the effects of another drug; to enhance the effects of another drug; to ‘come 
down’ off of another drug) in addition to using because one is under the influence of 
another substance. Furthermore, we included other relevant motives related to using to be 
able to use another drug for a longer period of time, as well as using to alleviate side 
effects of medications, which have been considered in illness factors in variations of the 
DUMQ (Spencer, Castle, & Michie, 2002; Thornton et al., 2012). Effects of other 
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substances motives would likely be pertinent for use of all substances but would 
demonstrate a positive relationship with frequency of use, such that those who use 
substances more often will use to counteract and manage effects of other substances, as 
well as use because of intoxication with other substances. Indeed, in a study of 
prescription stimulant use motives the findings suggested that using prescription 
stimulants to counteract the effects of other substances became a more prominent motive 
as participants’ frequency of prescription stimulant use increased (Teter et al., 2005)     
Incomplete Coverage of the Constituents of Motives 
To date, the vast majority of studies of motives have used frequency ratings to 
measure the frequency at which one uses for a given motive. Some measures of substance 
use motives have assessed motives utilizing dichotomous measures of applicability to the 
user (i.e., yes/no; e.g., Bailly, Carman, Forslund, 1991), while most used single Likert-
type frequency scales (e.g., how often do you drink for this reason – ranging from 1 
[almost never/never] to 5 [almost always/always]; Grant et al., 2007). While other 
constituents of motives will be discussed below and warrant consideration, measuring the 
frequency at which one uses for a given reason has yielded important concurrent 
predictions of substance use-related problems, SUD severity, and substance use 
frequency and quantity.  
Affect Enhancement Motives and Predictions. Specifically, using more often for 
enhancement/enjoyment motives has predicted increased alcohol use frequency and 
quantity (Grant et al., 2007), past 6 month marijuana use (Simons, Correia, Carey, & 
Borsari, 1998), number of prescription opioid pills taken in the past 3 months, number of 
prescription opioid pills taken in a typical day, and frequency of prescription opioid use 
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in the past 3 months (Jones, Spradlin, Robinson, & Tragesser, 2014), and is positively 
correlated with past 90-day marijuana use frequency (Lee, Neighbors, Hendershot, & 
Grossbard, 2009) and more frequent misuse of prescription opioids (Jones, Spradlin, 
Robinson, & Tragesser, 2014). Increased use of marijuana for enhancement motives 
predicted greater likelihood of abuse/dependence; however, using more often for 
enhancement motives has predicted less use-related negative consequences ((Lee, 
Neighbors, Hendershot, & Grossbard, 2009). With regard to prescription opioids, on the 
other hand, using more often for enhancement motives has predicted more use-related 
negative consequences (Jones, Spradlin, Robinson, & Tragesser, 2014). With prescription 
stimulant use, using more often for enhancement motives was associated with more use-
related negative consequences (Blevins, Stephens, & Abrantes, 2016). Indeed, the 
enhancement factor captured in the RUDS positively correlated with frequency of 
alcohol, marijuana, and “other drug” use (Novacek, Raskin, & Hogan, 1991).  
Social Interaction Motive Predictions. Some studies have identified factors that 
combined enhancement content with social content (i.e., social/recreation; 
social/enhancement). These studies suggested using more often for these motives 
predicted increased frequency of non-medical prescription drug use (Milner, 2015) and 
number of SUD symptoms in the context of alcohol, opioid, and stimulant use (Blevins, 
Lash, & Abrantes, 2018). More frequent use for social/recreation motives is associated 
with increased lifetime non-medical prescription drug use and use-related problems 
(Milner, 2015). Using alcohol more often for social motives has predicted higher 
drinking frequency and quantity, but to a lesser extent than using for enhancement 
motives (Grant et al., 2007). In the context of marijuana use, using more often for social 
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reasons predicted higher frequency of marijuana use-related problems when accounting 
for lifetime use and gender (Simons, Correia, Carey, & Borsari, 1998). While the MMQ 
does not include a social motives factor, per se, using marijuana more often for 
celebration and social anxiety motives has yielded significant positive correlations with 
marijuana use frequency and use-related problems (Lee, Neighbors, Hendershot, & 
Grossbard, 2009). Using prescription opioids more often for social reasons positively 
predicted the typical number of pills ingested in a day and frequency of use in the past 3 
months; however, social reasons were not correlated with frequency of misusing 
prescription opioids (Jones, Spradlin, Robinson, & Tragesser, 2014). Using prescription 
stimulants more often for social reasons was correlated with more use-related negative 
consequences and higher frequency of use (Blevins, Stephens, & Abrantes, 2016).  
Conformity Motive Predictions. Using substances more often for social belonging 
reasons (i.e., encompassing both social acceptance and conformity content) has related to 
less frequently using alcohol, marijuana, and “other drugs.” Using for these reasons was 
found to be more typical for those who use alcohol only and those who use other drugs 
only, but not those that use both (Novacek, Raskin, & Hogan, 1991). Using alcohol more 
frequently for conformity motives has predicted less frequent drinking and quantity 
overall (Grant et al., 2007). While accounting for lifetime marijuana use and gender, 
Simons and colleagues (1998) found increased use for conformity motives to predict 
increased use-related problems. In another study of marijuana use motives, using more 
frequently for conformity motives was positively correlated with use-related problems, 
but was not related to frequency of marijuana use (Lee, Neighbors, Hendershot, & 
Grossbard, 2009). For prescription stimulant use, using more for conformity reasons 
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predicted less use-related consequences (Blevins, Stephens, & Abrantes, 2016). In regard 
to all non-medical use of prescription medications, increased use for conformity reasons 
demonstrated a small correlation with increased overall use, recent use, and use-related 
problems, but not lifetime use; however, conformity did not significantly predict 
frequency of non-medical prescription medication use when accounting for race, age, 
gender, and frequency of other substance use (Milner, 2015). Lastly, the frequency of 
using for conformity motives was found to be higher for marijuana users compared to 
alcohol users (Spencer, Castle, & Michie, 2002).  
Arousal Motive Predictions. Using marijuana more often to alleviate boredom has 
significantly positively predicted frequency of marijuana use and is associated with more 
use-related consequences (Lee, Neighbors, Hendershot, & Grossbard, 2009). In addition, 
using opioids, alcohol, and stimulants more often to alleviate boredom and get energy 
has significantly positively predicted more SUD symptoms (Blevins, Lash, & Abrantes, 
2018).  
Affective Coping Motive Predictions. Grant and colleagues’ (2007) findings 
suggested that using alcohol more frequently for coping with depression reasons 
positively predicted drinking quantity while coping with anxiety positively predicted use-
related problems. Using marijuana more often for coping reasons has significantly 
predicted increased marijuana use in the past 6 months and use-related consequences, and 
has been correlated with increased past 90-day use and use-related consequences 
(Simons, Correia, Carey, & Borsari, 1998; Lee, Neighbors, Hendershot, & Grossbard, 
2009). Using prescription opioids more often for coping reasons has predicted increased 
number of pills ingested in a day, frequency of use in the past 3 months, and use-related 
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consequences. In addition, prescription opioid coping use was positively correlated with 
frequency of misuse (Jones, Spradlin, Robinson, & Tragesser, 2014). For opioid, alcohol, 
and stimulant use, one study found a positive correlation between use for coping with 
depression reasons and SUD symptoms, while use for coping with depression and coping 
with anxiety reasons were positively correlated with frequency of alcohol use in a given 
week. More frequent stimulant use was associated with less use for coping with anxiety 
motives. In this sample, using to cope with anxiety was more characteristic of alcohol 
users than cocaine users, but differences between alcohol users and opioid users were not 
found (Blevins, Lash, & Abrantes, 2016). Spencer and colleagues (2002) suggested that 
using substances more often for coping reasons positively predicted quantity of use, 
dependence, and use-related problems. In this study, coping motives were more frequent 
for marijuana users compared to alcohol users. Milner’s (2016) NPDMQ measure 
combined self-medication for the function of substance (e.g., to reduce pain) with affect 
self-medication (i.e., coping) into a self-medication motive factor. Here, non-medical use 
of prescription medication use for more self-medication reasons predicted more frequent 
use in the past 6 months and use-related problems (after accounting for frequency of use; 
Milner, 2016).  
Functional or Self-Medication Motive Predictions. Other facets of self-medication 
motives used to predict substance use patterns include sleep/rest, pain, weight loss, 
performance, withdrawal, illness and pain/sleep motives. Using marijuana more 
frequently for sleep/rest reasons has been positively correlated with frequency of use and 
use-related problems. Sleep/rest motives predicted higher frequency of use and, after 
accounting for frequency of marijuana use, sleep/rest significantly positively predicted 
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use-related problems (Lee, Neighbors, Hendershot, & Grossbard, 2009). In regard to 
prescription opioid use, using more often to relieve pain positively predicted frequency of 
use in the past 3 months and use-related problems; however, pain motives were not 
correlated with misuse.  Using prescription stimulants more often for weight loss 
purposes was correlated with and predicted more use-related negative consequences; 
however, weight loss motives did not significantly predict frequency of use. Non-medical 
use of prescription medications for performance reasons significantly predicted higher 
frequency of use in the past 6 months and was correlated with increased frequency, use-
related problems, and more recent use (Milner, 2015). Using alcohol, opioids, and 
stimulants more frequently for relief or avoidance of withdrawal symptoms significantly 
predicted more SUD symptoms. Both withdrawal and pain/sleep motives were positively 
correlated with more opioid use. While withdrawal motives were found to be more 
common for opioid users compared to stimulant and alcohol users, alcohol and opioid 
users used for withdrawal purposes at approximately the same frequency. In addition, 
using for pain/sleep reasons was more characteristic of alcohol and opioid use compared 
to stimulant use (Blevins, Lash, & Abrantes, 2018). Lastly, using substances to relieve 
the positive symptoms of psychosis or side effects of other medications (i.e., the illness 
motive factor) was found to significantly predict greater likelihood of dependence 
(Spencer, Castle, & Michie, 2002).  
Altered Perception or Experiential Processes Motive Predictions. Using alcohol, 
marijuana, and “other drugs” for creativity reasons was correlated with less frequent 
alcohol use but more frequent other substance use (Novacek, Raskin, & Hogan, 1991). 
Prescription stimulant use for expansion (of the mind) motives was correlated with and 
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predicted more use-related consequences (Blevins, Stephens, Abrantes, 2016). In regard 
to marijuana use, using more often for altered perceptions was significantly positively 
associated with frequency of use and use-related problems, while using for 
experimentation purposes was negatively associated with frequency of use and not 
related to use-related problems. Using marijuana for altered perceptions motives 
predicted greater likelihood of substance abuse and dependence, while experimentation 
predicted a lower likelihood of meeting criteria (Lee, Neighbors, Hendershot, & 
Grossbard, 2009).  
Relative Low Risk Motive Predictions. Relationships between relative low risk 
motive measure scores and substance use patterns have only been examined in the 
context of marijuana use. Using marijuana more frequently for relative low risk reasons 
was significantly correlated with and predicted higher frequency of marijuana use and 
was correlated with more use-related problems (Lee, Neighbors, Hendershot, & 
Grossbard, 2009).  
Effects of Other Substances Motive Predictions. Similarly, using in relation to the 
effects of other substances (i.e., to counteract or enhance the effects, or due to being 
under the influence of a substance), has only been examined in motive measures for 
marijuana use (Lee, Neighbors, Hendershot, & Grossbard, 2009) and in the context of 
alcohol, opioid, and stimulant use (Blevins, Lash, & Abrantes, 2018). Using a substance 
more often because of the effects of other substances has only demonstrated relationships 
with substance use patterns for marijuana. Specifically, using marijuana more often 
because one is under the influence of alcohol was related to more use-related 
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consequences, but not marijuana use frequency (Lee, Neighbors, Hendershot, & 
Grossbard 2009).  
Substitution Motive Predictions. Another motive factor, availability (i.e., using 
because it’s readily available), has been tested in relation to marijuana use patterns, but 
was not correlated with frequency of use or use-related problems; however, using more 
often for availability purposes negatively predicted frequency of use (Lee, Neighbors, 
Hendershot, & Grossbard, 2009). Interestingly, using substances for substitution purposes 
(i.e., to replace one substance with another) has not been studied in relation to use-related 
patterns.  
In summary, different substance use patterns have been differentiated by salient 
motives, and those motives primarily have been measured in terms of frequency of use in 
regard to that motive. Measuring motives in terms of frequency of use for a given motive 
has demonstrated concurrent validity, primarily with predicting use-related negative 
consequences, SUD severity, lifetime and current frequency of use, and frequency of 
misuse (i.e., of prescription medications). In addition, the research to date has identified 
substance classes that differed in terms of salient motives measured in terms of frequency 
of use for a given motive.  
Salient Motives by Substance. Prominent motives for alcohol use have included 
coping with both anxiety and depression, affective enhancement, to have a good time 
with others, to increase confidence, to sleep, to relax or relieve tension, to relieve 
boredom, to improve the effects of other substances, and to manage the after effects (i.e., 
“come down”) of other substances (Blevins, Lash, & Abrantes; Boys, Marsden, & Strang, 
2001; Johnston & O’Malley, 1986; Mueser, Nishith, Tracy, DeGirolamo, & Molinaro, 
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1995; Novacek, Raskin, & Hogan, 1991; Thornton, Baker, Johnson, Kay-Lambkin, & 
Lewin, 2012). Prominent motives for marijuana use have included coping with negative 
affect, affective enhancement, to conform, to gain social acceptance, to have a good time 
with others, to relax or relieve tension, to relieve boredom, to enhance an activity, to 
sleep, to emotive the effects of other substances, and to manage the after effects of other 
substances (Boys, Marsden, & Strang, 2001; Johnston & O’Malley, 1986; Novacek, 
Raskin, & Hogan, 1991; Spencer, Castle, & Michie, 2002; Thornton, Baker, Johnson, 
Kay-Lambkin, & Lewin, 2012). Further, Boys and colleagues’ (2001) suggested that 
marijuana was the predominant substance used for improving effects of other substances 
and managing the after-effects of other substances compared to alcohol and other 
substances. Salient motives for LSD use have included using to have a good time with 
friends, to relieve boredom, to have deeper insights, to experiment, to enhance affect, and 
to enhance activities (Boys, Marsden, & Strang, 2001; Johnston & O’Malley, 1986). The 
literature suggests that cocaine is mostly used for having a good time with others, 
increasing energy, staying awake, increasing one’s confidence, and affective 
enhancement, while it is specifically used less often for coping with anxiety (Blevins, 
Lash, & Abrantes, 2018; Boys, Marsden, & Strang, 2001; Johnston & O’Malley, 1986). 
Quite similarly, amphetamines have been found to be predominantly used to increase 
energy, stay awake, enhance activities, enhance affect, to improve the effects of other 
substances, to lose weight, and for having a good time with others (Boys, Marsden, & 
Strang, 2001; Johnston & O’Malley, 1986). Prominent motives for ecstasy use have 
included using to enhance activities, stay awake, lose weight, and enhance affect (Boys, 
Marsden, & Strang, 2001). Opioids, in general, have been specifically linked to using to 
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alleviate or avoid withdrawal symptoms, to cope with negative affect, to alleviate pain, 
and to sleep (Blevins, Lash, & Abrantes, 2018; Johnston & O’Malley, 1986). The 
literature suggests prescription opioids are mostly used to relax or relieve tension, to 
party, to relieve pain, to sleep, to cope with anxiety, to experiment, to counteract the 
effects of other substances, and because they are perceived as safer than other substances 
(Bennett & Holloway, 2017; Boyd, McCabe, Cranford, & Young, 2007; Johnston & 
O’Malley, 1986). Prescription stimulants have been found to be predominantly used to 
experiment, lose weight, to increase alertness, to help with studying or help with 
academics, to concentrate, to stay awake, to party, to enhance sport performance, to 
counteract the effects of other substance, and because they are perceived as safer than 
other substances (Bennett & Holloway, 2017; Boyd, McCabe, Cranford, & Young, 
2007). Prescription sleep medications have been specifically linked to using to sleep, 
cope with anxiety, to experiment, to counteract the effects of other substances, and 
because they are perceived as safer than other substances (Boyd, McCabe, Cranford, & 
Young, 2007). Sedatives and anxiolytics have been found to be predominantly used to 
sleep, cope with anxiety, counteract the effects of other substances, and because they are 
perceived as safer than other substances (Bennett & Holloway, 2017; Boyd McCabe, 
Cranford, & Younge, 2007). Lastly, salient motives for tranquilizer use have included 
using to cope with anxiety, sleep, counteract the effects of other substances, and to self-
medicate ADHD symptoms (Bennett & Holloway, 2017).  
Beyond Frequency 
As reviewed above, frequency of use for a particular substance, for a particular 
motive, is well developed in the literature. However, we posit that motivations to use 
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substances are far more complex than can be represented by measuring frequency alone 
and can be further assessed via conscious cognitive processes and evaluation of one’s use 
to achieve or satisfy a given motive. Specifically, we aim to provide more rich data than 
have been obtained thus far by measuring motives in relation to wanting, liking, and 
satisfaction.  
Robinson and Berridge (1993), by way of the Incentive-Sensitization Theory, 
established a discrepancy between liking and wanting substances as distinct reward 
mechanisms that a person is not directly aware of: Substance users, in the early stages of 
use, experience hedonistic (i.e., liking) motives to use, whereas more experienced users 
shift to wanting, or craving use even when using results in disappointment or 
dissatisfaction. Findings suggest, for some individuals, repeated exposure to a substance 
changes the brain’s mesocorticolimbic system and results in hypersensitivity to 
incentivizing effects (e.g., to feel more social around others; to experience euphoria) and 
substance-related stimuli (e.g., paraphernalia; bars; substance-using friends) (see 
Berridge & Robinson, 2016 for review). It is understood that Robinson and Berridge’s 
concepts of liking and wanting are subconscious, objective processes that differ from the 
more cognitive, goal-directed, and subjective liking and wanting (Robinson, Fischer, 
Ahuja, Lesser, & Maniates, 2015). These subconscious liking and wanting responses are 
differentiated by the key role of dopamine stimulation, such that manipulation of 
dopamine action influences intensity of wanting, but not liking. On the other hand, 
cognitive wanting is proposed to be comparatively unaffected by manipulation of 
dopamine (Dickinson, Smith, Mirenowicz, 2000). Although the cognitive and 
subconscious processes often accompany one another, the cognitive and subconscious 
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wanting constructs, at times, conflict (Berridge & Robinson, 2016). This may occur when 
someone recovering from a severe SUD still craves their substance of choice when 
presented with triggering cues despite a strong conscious desire not to use and maintain 
the benefits of sobriety.  
The distinction between the wanting and liking processes, that an individual is not 
directly aware of, and conscious cognitive processes suggests that more objective 
measures of subconscious processes (e.g., brain imaging and facial muscle activity) 
would be preferable in studies testing the Incentive-Sensitization Theory. However, in 
humans, researchers have often utilized self-report, subjective measures of wanting and 
liking derived from the Drug Effects Questionnaire.  These constructs were measured by 
asking participants “do you like the effects you’re feeling right now?” (liking) and “do 
you want more of what you consumed, right now?” (wanting; Evans et al., 2006; Leyton 
et al., 2002; Smith, Dang, Cowan, Kessler, Zald, 2016). Acknowledging the division of 
subconscious and conscious processes, the proposed measure aimed to index individuals’ 
cognitive interpretations of wanting substances (i.e., the degree to which one craves or 
feels compelled to use when thinking about a substance or remembering substance using 
cues). In addition, the measure collected data on cognitive interpretations of liking for 
specific reasons to use. To the author’s knowledge, subjective measures of substance 
liking have only been directed to the actual substance (i.e., how much do you like the 
effects of this drug) as opposed to the degree that one likes that they use a substance to 
achieve a given motive. Further, wanting substances is often described in the literature as 
such a salient drive, in the later stages of addiction, that it sometimes prevents actual 
satisfaction from use (or occurs even when the effects of use no longer meet one’s 
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expectations; Berridge & Robinson, 2011; Berridge & Robinson, 2016; Robinson & 
Berridge, 1993); however, satisfaction from substance use has yet to be measured in the 
wanting and liking context. We aimed to measure liking and satisfaction in terms of the 
degree to which one likes that they use a substance to achieve a given motive and the 
degree of satisfaction (i.e., fulfilment) of that motive via use, respectively.  
Collecting information beyond simply the frequency at which one uses for a given 
motive would potentially better inform identification of intervention points for behavior 
change. This allows us to index one’s cravings – what is driving them to use. It further 
allows examination of information that could be targeted for intervention: For example, 
does the individual like that they use alcohol to cope with depression? Responses here 
allow us to understand more accurately where they stand on the Stages of Change. Those 
in the earlier stages (i.e., precontemplation) may not see a problem with their use and find 
it personally acceptable to use for an endorsed reason such as this. These individuals will 
likely engage in more sustain talk (i.e., expressing desire to maintain substance use 
behavior). On the other hand, those that indicate more dislike with using to achieve this 
motive may be in the contemplation or later stages and may be more inclined to engage in 
change talk (i.e., expressing desire to change substance use behavior; Arkowitz, Miller, & 
Rollnick, 2015). Intervention strategies such as Motivational Enhancement Therapy may 
utilize these data, along with satisfaction ratings, to guide an individual to notice 
discrepancies between reasons to use and not use when the data indicate that motives to 
use are not being satisfied by substance use. Looking again at our example of using 
alcohol to cope with depression, one could further explore whether alcohol use is actually 
helping alleviate symptoms of depression (i.e., satisfying the motive to reduce feelings of 
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depression) and consider whether there may be more adaptive ways to combat these 
symptoms. While measuring the frequency at which one uses for a given motive may 
enlighten us about using in general, measuring liking and satisfaction may relate more to 
a specific individual’s motives for using in the context of their addiction. 
The Present Study  
In alignment with MI and the MET model, the authors proposed an assessment 
tool that comprehensively captures the common motives to use substances – assessing the 
relevance, in terms of relative strength, of each motive factor for any given individual. 
Several measures of specific motives have been developed and researched previously; 
however, existing measures have either been limited in their breadth of motivations to use 
or have been applied to one substance or a narrow list of substance types. Existing 
measures have also only examined motives for substance use by measuring the frequency 
at which one uses for a given motive. We intended to include motives that have been 
selectively included in some measures that are likely applicable to other substances not 
measured and reduce the inconsistency in item content and factor labeling across 
measures. Moreover, we expanded the measurement of motives to incorporate additional 
components of motivation relevant to substance use, allowing a more comprehensive 
understanding of why people use.    
Thus, the purpose of the current study was to develop a self-report measure of 
motives to use substances, guided by the Addiction Syndrome Model, to capture several 
components of the comprehensive nature of addiction (i.e., antecedents and 
manifestations) as well as details necessary to capture nuances and distinctions between 
different objects of addiction (i.e., specific motivations to use, specific points of contact 
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with the object, etc.). Implications of this measure were driven by the Stages of Change 
model and the MI framework, such that, ultimately, data from the measure may direct 
Motivational Enhancement Therapy dialogue by teasing out unique intervening variables 
related to use that will be relevant to a given individual, thus guiding treatment, 
specifically by clearly outlining barriers to change, providing an opportunity to capitalize 
on client-identified reasons to change, and providing a basis of use history, change 
history and current status. Findings may expand the current understanding of motivations 
to use and quit using substances by providing more explanatory data and determining 
prevalent trends and relationships of motivations by substance type and experience with 
use. 
The present study proposed to extend and integrate the literature on motivations to 
use substances, and address gaps in the literature, by developing a reasonably 
comprehensive measure of motivations. The goals of creating the proposed measure were 
to capture facets of motivation represented in the literature comprehensively, test the 
factor structure of motivations to use, address gaps in the literature by testing the salience 
of these motives to several common substances of use (i.e., alcohol, cannabis, opioids, 
stimulants, sedatives/anxiolytics, hallucinogens/dissociatives), and extend the literature 
by assessing distinguishable components of motivations (i.e., frequency, wanting, liking, 
and satisfaction) for these substances.  
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Proposed Motivation Factors 
We proposed a nine-factor model of motives to use substances derived from 
previous measures and the existing literature (see Table 1 for an outline of previous 
measures of motivations by substance type) as follows: 
Affect Reduction/Negative Arousal (ARNA). We hypothesized a factor containing 
items related to using substances to cope with aversive affect (e.g., loneliness, depression, 
anxiety, irritability, guilt) and decrease arousal (e.g., stress, tension, restlessness, racing 
thoughts).  
Affect Enhancement/Positive Arousal (AEPA). We hypothesized a factor 
containing items related to improving one’s baseline affective state. Use of substances to 
celebrate, to feel elated or euphoric, for enjoyment, and to increase feelings of self-
confidence or effectiveness were expected to fall within this factor. In addition, this 
factor was expected to include content related to using to increase arousal (e.g., to relieve 
boredom, to feel ‘alive,’ and to perk up or become alert).  
 Social/Relational (SR). We hypothesized a factor that would encompass items 
related to social rewards (e.g., acceptance and approval), social problems (e.g., feeling 
more confident in social situations and during conflicts), social facilitation (e.g., to make 
friends; improving ability to communicate with others and express one’s thoughts and 
feelings), and social enhancement (e.g., enjoying other’s company; improving social 
situations like parties). 
Altered Perceptions/Experiential Processes (APEP). We hypothesized a factor 
containing items related to using substances to experience the world and one’s own 
perceptions and sensations in a different or novel way. We also expected this theme 
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would be related to using for the sake of learning and trying new things. An example of 
an item hypothesized to tap this factor was to enhance and change my senses (e.g., see 
things differently).  
Relative Low Risk (RLR). We hypothesized a factor that would include items 
related to using substances because they are perceived as socially, physiologically, or 
legally “safer” than other substances. Examples of items relating to this factor included 
using because it is prescribed to me by a doctor, because it has fewer side effects than 
other drugs, because I can use it legally, and because it’s easier to hide my use from 
others than for other drugs.  
 Functional/Self-Medication (FSM). This factor, overall, was expected to 
encompass the use of substances to address functional problems. This factor was 
expected to include motivations to use substances for their neurochemical enhancement 
of functions: for physical pain, to relax, trouble sleeping, staying awake, enhancing 
physical performance, focusing attention, and appetite control. We hypothesized using to 
avoid withdrawal effects would also load on this factor and would include content related 
to using substances to avoid psychological and physiological symptoms that occur from 
refraining to use a substance after prolonged use over an extensive period of time.  
 Substitution (SUB). We hypothesized a factor comprised of items related to using 
one substance to substitute for another or to supplement another substance. Items 
hypothesized to load onto this factor included using to get the same effects as something 
I’m prescribed when I run out of the prescription, to use a drug that is more powerful 
than one I’ve gotten used to, and to help me stop or decrease my use of another drug.  
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 Conformity/Rebellion (CR). We hypothesized a factor that would encompass the 
use of substances to rebel or conform to norms and expectations on a bipolar dimension. 
Conformity-related content would include items such as using to follow what my friends 
are doing and to not be the only one not doing it. Rebellion-related content would include 
items such as using to experience the thrill of doing something I’m not supposed to do 
and to rebel against authority or society.  
 Effects of Other Substances. We hypothesized a factor containing items related to 
managing the strength of effects, negative effects, and quality of effects of other 
substances. Example items included using to counteract the effects of another drug, to 
enhance the effects of another drug, to be able to use another drug for a longer period of 
time, and to ‘come down’ off of another drug.  
Testing Hypotheses Related to the Validity of the Construct   
Hypothesis 1: Factor Structure  
We expected the aforementioned 9-factor model to emerge from the data. By 
testing the factor structure for motives measured by the frequency of using substances for 
a given reason (i.e., frequency), how much one likes that they use substances for a given 
reason (i.e., liking), and the degree to which a given reason is satisfied by use (i.e., 
satisfaction), we anticipated similar factor structures would emerge. While the existing 
motives measure literature supports motives measured by frequency loading as 
hypothesized, the liking and satisfaction factor structures were exploratory given the 
novel measurement method of substance use motives; however, we expected the structure 
to resemble that for frequency. Given the more comprehensive nature of the item content 
included in the current study, the factor structure was expected to be similar to those in 
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existing measures, but not exactly the same because we are including content not fully 
captured by any one existing measure. In addition, we anticipated the factor structure 
may suggest one less, or one more, factor fit the data better.  
Hypothesis 2: Wanting, Liking, and Satisfaction Predicting Frequency of Use 
 By measuring individuals’ substance wanting ratings and liking and satisfaction 
ratings for a variety of motives, we expected these variables to predict the frequency of 
substance use in a consistent pattern, such that as frequency of substance use increases, 
the degree of wanting increases while liking and satisfaction decreases. While 
exploratory in nature, we aimed to test these relationships for the use of six classes of 
substances to determine if the relationships hold across substances.   
Hypothesis 3: Wanting, Liking, and Satisfaction Predicting Severity and Change 
 In addition, we tested whether individuals’ substance wanting ratings and liking 
and satisfaction ratings for motives predicted DSM-5 SUD severity, consequences of use, 
desire for use status, current status on the Stages of Change, and number of reasons for 
quitting use. Because frequency of use often accounts for a large amount of variance in 
use-related problems (Carey & Correia, 1997; Cooper 1994), we examined whether 
wanting, liking, and satisfaction measures predicted these outcomes over and above 
frequency of use. Here, we expected wanting to be lower, and liking and satisfaction 
ratings to be higher for those who met less criteria for a SUD, had more perceived 
positive consequences of use, wanted to use as much as possible (i.e., desire for use 
status), were at earlier Stages of Change, and endorsed less reasons to quit using, whereas 
wanting would be higher and liking and satisfaction would be lower for those who met 
more criteria for a SUD, had more perceived negative consequences of use, wanted to 
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completely quit using, were further on the Stages of Chance, and endorsed more reasons 
to quit using. 
Hypothesis 4: Incremental Validity Testing of Frequency, Liking, and Satisfaction Motive 
Measures 
While motives measured by frequency have consistently predicted use-related 
patterns and outcomes in the literature, we hypothesized that measuring motives in term 
of liking and satisfaction would increase the predictive ability of motives above and 
beyond that of frequency motives. We intended to test for incremental validity by treating 
frequency motives as a covariate and entering liking and satisfaction motives in the 
second block, accounting first for the variance frequency measures capture in substance 
use-related patterns and substance use severity in the model.  
Hypothesis 5: Motives by Drug of Choice   
 In congruence with the literature, we aimed to investigate whether motives vary 
by individuals’ drug of choice. To the extent that previous studies have identified salient 
motives for particular substances of use, we proposed some predictions as follows:  
1. Alcohol use would predominantly be for motives captured in the Affect 
Reduction/Negative Arousal (coping with negative affect; relax; relieve tension), 
Affect Enhancement/Positive Arousal, Social/Relational (confidence; 
celebration), Relative Low Risk (socially acceptable; legal in some contexts), 
Functional/Self-Medication (sleep; pain; black out; avoid withdrawal), and 
Conformity/Rebellion (towards conformity) factors.  
2. Cannabis (or synthetic cannabinoid) use would predominantly be for motives 
addressed in Affect Reduction/Negative Arousal (coping with negative affect and 
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decreasing arousal with more relaxing strains), Affect Enhancement/Positive 
Arousal (increasing arousal with more activating strains), Social/Relational 
(celebration), Altered Perceptions/Experiential Processes, Relative Low Risk 
(socially acceptable; legal in some contexts; [synthetic cannabinoids] does not 
show up on drug test), Functional Self-Medication (sleep; pain; increase appetite), 
and Conformity/Rebellion (towards rebellion) factors.   
3. Stimulant (cocaine, methamphetamine, or prescription stimulant) use would 
predominantly be for motives addressed in Affect Reduction/Negative Arousal 
(coping with depression [but not coping with anxiety or decreasing arousal]), 
Affect Enhancement/Positive Arousal (feel alive; perk up), Social/Relational 
(celebration), Relative Low Risk (legal in some contexts; confidence in purity; 
prescribed by a doctor), and Functional/Self-Medication (concentration; stay 
awake; study; enhance performance; decrease appetite) factors.  
4. Opioid (heroin or prescription opioid) use would predominantly be for motives 
addressed in Affect Reduction/Negative Arousal (coping with anxiety; relax; 
release tension), Affect Enhancement/Positive Arousal (pleasure; euphoria), 
Social/Relational (celebrate; lose inhibitions), Relative Low Risk (legal in some 
contexts; confidence in purity; prescribed by a doctor), and Functional/Self-
Medication (pain; sleep; avoid withdrawal) factors.  
5. Sedative/anxiolytic (benzodiazepine and prescription sleep aid) use would 
predominantly be for motives addressed in Affect Reduction/Negative Arousal 
(coping with anxiety; decreasing arousal), Affect Enhancement/Positive Arousal 
(feel at peace), Relative Low Risk (legal in some contexts; confidence in purity; 
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prescribed by a doctor), and Functional/Self-Medication (sleep; black out; avoid 
withdrawal) factors.  
6.  Hallucinogen and/or dissociative (e.g., LSD, psilocybin, ecstasy, MDMA, molly, 
2-CE, ketamine, and synthetic cathinone) use would predominantly be for Affect 
Enhancement/Positive Arousal (feel euphoric; have fun; reduce boredom; feel 
alive; have energy), Social/Relational (celebrate; relate to others), and Altered 
Perceptions/Experiential Processes (experience a blending of senses; perceive 
things differently; be more creative) factors.   
Because no single study has examined the salience of motives related to content 
hypothesized to load onto the Effects of Other Substances factor in the presence of all 
substance classes we will address (i.e., alcohol, illicit substances, and prescription 
substances), it was unclear which substances this factor would be most prominent for. We 
did not have any hypotheses for the salience of the hypothesized Substitution factor given 
the lack of literature regarding the relationship of related content to substance classes.  
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 – METHODOLOGY  
IRB Statement 
 Collection of data was initiated after approval by The University of Southern 
Mississippi’s Institutional Review Board (see Appendix A for IRB approval letter).  
Participants 
 We aimed to collect data from adults who use or have used alcohol, cannabis, 
stimulants, opioids, sedatives / anxiolytics, or hallucinogens / dissociatives. We aimed to 
obtain a sample of 600 participants, with at least 100 participants who use or have used 
each of the six substance classes. Many adults in the U.S. currently use alcohol (ages 18-
25 = 56.3%; ages 26 or older = 55.8 percent) and cannabis (ages 18-25 = 22.1 percent; 
ages 26 or older = 7.9 percent), while much fewer use stimulants, opioids, sedatives / 
anxiolytics, and hallucinogens / dissociatives (ages 18-25 = .2 to 2.1 percent; ages 26 or 
older = .1 to 1.1 percent; Substance Abuse and Mental Health Services Administration, 
2018). Our intention to adequately represent use of each substance class, despite low base 
rates, was to aid in the external validation of the proposed questionnaire.  
Participants were recruited from an undergraduate research pool at a medium-
sized Southeastern university, in which participation was compensated in course credit or 
extra credit. We also recruited participants from a medium-sized Midwestern university 
via their psychology department listserv. We recruited participants through flyer 
announcements posted at coffee shops and bars in the southern Mississippi region. In 
addition, we recruited participants through Facebook and Reddit social media outlets. All 
participants recruited through sources outside of the undergraduate research pool were 
entered for a drawing of six $25 Amazon gift cards for completing the survey. 
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Individuals 18 years of age or older who had past or current experience with any of the 
substances of interest were invited to participate. 
Materials  
Frequency of Substance Use 
Participants were given an extensive, but not exhaustive, list of common 
substances of use. Each substance was accompanied by a use history scale in which 
participated indicated whether they have never used, used to use but no longer use, 
currently use, or preferred not to say. Those who indicated past or current use also 
completed a frequency of use scale in which participants indicated their typical use 
pattern or, if no longer in use, their typical use pattern prior to quitting. Response options 
ranged from never use to use multiple times per day (see Appendix B).  
Drug(s) of Choice History 
Following completion of the previous section, participants were asked to rank 
their top three drugs of choice from the substances they had previously endorsed. For 
participants’ drug(s) of choice, we collected additional data regarding participants’ 
history of use, including how long the individual has (had) been using the substance, age 
of initial use, and route(s) of administration. We also asked participants to indicate their 
perception of their consequences and experiences from using their drug(s) of choice on 
two 7-point Likert-type scales ranging from always negative to always positive (see 
Appendix C).  
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Exposure to Substance 
Although appearing obvious, a crucial component of the precursors to an 
addiction syndrome is that the individual must (a) be exposed to the substance and (b) 
interact with the substance (Shaffer et al., 2004). We explored these antecedents to 
addiction by asking participants the modality in which they first heard about their drug(s) 
of choice (e.g., through television, music, a family member, friends, a drug dealer, a 
doctor, etc.), who they were with when they first saw their drug(s) of choice firsthand, 
and who they were with when they first used their drug(s) of choice. A shared 
manifestation among all substances of addiction is a social drift that may manifest in 
delinquency, criminal activity, maladaptive relationships, spending time with others who 
use, or using in isolation (Shaffer et al., 2004). As such, participants indicated the 
frequency at which they acquire(d) each substance from a wide-ranging list of sources 
and the frequency at which they use the substance with persons of varying relationships 
to the participant (e.g., by myself, a drug dealer, siblings, etc.) (see Appendix D).  
Quitting or Reducing Status and Treatment History 
Participants indicated their ideal drug(s) of choice intake status (i.e., decrease, 
increase, or continue current use) for their drug(s) of choice. Responses ranged from 
completely quit using to use as much as possible. Following the ideal status ratings, 
participants specified their current status regarding continuing to use the drug(s) of 
choice. Responses for this item ranged from I have not quit or reduced use, and do not 
intend to, to I’ve successfully quit or reduced use for more than 2 years. The current 
status endorsement options were designed to (a) reflect the Transtheoretical Model for 
Stages of Change and (b) map participants’ statuses onto the motivations to use and 
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reasons for quitting or reducing use. Participants also provided data on their treatment 
history, including number of treatments, type of treatment (12-step, outpatient, inpatient), 
and whether they were currently in treatment (see Appendix E). 
SUD Diagnostic Criteria 
Substance Use Disorder severity was assessed by asking participants to indicate 
the extent to which the eleven Diagnostic and Statistical Manual of Mental Disorders 5 
(DSM-5; American Psychiatric Association, 2013) criteria applied to their use of their 
drug(s) of choice. Each criterion was rated on a 6-point Likert-type scale (1 = not at all 
true of me; 2 = minimally true of me; 3 = a little true of me; 4 = moderately true of me; 5 
= very much true of me; 6 = completely true of me; see Appendix F).  
Motivations for Quitting or Reducing 
We assessed the extent to which participants wanted to quit or reduce their 
drug(s) of choice use from an extensive list of potential intrinsic and extrinsic 
motivations. Individuals who had already quit or reduced their use rated items based on 
past reasons for quitting or reducing use. Several motivations were derived from the 20-
item Reasons for Quitting Scale (Curry, Wagner, & Grothaus, 1990; RFQ) which 
includes two facets of intrinsic motivation (health concerns and self-control) and extrinsic 
motivation (immediate reinforcement and social pressure). We expanded this measure by 
including items related to improving memory, productivity, and clarity in thinking, 
quitting or reducing before a more negative consequence occurs (e.g., to stop before 
progressing to a “harder” drug; to stop before endangering someone), and quitting or 
reducing because a negative consequence occurred (e.g., an embarrassing behavior due to 
intoxication; see Appendix G). The original RFQ factor structure for intrinsic and 
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extrinsic motivations has been validated with tobacco smokers (Curry, Grothaus, 
McBride, 1997) and demonstrated adequate reliability (intrinsic alpha = .83; extrinsic 
alpha = .75).  
Motivations to Use 
We generated 112 motivations for both global- and specific-substance use that 
reflected the proposed 9-factor model based on motivations previously established in the 
literature (See Appendix H). Participants responded to the full 112-item measure for any 
endorsement of current or past substance use falling under six substance classes: alcohol, 
cannabis, stimulants, opioids, sedatives/anxiolytics, and hallucinogens/dissociatives. 
Wanting. Participants were provided with an operational definition of wanting 
(i.e., craving), and subsequently rated their overall level of wanting intensity. Participants 
responded to two wanting items: “When you think about alcohol and/or drugs how 
intense are your cravings?” and “When you encounter a reminder about alcohol and/or 
drugs (e.g., people, places, things) how intense are your cravings?” The two wanting 
questions were answered on 6-point Likert-type scales (1 = not at all; 2 = minimally; 3 = 
a little; 4 = moderately; 5 = very much; 6 = extremely). We calculated a mean total 
wanting score from the two items.  
Frequency, Liking, and Satisfaction. Participants responded to each motivation 
item three times: “How frequently you use alcohol and/or drugs for that reason or 
motive,” How much you like using alcohol and/or drugs for that reason or motive” and 
“How much that reason or motive is satisfied when you use alcohol and/or drugs.”  The 
frequency measure was answered on a 6-point Likert-type scale (1 = Never; 2 = Rarely; 3 
= Occasionally; 4 = Often; 5 = Almost Always; 6 = Always).  The liking and satisfaction 
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questions were answered on 6-point Likert-type scales (1 = not at all; 2 = minimally; 3 = 
a little; 4 = moderately; 5 = very much; 6 = extremely). Lower ratings on the wanting 
scale indicated the individual felt less compelled to use substances, while higher ratings 
indicated the individual felt more compelled to use substances. Low ratings on the 
frequency scale indicated the individual used substances for a given motive less often, 
whereas higher ratings indicated the individual used substances for a given motive more 
often. Lower ratings on the liking scale indicated the individual did not like that they used 
the substance for that motive (i.e., to achieve that goal), whereas higher ratings indicated 
the individual liked that they used for that motive. Lower ratings on the satisfaction scale 
indicated a specific motivation to use was less satisfied by way of substance use, while 
higher ratings indicated the given motivation was satisfied to a greater degree from use. 
Items were presented under a heading of their hypothesized factor loading label to 
provide further semantic clarity. After responding to the frequency, liking and satisfaction 
measures for each presented set of items, participants were asked to indicate which 
substances they use, or used, for this set of reasons. These motivations formed the 
Motivations to Use Substances Questionnaire (MUSQ).   
Design and Procedure 
 Participants recruited from the Southeastern university registered for the study 
through the undergraduate research participation system (SONA) and subsequently 
received an email with a web link to complete the online questionnaire generated through 
Qualtrics. Those recruited from flyers, social media, and the Midwestern university’s 
psychology department listserv were prompted to copy the posted web link into an 
internet browser to complete the online questionnaire.  
 
54 
Participants accessed the questionnaire through the provided web link. The 
beginning prompt was an informed consent page detailing the anonymity of responses, 
voluntary nature of participation, and local mental health addiction counseling services’ 
contact information (in both the Midwestern and Southeastern regions). Consenting 
participants identified their recruitment source to inform the generalizability of findings. 
Participants responded to general demographic questions (e.g., gender identity, age, 
race/ethnicity, years of education, etc.) and reported their frequency of use (or past use) 
for several classes of substances. Indication of any past or present use of substances 
prompted the individual to indicate their top three drugs of choice. Participants were 
given the option to provide less than three drugs of choice if applicable. For the three (or 
less) drugs of choice, participants were asked to provide additional data for each endorsed 
substance regarding the duration of their use, routes of administration, experiences and 
consequences of use, age of onset of use, sources of exposure to the substance, treatment 
history, and ideal and current quit status. Participants were then prompted to complete the 
SUD diagnostic criteria questionnaire and the Reasons for Quitting (revised) 
questionnaire. Following collection of this descriptive data, participants who indicated 
any past or present use of alcohol, cannabis (or synthetic cannabinoids), stimulants 
(cocaine, methamphetamine, or prescription stimulants), opioids (heroin or prescription 
opioids), sedatives/anxiolytics (benzodiazepines and prescription sleep aids), or 
hallucinogens and/or dissociatives (ecstasy, MDMA, molly, hallucinogens, dissociatives, 
and synthetic cathinones) were prompted to complete the Motivations to Use Substances 
Questionnaire (MUSQ) in reference to their overall use or past use of any of the six 
classes of substances. Following completion of the MUSQ, participants that did not 
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participate for research or extra credit were prompted to enter their email to be entered 
into the drawing for six $25 Amazon gift cards. The present study, given the nature of 
Exploratory Factor Analysis (EFA), was an exploratory design (Costello & Osborne, 
2005).  
Statistical Analyses 
Date Preparation 
 We began the analysis process by first screening the data for values outside of the 
range (e.g., a value of 7 on a motivation item) in frequencies analyses of our variables of 
interest to exclude any participants with out-of-range values. Additionally, we examined 
the frequency of missing data for each item to determine if the frequency of missing data 
for an item was high (i.e., 10 percent or higher). Data missing at a high frequency was 
investigated for trends of random or systematically missing values. Data missing 
randomly did not warrant exclusion or imputation, while data missing systematically is 
addressed in the discussion. The test statistic of skewness and kurtosis for the item 
responses was examined to determine univariate normality of the distribution. Finally, we 
created z-scores for the motivation items to identify any outliers that warranted exclusion 
from the analysis with a criterion of +/- 3 standard deviations.  
Hypothesis 1: Factor Structure 
We planned to conduct Exploratory Factor Analyses (EFAs) on participants’ 
responses to the frequency, liking, and satisfaction scales for the 112 motivation items; 
however, all motive liking and satisfaction items were missing more than ten percent of 
data, with the majority missing between 50 and 85 percent of data. Therefore, EFAs for 
MUSQ liking and satisfaction items were not run. For the frequency EFA, we used 
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principal axis factoring and direct oblimin rotation. We used the principal axis factoring 
extraction because we aimed to determine shared variance, and assumed imperfect 
reliability, among scores to explore the underlying latent constructs (Costello & Osborne, 
2005). Direct oblimin rotation was used to allow the factors to correlate and explore those 
relationships. Because we had a theoretical basis for the factor structure, we fixed the 
number of factors to extract to 9, suppressing small coefficients below .35 as our 
predetermined cut-off criterion for relationship strength. To explore alternative factor 
structures and supporting evidence for the hypothesized factor structure, we utilized scree 
tests and parallel analyses (Horn, 1965; O’Connor, 2000).  
 Examination of the scree plots assisted in determining the number of factors; that 
is, visualizing a line through the eigenvalues beginning from right to left of the graph and 
determining the first change in slope (i.e., “bend”) to indicate the number of factors as 
identified on the x-axis. We anticipated the 9-factor model would emerge from this test, 
but also tested alternative models at +/- 1 factor (i.e., an 8- and 10-factor model). We also 
employed parallel analyses using the actual data permutation approach (O’Connor, 2000) 
to allow for eigenvalue comparisons for the present data to eigenvalues for a random 
dataset that yields equivalent statistical properties (i.e., means, standard deviations, and 
distributions). Using this approach, parallel analyses call for the factor analyzation of the 
randomized dataset and can be used to determine the number of factors to retain for 
which the present-data eigenvalue was greater than the randomized-data eigenvalue. 
When results from a parallel analysis are inaccurate, they tend to overestimate the 
number of factors to retain. Glorfeld (1995) suggests using the parallel analysis result as a 
starting point, but also considering one or two less factors. As such, we tested models for 
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the identified number of factors from the parallel analysis as well as those with within the 
range of our lowest expected number of factors to arrive at both a theoretically sound and 
simple factor structure. 
We examined the Kaiser-Meyer-Olkin analyses to ensure sufficient variability to 
examine the EFA, with a value criterion of at least .70. In addition, Bartlett’s Test of 
Sphericity was examined to confirm the legitimacy of the factor structure through a 
statistically significant value of p < .05. Communalities were assessed for potentially 
weak-loading items that fall below .20.  
 When examining the pattern matrix, we considered removal of items that had 
weak loadings with coefficients below .35 or double loadings (i.e., items loading on more 
than one factor with coefficients at or above .35) to ultimately arrive at a simple factor 
structure. The same removal process was utilized for the alternative models. Once the 
simplest factor structures were determined for the proposed and alternative models, we 
determined which model should be used consonant with theoretical justification. 
Similarly, after determining the final factor structure with the appropriate items, we 
named the factors based on content and theory. 
 Once we had the final factor structure, we conducted reliability analyses utilizing 
Cronbach’s alpha to determine internal consistency for scores within each factor. We 
considered alphas of .70 or higher to indicate sufficiently reliable dimension scores. If 
reliability was improved by deletion of an item in item analysis, we considered the item’s 
utility within the factor and considered removal if reliability was greatly improved before 
aggregation of items. Lastly, we reviewed the factor correlations and MUSQ scale score 
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correlations for strength and directionality to determine whether the relationships among 
factors make theoretical sense.   
Hypothesis 2: Wanting, Liking, and Satisfaction Measures 
 To test the hypothesized relationships between wanting, liking, and satisfaction, 
we planned to conduct a multiple regression using each of the motive factor scaled scores 
(liking and satisfaction) and total wanting scores to predict the variance for the six 
substance class use frequency scales. However, it was later determined that this statistical 
plan would call for as many as 72 multiple regressions (i.e., the number of factors 
multiplied by six substance classes). For a more parsimonious interpretation, we 
conducted multiple regressions using each of the motive factor scaled scores for liking 
and satisfaction and total wanting scores to predict the variance in participants’ maximum 
frequency score for their most frequently used substance (i.e., using one dependent 
variable versus six). To correct for Type I error, we used a Bonferroni correction by 
dividing .05 by the number of analyses run.  
Hypothesis 3: Wanting, Liking, and Satisfaction Predicting Severity and Change  
We planned to conduct five hierarchical regressions, accounting for substance use 
frequency in Block 1, using each of the motive factor scaled scores (liking and 
satisfaction) and total wanting scores in Block 2 to predict the variance in severity of 
DSM-5 SUD, perception of consequences from use, desire for use status (ranging from 
wanting to quit to wanting to use as much as possible), current status on the Stages of 
Change, and number of reasons to quit using measured on the revised RFQ. Again, upon 
collecting the data, it was determined that this statistical plan did not fit the data because 
we: (a) did not collect an overall substance use frequency score (although we could have 
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used the variable created for hypothesis 2 for participants’ maximum frequency score for 
their most frequently used substance); (b) did not consider that there would be multiple 
liking and satisfaction factor scaled scores intended for Block 2 and were unable to index 
a single liking and satisfaction score by calculating the mean due to very small and 
variable sample sizes per factor scaled score; and (c) did not consider that the dependent 
variables were collected in relation to participants’ drug(s) of choice and therefore 
participants’ may have had one, two, or three DSM-5 SUD scores per substance. 
Calculating mean scores for the dependent variables would not have made theoretical 
sense, as someone could have no DSM-5 severity for one substance and high DSM-5 
severity for another, averaging out to moderate severity. Further, given the number of 
factors determined for the MUSQ and the fact that regressions can only enter one 
dependent variable into the model, this statistical plan would have called for a minimum 
of 60 regressions (i.e., assuming we went with participants’ maximum frequency score 
for their most frequently used substance for Block 1 and averaged participants’ scores 
across the dependent variables by their drug(s) of choice). To test these multivariate 
relationships, we instead conducted canonical correlation analyses by considering the 
aforementioned independent variables as one variable set and the severity and change 
variables as another variable set. To work around the non-existent substance use 
frequency variable and possibility of multiple severity and change sets by substance 
classes, we examined frequency of use and severity and change variables only in relation 
to alcohol and cannabis use, as there was a disproportionally higher endorsement of these 
substances as drugs of choice compared to others.   
 
60 
Hypothesis 4: Incremental Validity Testing of Frequency, Liking, and Satisfaction Motive 
Measures 
Similarly, we aimed to test whether this novel method of assessing substance use 
motives (i.e., liking and satisfaction) would increase the predictive ability beyond that of 
the status quo frequency measures of motives, by conducting a series of five hierarchical 
regressions to predict the variance in severity of DSM-5 SUD, perception of 
consequences from use, desire for use status, current status on the Stages of Change, and 
number of reasons to quit using measured on the revised RFQ. Here, we planned to 
account for frequency motive scaled scores in Block 1 and enter liking and satisfaction 
motive scaled scores in Block 2. We ran into the same problems here as we did with the 
statistical plan for hypothesis 3, as we did not consider the fact that we would ultimately 
need to run an unreasonable number of analyses due to having multiple frequency, liking, 
and satisfaction factor scaled scores and multiple values for the dependent variables by 
participants’ drug(s) of choice. Again, we instead tested these multivariate relationships 
through more parsimonious canonical correlations by focusing only on alcohol and 
cannabis use-related variables.  
Hypothesis 5: Motives by Drug of Choice 
Lastly, we explored whether motives differed by drug of choice using a 
MANOVA, with drug of choice as the independent variable and the motive factors 
identified with the frequency scale serving as the dependent variables. We tested the 
assumption of homogeneity of covariance matrices with Box’s M test. If the assumption 
of homogeneity of covariance matrices was violated, we planned to examine Pillai-
Bartlett trace to determine statistical significance of the omnibus test; however, if the 
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assumption was not violated, we planned to examine Wilks’s lambda. We planned to 
conduct subsequent discriminant analyses to determine where differences in motives 
differ by drug of choice; however, we later determined this analysis would not answer the 
research question given that the functions would compare where combinations of 
substances differed by patterns of significant motives rather than where a given motive 
was more or less salient by participants’ drug of choice.  As such, we followed up the 
MANOVA with post-hoc ANOVAs.  
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 – RESULTS   
Data Preparation 
Of the total sample (N = 440), seventy-three participants were removed due to 
random responding (i.e., responding all “1s” to all frequency motive items) or not 
responding to the MUSQ questionnaire at all. Although participants were to be excluded 
based on responding “never used” and/or “prefer not to say” to all substances of interest, 
no additional participants needed to be excluded after excluding the aforementioned 73 
participants. A number of substance-specific responses were removed from analyses due 
to participants responding despite indicating in “Other (specify)” spaces that they had 
never used the substances in question. We excluded one participant’s cannabis- and 
prescription stimulant-related, three participants’ prescription stimulant-related, two 
participants’ prescription opioid-related, and one participant’s hallucinogen-related 
responses. These participants’ lack of a use history with these substances was confirmed 
through examination of their substance use pattern and frequency history responses. All 
other responses from these participants were retained. Thus, the final dataset consisted of 
367 participants (see Table 2 for demographic characteristics).  
Table 2  
Demographics 
 n % Min Max M SD 
Age 367  18 81 23.29 7.84 
Gender       
     Female 272 74.1     
     Male 84 22.9     
     Prefer not to say  3 .8     
     Cisgender 3 .8     
     Transman 2 .5     
     Transwoman 1 .3     
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Table 2 Continued 
     Gender queer 1 .3     
     Other 1 .3     
Marital Status       
     Single 296 80.7     
     Married 27 7.4     
     Engaged 21 5.7     
     Divorced 12 3.3     
     Prefer not to say 6 1.6     
     Separated 3 .8     
     Widowed 2 .5     
Race / Ethnicity       
     White 241 65.7     
     Black 78 21.3     
     Biracial / Multiracial 25 6.8     
     Hispanic / Latinx / 
          Spanish 
9 2.5     
     Prefer not to say 5 1.4     
     East Asian / Asian    
          American                                 
3 .8     
     South Asian / Indian  
          American 
3 .8     
     Middle Eastern / 
Arab 
          American 
2 .5     
     Other 1 .3     
Recruitment Method       
     USM 269 73.3     
     Reddit 52 14.2     
     Facebook 32 8.7     
     SIUE 6 1.6     
     Flyer 6 1.6     
 
 Next, we examined frequencies for all variables of interest (Tables 4 and 5). No 
MUSQ motive frequency items had ten percent or more missing data; however, as 
mentioned previously, all liking and satisfaction items were missing a substantial amount 
of data, with the majority missing between 50 and 85 percent of data. Although we were 
unable to run EFAs for MUSQ liking and satisfaction items, liking and satisfaction factor 
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scale scores were calculated based on the final resulting frequency factor items for 
subsequent analyses. Specifically, we calculated the mean value for items within a given 
frequency factor for corresponding liking and satisfaction factors. We examined 
frequencies for each of the 14 substance classes (i.e., alcohol, cannabis, prescription 
stimulants, prescription opioids, prescription benzodiazepines, heroin, cocaine, 
methamphetamine, MDMA, hallucinogens, dissociatives, prescription sleep aids, 
synthetic cannabinoids, and synthetic cathinones) that fell within participants’ top three 
substances of choice. There were significantly more individuals who endorsed alcohol 
(48 percent; n = 328) and cannabis (34.8 percent; n = 238) in their top three substances of 
choice than the other substances, which ranged from n = 2 to 68 (.3 to 10 percent; see 
Table 4). We created a variable for frequency of substance use for participants’ most 
frequently used substance to serve as the dependent variable for hypothesis 2 to allow for: 
(a) a larger sample size and (b) wanting, liking, and satisfaction variables, which were 
related to participants’ overall substance use regardless of substance class, to better align 
with frequency of substance use in general. This variable was not missing any data. 
Therefore, with the exception of hypotheses 1 and 2, all subsequent analyses focused 
only on alcohol and cannabis use and use-related variables. 
 
 
 
 
 
 
 
 
Table 3  
Descriptives for Variables of Interest 
  
 
 
 
 
 
 
 
 n % Min Max M SD  Skewness Kurtosis 
Frequency of Most 
Frequently Used 
Substance 
367 100 1 7 4.21 1.81  .395 -1.10 
Drugs Fall within Top 
3 Drugs of Choice  
         
     Alcohol 300 81.7        
    Cannabis 224 61        
     Rx Stimulants 63 17.2        
     Rx Opioids  47 12.8        
     Hallucinogens 46 12.5        
     Rx Benzodiazepines 29 7.9        
     Cocaine 26 7.1        
     Rx Sleep Aids 25 6.8        
     Heroin 23 6.3        
     MDMA / Molly / 
          Ecstasy 
23 6.3        
     Methamphetamine 16 4.4        
     Synthetic 
Cannabinoids 
4 1.1        
     Dissociatives 3 .8        
     Synthetic 
Cathinones 
1 .3        
Alcohol Use-Related 
Variables 
         
     Frequency of Use 296  1 7 3.32 1.28  1.12 1.39 
     Ideal Use 291  1 7 3.25 1.27  -.42 -.60 
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      Stage of Change 300  1 12 4.79 4.05  .45 -1.40 
     DSM-5 AUD 
Severity 
289  1 5.91 1.81 1.15 .96 2.01 3.38 
     Consequences /  
          Experiences                                     
299  1.5 7 4.69 1.13 .76 -.09 -.19 
     RFQ 273  33 165 61.02 30.81 .97 1.39 1.58 
Cannabis Use-Related 
Variables 
         
     Frequency of Use 210  1 7 3.72 1.96  .47 -.96 
     Ideal Use 214  1 7 2.95 1.80  .50 -.79 
     Stage of Change 223  1 12 5.93 4.18  .06 -1.58 
     DSM-5 CUD 
Severity 
217  1 6 1.79 1.08 .94 1.81 2.97 
     Consequences /        
          Experiences  
224  1 7 5.27 1.45 .88 -.96 .68 
     RFQ 205  33 165 58.76 32.07 .98 1.55 1.83 
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Table 4  
Descriptives for Motivations for Using Substances Questionnaire (MUSQ) 
 
Variables of Interest n % Min Max M SD  Skew. Kurt. 
Frequency of Most 
Frequently Used 
Substance 
367 100 1 7 4.21 1.81  .395 -1.10 
Drugs Fall within 
Top 3 Drugs of 
Choice  
         
   Alcohol 300 81.7        
   Cannabis 224 61        
   Rx Stimulants 63 17.2        
   Rx Opioids  47 12.8        
   Hallucinogens 46 12.5        
   Rx    
Benzodiazepines 
29 7.9        
   Cocaine 26 7.1        
   Rx Sleep Aids 25 6.8        
   Heroin 23 6.3        
   MDMA / Molly /                  
Ecstasy 
23 6.3        
   Methamphetamine 16 4.4        
   Synthetic 
Cannabinoids 
4 1.1        
   Dissociatives 3 .8        
   Synthetic 
Cathinones 
1 .3        
Alcohol Use-
Related Variables 
         
   Frequency of Use 296  1 7 3.32 1.28  1.12 1.39 
   Ideal Use 291  1 7 3.25 1.27  -.42 -.60 
   Stage of Change 300  1 12 4.79 4.05  .45 -1.40 
   DSM-5 AUD    
Severity 
289  1 5.91 1.81 1.15 .96 2.01 3.38 
   Consequences /        
Experiences  
299  1.5 7 4.69 1.13 .76 -.09 -.19 
   RFQ 273  33 165 61.02 30.81 .97 1.39 1.58 
Cannabis Use-
Related Variables 
         
   Frequency of Use 210  1 7 3.72 1.96  .47 -.96 
   Ideal Use 214  1 7 2.95 1.80  .50 -.79 
   Stage of Change 223  1 12 5.93 4.18  .06 -1.58 
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Table 4 Continued 
 
Next, we examined frequencies for the variables of interest focused on alcohol 
and cannabis use. All variables of interest in relation to alcohol and cannabis use were 
examined (i.e., frequency of use, DSM-5 alcohol/cannabis use disorder severity, 
consequences and experiences from use, RFQ alcohol/cannabis, ideal use status, and 
stage of change status). All variables of interest were missing more than ten percent of 
data, with the percentage of missing data ranging from 18.3 to 42.8 percent. However, 
when re-examining the frequencies for these variables by only calculating for those who 
endorsed alcohol or cannabis as a substance in their top three substances of choice, all 
percentages of missing data for the variables of interest fell below ten percent.  
 We also calculated z-scores to identify outliers greater than +/- 3 standard 
deviations, rounding to the nearest whole number. Although there were several outliers 
for the MUSQ motive frequency items, none were deleted because these outliers are part 
of our population of interest (i.e., those who use very often and never for that reason). 
Looking at the other variables of interest (i.e., drug of choice frequency, DSM-5 severity, 
consequences and experiences from use, RFQ, ideal use, and stage of change), we 
excluded two participants’ DSM-5 alcohol (Zs = 3.56) and three participants’ DSM-5 
cannabis (Z-score range = 3.80 – 3.88) severity scores from relevant analyses. We also 
   DSM-5 CUD 
Severity 
217  1 6 1.79 1.08 .94 1.81 2.97 
   Consequences /        
Experiences  
224  1 7 5.27 1.45 .88 -.96 .68 
   RFQ 205  33 165 58.76 32.07 .98 1.55 1.83 
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excluded 26 participants’ MUSQ motive frequency factor scaled scores from relevant 
analyses (Z-score range = 3.70 – 6.06).  
 Finally, we examined skewness and kurtosis for all variables of interest, including 
MUSQ factor scaled scores. Skewness for MUSQ motive frequency factor scaled scores 
ranged from .43 to 3.34, liking factor scaled scores ranged from -.44 to .75, and 
satisfaction factor scaled scores ranged from -.30 to .75. Kurtosis for MUSQ motive 
frequency factor scaled scores ranged from -.76 to 11.84, liking factor scaled scores 
ranged from -1.14 to .27, and satisfaction factor scaled scores ranged from -1.10 to -.02. 
For all other variables of interest, skewness ranged from -.96 to 2.01 and kurtosis ranged 
from -1.58 to 3.38.  
Hypothesis 1: Factor Structure of the Frequency Items 
To account for missing data for frequency motive items, we imputed the missing 
data using linear trend at point. We first examined the data using principal axis factoring 
without extracting a set number of factors. With a Kaiser-Meyer-Olkin (KMO) result 
closer to 1 (at least .70 or above) indicative of better ability of our data to create a factor 
structure, our result of .931 was ideal. Bartlett’s Test of Sphericity was also significant (p 
< .001), suggesting the variables were related and could create a factor structure. 
Examination of communalities did not identify any items for potential deletion (lowest 
communality value = .78). We hypothesized a 9-factor solution, but also examined +/- 1 
of the hypothesized factor solution. Parallel analysis suggested as many as 14 potential 
factors. Specifically, the eigenvalues for the first 15 factors were 35.39, 6.40, 5.77, 4.54, 
4.28, 3.09, 2.59, 2.26, 2.13, 1.76, 1.44, 1.36, 1.30, 1.18, and .99. The random data 
permutation eigenvalues at the 95th percentile were 1.74, 1.64, 1.57, 1.49, 1.45, 1.39, 
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1.35, 1.32, 1.27, 1.23, 1.20, 1.17, 1.14, 1.11, and 1.08. Therefore, to test the range of 
possible solutions, we examined 8-, 9-, 10-, 11-, 12-, 13-, and 14-factor models to 
ultimately arrive at a simple factor solution that was theoretically sound.   
9-Factor Model 
Thirteen items were deleted due to factor loadings below .35 and 10 items were 
deleted due to double loadings (i.e., items loading at or above .35 on more than one 
factor, beginning with deletion of items with double loadings of the lowest values in the 
pattern matrix). Based upon the content of the items with salient pattern coefficients, the 
resulting factors were given the following labels: (Factor 1) Affect Reduction/Negative 
Arousal; (Factor 2) Relative Low Risk/Substitution/Effects of Other Substances; (Factor 
3) Conformity; (Factor 4) Altered Perceptions/Experiential Processes; (Factor 5) Relative 
Low Risk in Comparison to Other Substances; (Factor 6) Rebellion; (Factor 7) Increasing 
Positive Affect; (Factor 8) Performance; (Factor 9) Positive Social Interactions. Factor 1 
contained 24 of the 25 items hypothesized to load on the Affect Reduction/Negative 
Arousal factor, with one item (i.e., to feel more in control of my life) deleted due to a 
weak loading. Factor 2 contained 12 items and combined several items from the 
hypothesized Relative Low Risk, Substitution, Functional/Self-Medication, and Effects 
of Other Substances factors. Two items hypothesized to load on the Relative Low Risk 
factor (i.e., because I can use it legally; because it is prescribed by a doctor) loaded with 
items related to managing effects of other substances (e.g., to counteract the effects of 
another substance) and substitution (e.g., to use a drug more powerful than the one I 
have gotten used to) in this single factor. In addition, one item hypothesized to load on a 
Functional/Self-Medication factor (i.e., to avoid drug or alcohol withdrawal symptoms) 
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loaded on this factor. Factor 3 contained seven items. All six conformity-related items 
expected to load onto a Conformity/Rebellion factor were retained, and one item (i.e., to 
avoid hurting someone’s feelings) hypothesized to load onto a Social/Relational factor 
loaded on this factor. Factor 4 retained all seven items hypothesized to load onto the 
Altered Perceptions/Experiential Processes factor. Factor 5 retained eight of the 11 items 
hypothesized to load onto the Relative Low Risk factor. As previously mentioned, two 
items loaded on Factor 2 while one item (i.e., because I can get high without screening 
positive on a drug test) was deleted due to a weak factor loading. Factor 6 retained all 
seven rebellion-related items expected to load onto a Conformity/Rebellion factor. Factor 
7 retained 12 of the 14 items hypothesized to load on the Affect Enhancement/Positive 
Arousal factor. The other two items (i.e., to perk up or become alert; to feel like I have 
energy) were deleted due to double loadings on this factor and Factor 8. Factor 8 retained 
six of the 13 items hypothesized to load on a Functional/Self-Medication factor. As 
previously mentioned, one item (i.e., to avoid drug or alcohol withdrawal symptoms) 
loaded on Factor 2 while the other six items were deleted due to weak factor loadings. 
The final factor yielded a Performance factor likely tied to the characteristics of stimulant 
use. Factor 9 retained six of the 17 items hypothesized to load onto a Social/Relational 
factor. Again, one item (i.e., to avoid hurting someone’s feelings) loaded onto Factor 3. 
Four items were deleted due to weak factor loadings, while six items were deleted due to 
double loadings. Specifically, two items (i.e., to celebrate with others; to make social 
gatherings/parties more fun) loaded on both Factor 7 and 9, while four items (i.e., to help 
me relate to others better; to feel accepted by others; to have a sense of belonging to a 
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social group; to enhance my social status, or be perceived as “cool” by others) loaded on 
Factor 3 and 9.  
8- and 10-Factor Models 
For the 8-factor model, 12 items were deleted due to factor loadings below .35 
and seven items were deleted due to double loadings. The resulting factors were (Factor 
1) Affect Reduction/Negative Arousal; (Factor 2) Substitution/Effects of Other 
Substances; (Factor 3) Conformity; (Factor 4) Relative Low Risk in Comparison to Other 
Substances; (Factor 5) Altered Perceptions/Experiential Processes; (Factor 6) Rebellion; 
(Factor 7) Increasing Positive Affect/Positive Social Interactions; (Factor 8) Performance. 
Factor 1 contained all 25 items hypothesized to load onto the Affect Reduction/Negative 
Arousal factor plus one item hypothesized to load onto the Functional/Self-Medication 
factor (i.e., to black out or blot out awareness). Factor 2 contained ten of the items that 
loaded onto Factor 2 for the 9-factor model. It also retained three additional items 
hypothesized to load onto an Effects of Other Substances factor that were deleted during 
the solution process for the 9-factor model and did not include the two items retained for 
Factor 2 for the 9-factor model that were related to Relative Low Risk. Factor 3 mirrored 
the Conformity Factor 3 for the 9-factor model, minus one item (i.e., to avoid hurting 
someone’s feelings). Factor 4, Factor 5, and Factor 6 contained the same items as Factor 
5, Factor 4, and Factor 6, respectively, of the 9-factor model. Factor 7 retained 20 items. 
Eight items were retained from the 14 items hypothesized to load onto the Affect 
Enhancement/Positive Arousal factor, while 12 items were retained from the 17 items 
hypothesized to load onto the Social/Relational factor. Three items (i.e., to improve my 
self-esteem; to feel euphoric/at peace; to feel content with life) from the hypothesized 
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Affect Enhancement/Positive Arousal factor and one item (i.e., to avoid or manage 
conflict with others) from the hypothesized Social/Relational factor were deleted due to 
weak factor loadings. One item (i.e., to feel more pleasure) double loaded on Factor 1 
and Factor 7, while one item (i.e., to avoid hurting someone’s feelings) double loaded on 
Factor 3 and Factor 8. Three items (i.e., to feel accepted by others; to have a sense of 
belonging to a social group; to enhance my social status, or be perceived as “cool” by 
others) double loaded onto Factor 3 and Factor 7. Finally, Factor 8 contained the same 
items as Factor 8 in the 9-factor model. Compared to the 9-factor solution, the 8-factor 
model essentially combined two theoretically distinct motive domains (i.e., increasing 
positive affect and positive social interactions) into one factor. Therefore, the 8-factor 
solution was deemed less theoretically sound as the 9-factor model.  
For the 10-factor model, nine items were deleted due to factor loadings below .35 
and eight items were deleted due to double loadings. The resulting factors were (Factor 1) 
Affect Reduction/Negative Arousal; (Factor 2) Substitution/Effects of Other Substances; 
(Factor 3) Conformity; (Factor 4) Relative Low Risk in Comparison to Other Substances; 
(Factor 5) Positive Social Interactions; (Factor 6) Rebellion; (Factor 7) Altered 
Perceptions/Experiential Processes; (Factor 8) Performance; (Factor 9) Affect 
Enhancement/Positive Arousal; (Factor 10) Self-Medication. Factor 1 retained 23 of the 
25 items hypothesized to load onto the Affect Reduction/Negative Arousal factor. One 
item (i.e., to feel more in control of my life) was deleted due to a weak factor loading, 
while one item (i.e., to reduce unpleasant physical sensations) loaded on both Factor 1 
and Factor 10. Factor 2 contained nine items – two items (i.e., to have something to use 
when my preferred substance is not available; to help me stop or reduce my use of 
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another drug) which were hypothesized to load onto a Substitution factor and all seven 
items hypothesized to load onto an Effects of Other Substances factor. Factor 3 contained 
the same Conformity items as Factor 3 in the 9-factor model. Factor 4 contained the same 
Relative Low Risk items as Factor 5 in the 9-factor model, minus one item (i.e., because 
it is easier to hide my use from others than for other drugs) which was deleted due to a 
double loading on this factor and Factor 10. Factor 5 contained 14 of the 17 items 
hypothesized to load onto the Social/Relational factor. One item (i.e., to avoid or manage 
conflict with others) was deleted due to a weak factor loading, while two items (i.e., to 
avoid hurting someone’s feelings; to enhance my social status, or be perceived as “cool” 
by others) were deleted due to double loadings on Factor 2 and Factor 10, and Factor 3 
and Factor 5, respectively. Factor 6, Factor 7, and Factor 8 retained the same Rebellion, 
Altered Perceptions/Experiential Processes, and Performance items retained in Factor 6, 
Factor 4, and Factor 8, respectively, of the 9-factor model. Factor 9 contained 10 of the 
14 items hypothesized to load onto the Affect Enhancement/Positive Arousal factor. One 
item (i.e., to improve my self-esteem) was deleted due to a weak factor loading. Again, 
two items (i.e., to perk up or become alert; to feel like I have energy) were deleted due to 
loading on Factor 8 and Factor 9. The last item (i.e., to feel more self-confident or 
effective) was deleted due to double loading on Factor 5 and Factor 9. Lastly, Factor 10 
contained six items – two items (i.e., because I can use it legally; because it is prescribed 
by a doctor) hypothesized to load onto a Relative Low Risk factor, three items (i.e., to get 
the same amount of the drug I think I need when my doctor wont prescribe enough to me; 
to use a drug that is more powerful than one I have gotten used to; to get the same effects 
as something I’m prescribed when I run out of the prescription) hypothesized to load 
 
75 
onto a Substitution factor, and one item (i.e., to avoid drug or alcohol withdrawal 
symptoms) hypothesized to load onto a Functional/Self-Medication factor.  
Taken together, the 8-factor solution combined two distinct substance use motives 
(increasing positive affect and enhancing social interactions) into a single factor. While 
the 9- and 10-factor models parsed this content apart, several factors combined content in 
other domains. For example, the 9-factor model combined motives related to the relative 
low risk of use, using to substitute one substance for another, and using to manage the 
effects of other substances in Factor 2. The 10-factor model also combined content 
related to using to substitute one substance for another and using to manage the effects of 
other substances in Factor 2, and combined motives related to the relative low risk of use 
and using to substitute one substance for another in Factor 10. It thus appeared 
appropriate to examine additional alternative models suggested by parallel analysis to 
determine if emerging factors would appear more distinct.  
11-, 13-, 12- and 14-Factor Models 
We expanded the factor solutions to look at alternative models with up to 14 
factors based on the parallel analysis. After completing item removal based on our set 
weak loading and double loading criteria, the last factor cells for the 11-, 13-, and 14-
factor models did not contain any items and thus did not warrant interpretation. The 12-
factor model yielded the most definition and coherent, clean factors in comparison to the 
8-, 9-, and 10-factor models.  
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12-Factor Model 
The interpretation of the final 12-factor model changed slightly (i.e., the number 
of items retained and clarity of defined factors) based on item analyses (see Page 78 
below). The resulting factors were: (Factor 1) Reduce Anxiety/Unpleasant Arousal; 
(Factor 2) Conformity; (Factor 3) Effects of Other Substances; (Factor 4) Relative Low 
Risk; (Factor 5) Positive Social Interactions; (Factor 6) Rebellion; (Factor 7) Altered 
Perceptions/Experiential Processes; (Factor 8) Performance/Arousal Enhancement; 
(Factor 9) Increase Positive Affect; (Factor 10) Manage Negative Social Interactions; 
(Factor 11) Reduce Negative Affect; (Factor 12) Substitution. See Table 5 for the 
frequency factor scaled score descriptives and Table 6 for the pattern matrix. 
In arriving at a simple factor solution, eight items were deleted due to weak 
loadings and 13 items were deleted due to double loadings. Factor 1 contained 12 of the 
25 items hypothesized to load onto an Affect Reduction/Negative Arousal factor. Two 
items (i.e., to feel more in control of my life; to be less inhibited) were deleted due to 
weak factor loadings. Four items (i.e., to reduce feelings of anger or frustration; to avoid 
or blot out my emotions; to forget, escape, or avoid my problems; to reduce feelings of 
sadness or depression) were deleted due to double loading on Factor 1 and Factor 11. 
One item (i.e., to reduce unpleasant physical sensations) was deleted due to double 
loading on Factor 1 and Factor 8. Ultimately, Factor 1 appeared to contain content from 
the hypothesized Affect Reduction/Negative Arousal factor solely related to reducing 
anxiety and unpleasant arousal. Factor 2 retained all six conformity-related items 
originally hypothesized to load onto a Conformity/Rebellion factor. Factor 3 retained all 
seven items hypothesized to load onto an Effects of Other Substances factor. Factor 4 
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retained seven of the 11 items hypothesized to load onto a Relative Low Risk factor. Two 
items (i.e., because I can use it legally; because it is prescribed by a doctor) loaded, 
instead, on Factor 12. One item (i.e., because I can get high without screening positive on 
a drug test) was deleted due to a weak factor loading, while the other item (i.e., because 
it is easier to hide my use from others than for other drugs) was deleted due to a double 
loading on Factor 4 and Factor 12. Factor 5 retained 13 of the 17 items hypothesized to 
load onto a Social/Relational factor. Two of the items (i.e., to avoid hurting someone’s 
feelings; to avoid or manage conflict with others) loaded onto Factor 10, while the other 
two items (i.e., to enhance my social status, or be perceived as “cool” by others; to help 
me express myself to others) were deleted due to double loadings on Factor 5 and Factor 
2, and Factor 5 and Factor 10, respectively. Factor 6 retained all seven rebellion-related 
items originally hypothesized to load onto a Conformity/Rebellion factor. Factor 7 
retained all seven items hypothesized to load onto an Altered Perceptions/Experiential 
Processes factor. Factor 8 retained the same six performance- and arousal enhancement-
related items from the hypothesized Functional/Self-Medication factor as was found in 
the 8-, 9-, and 10- factor alternative models. Factor 9 retained 12 of the 14 items 
hypothesized to load onto an Affect Enhancement/Positive Arousal factor. The two items 
that were not retained (i.e., to perk up or become alert; to feel like I have energy) were 
deleted due to double loading on Factor 8 and Factor 9. Factor 10 contained two items 
originally hypothesized to load onto a Social/Relational factor. Of note, these items 
appeared to relate to managing negative social interactions, as opposed to the content in 
Factor 8 that related to enhancing positive social interactions. Factor 11 contained six of 
the 25 items originally hypothesized to load onto an Affect Reduction/Negative Arousal 
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factor. These motives specifically address negative affect (e.g., to reduce feelings of 
hopelessness; to feel less lonely; to feel less ashamed), as opposed to addressing the 
anxiety and negative arousal motives that were contained in Factor 1. Finally, Factor 12 
retained the same six items that were retained in Factor 10 of the 10-factor model; 
however, three items were deleted based on item analysis (see below) to further solidify 
the content within the factor and remove content hypothesized to load onto 
Functional/Self-Medication and Relative Low Risk factors. The final factor thus yielded a 
discrete Substitution factor.  
9-Factor Model Versus 12-Factor Model 
Compared to the 9-factor model, the 12-factor model created cleaner motive 
factors that further distinguished item content compared to what was originally 
hypothesized. The 12-factor model cleaned up the large Factor 1 from the 9-factor model 
by dividing Affect Reduction/Negative Arousal into a negative affect factor and an 
anxiety-related factor. It further cleaned up Factor 2 from the 9-factor model by parsing 
apart the combined Relative Low Risk/Substitution/Effects of Other Substances content 
into separate Relative Low Risk, Substitution, and Effects of Other Substances factors. 
Lastly, the 12-factor solution revealed an additional factor that comprised motives related 
to using substances to manage negative social interactions. Ultimately, the 12-factor 
model final solution captured 67.99 percent of the variance in motivations for substance 
use, whereas the 9-factor model captured 60.31 percent of the variance.  
12-Factor Model Item Analysis 
We conducted reliability analyses utilizing Cronbach’s alpha to determine internal 
consistency for scores within each factor (see Table 5). Cronbach’s alphas for the 12-
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factor simple solution ranged from .818 to .950. We conducted alpha-if-item-deleted 
analyses to determine if alphas would greatly improve through deletion of any additional 
items. We deleted one item (i.e., because it has greater purity than other drugs) from 
Factor 4 to improve alpha from .929 to .938. We deleted one item (i.e., to be different) 
from Factor 6 to improve alpha from .910 to .915. We deleted two items (i.e., to enhance 
or facilitate physical [or sport] performance; to decrease my appetite) from Factor 8 to 
improve alpha from .883 to .892, and from .892 to .915. Lastly, we deleted three items 
(i.e., because I can use it legally; because it is prescribed by a doctor; to avoid drug or 
alcohol withdrawal symptoms) from Factor 12 to improve alpha from .818 to .830, to 
.836, and finally to .868, respectively. In addition, the deletion of these latter three items 
allowed for more consistent content within the factor. The inter-item correlations for the 
deleted items by alpha ranged from .456 to .566 and were relatively weaker compared to 
the final inter-item correlations which ranged from .600 to .872. Cronbach’s alpha for the 
final 12-factor model ranged from .854 to .950.  
 
 
 
 
Table 5  
Means, Standard Deviations, Corrected Item-Total Correlations, and Alpha if Deleted 
 
M SD rt 
Cronbach’s 
Alpha 
Alpha if 
Deleted 
1. Reduce Anxiety / Unpleasant Arousal    .949  
18. To calm down 2.82 1.59 .837  .942 
13. To stop worrying 2.62 1.55 .794  .943 
22. To feel less stressed 3.08 1.72 .830  .942 
23. To release tension 2.67 1.61 .804  .943 
20. To feel less on edge 2.63 1.64 .810  .943 
11. To reduce feelings of anxiety or nervousness 2.87 1.63 .799  .943 
15. To slow down racing thoughts 2.18 1.55 .744  .945 
19. To relax, loosen up, or unwind 3.44 1.56 .695  .947 
5. To feel less irritable 2.34 1.51 .719  .946 
14. To reducing feelings of fear 1.84 1.29 .716  .946 
25. To decrease restlessness 1.99 1.46 .674  .947 
24. To feel like nothing can bother me 2.27 1.61 .675  .947 
2. Conformity    .885  
103. To not be the only one not doing it 1.42 .95 .736  .858 
100. To satisfy social pressure to use 1.36 .84 .753  .856 
104. To be just like everybody else 1.34 .87 .674  .868 
101. To follow what my friends are doing 1.64 1.08 .758  .857 
102. To avoid being made fun of 1.26 .77 .639  .874 
105. To avoid being rejected 1.29 .76 .655  .872 
3. Effects of Other Substances    .914  
111. To counteract the effects of another drug 1.39 .93 .799  .897 
112. To reduce the effects of, or “come down” 
off of another drug  1.46 .95 .779 
 
.897 
108. To enhance the effects of another drug 1.67 1.24 .814  .895 
 
 
 
Table 5 Continued 
110. Because I am under the influence of 
another drug 1.50 1.05 .797 
 
.894 
109. To be able to use another drug for a longer 
period of time 
1.42 1.05 .726  .903 
106. To reduce the effects of another drug  1.33 .83 .692  .906 
107. To help with the side effects of a 
medication 
1.26 .76 .600  .915 
4. Relative Low Risk     .938  
67. Because it has fewer side effects than other 
drugs 
2.25 1.71 .872  .919 
66. Because it is not as bad for you as other 
drugs 
2.42 1.81 .825  .925 
68. Because it does not cause me as many 
problems as other drugs 
2.33 1.80 .829  .924 
65. Because I can handle the high better than 
with some other drugs 
2.14 1.70 .808  .927 
64. To get high / intoxicated with something I 
think is safer than other drugs 
2.43 1.76 .817  .926 
69. Because it is more socially acceptable than 
other drugs 
2.29 1.71 .737  .936 
5. Positive Social Interactions    .950  
46. To help me feel sociable or friendly  2.72 1.66 .817  .944 
44. To make social gathering and parties more 
fun 
3.23 1.68 .753  .946 
41. To lose my inhibitions in social situations 2.41 1.55 .752  .946 
45. To feel more confident and sure of myself 
around others 
2.47 1.62 .787  .945 
48. To enjoy social interactions  2.83 1.65 .798  .945 
43. To have a reason/excuse to socialize  2.24 1.53 .780  .945 
54. To celebrate with others 3.23 1.61 .653  .949 
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42. To feel accepted by others 1.93 1.35 .716  .947 
40. To make friends 1.98 1.30 .722  .947 
47. To help me relate to others better 2.04 1.48 .785  .945 
55. To have a sense of belonging to a social 
group 
1.99 1.46 .745  .946 
49. To communicate with others better 2.02 1.49 .729  .947 
52. To feel more intimate with, connected to, or 
closer to others 
2.04 1.42 .731  .947 
6. Rebellion    .915  
95. To break rules 1.47 .98 .840  .889 
96. To rebel against authority or society 1.48 .98 .792  .896 
97. To do something risky or dangerous 1.59 1.08 .814  .892 
94. To do something illegal 1.43 .94 .688  .910 
99. To experience the thrill of doing something 
I’m not supposed to do 
1.72 1.19 .761  .902 
93. To do something socially unacceptable  1.49 .98 .689  .910 
7. Altered Perceptions / Experiential 
Processes 
   .930  
60. To change my understanding of my 
perceptions (e.g., a spiritual awakening; special 
understanding of the universe; realizing the 
meaning in life) 
1.87 1.44 .851  .912 
61. To experience a blending of senses (e.g., 
tasting colors; seeing music as colors or 
patterns) 
1.62 1.22 .766  .921 
58. To alter how I perceive my environment 
(e.g., hear music in greater detail or complexity; 
enhance or dull sensations; drown out 
distractions) 
2.19 1.60 .839  .913 
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59. To cause me to perceive things that are not 
present (i.e., to hallucinate; to see patterns or 
distortions that are not actually present) 
1.69 1.27 .742  .923 
62. To seek new experiences  2.13 1.53 .824  .915 
57. To help me be more creative 1.99 1.44 .752  .922 
63. To know what it’s like to be under the 
influence of these substances 
2.00 1.48 .685  .928 
8. Performance / Arousal Enhancement    .915  
80. To perform better on school (or 
occupational) work/tests 
1.67 1.30 .850  .874 
77. To focus or pay attention 1.80 1.37 .859  .871 
81. To study better 1.66 1.28 .808  .889 
78. To stay awake  1.61 1.18 .712  .920 
9. Increase Positive Affect    .936  
30. To feel more joy or happiness  2.83 1.68 .824  .926 
39. To help me get into a good mood  2.94 1.70 .798  .927 
37. To have fun 3.74 1.73 .688  .932 
34. To celebrate 3.33 1.63 .628  .934 
32. To feel more pleasure 2.65 1.70 .746  .929 
28. To feel more excited 2.46 1.55 .712  .931 
35. To feel content with life 2.24 1.60 .756  .929 
38. To feel alive 2.3 1.69 .735  .930 
29. To feel less bored 2.53 1.60 .678  .932 
36. To feel euphoric or feel at peace 2.76 1.81 .709  .931 
31. To feel more self-confident or effective 2.68 1.70 .674  .932 
33. To improve my self-esteem 2.18 1.49 .637  .933 
10. Manage Negative Social Interactions    .854  
50. To avoid hurting someone’s feelings 1.40 .94 .756  --- 
51. To avoid or manage conflict with others 1.55 1.12 .756  --- 
11. Reduce Negative Affect    .909  
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9. To feel less ashamed 1.67 1.24 .739  .895 
8. To reduce feelings of helplessness 2.03 1.47 .813  .883 
7. To reduce feeling of hopelessness 2.26 1.56 .828  .880 
10. To feel less guilty 1.66 1.27 .700  .900 
12. To feel less lonely 2.21 1.49 .722  .897 
2. To forget, escape, or avoid my memories 2.51 1.63 .710  .900 
12. Substitution    .868  
92. To get the same effects as something I’m 
prescribed when I run out of my prescription 
1.29 .86 .821  .747 
89. To get the same amount of the drug I think I 
need when my doctor won’t prescribe enough to 
me 
1.27 .82 .744  .821 
90. To use a drug that is more powerful than one 
I have gotten used to 
1.35 .96 .693  .874 
 
 
 
 
 
 
 
 
 
 
Table 6  
Direct-Oblimin Rotated Factor Pattern Matrix: Motivations for Using Substances Questionnaire 
 
Factor Items        
Factor 
1 2 3 4 5 6 7 8 9 10 11 12 
1. Reduce Anxiety / Unpleasant Arousal 
18. To calm 
down .827 -.006 .009 .044 .042 .055 .017 .066 -.026 .055 -.045 -.021 
13. To stop 
worrying .741 .037 -.057 .015 .070 .051 .049 -.006 -.012 .003 .054 .058 
22. To feel less 
stressed .689 .109 -.016 .060 .030 .067 .067 .096 .118 -.053 -.002 -.041 
23. To release 
tension .666 .091 .036 .122 .016 -.031 .106 .009 .085 .074 -.034 -.062 
20. To feel less 
on edge .664 .035 .097 .044 .047 .005 .043 -.054 .084 -.001 .095 .002 
11. To reduce 
feelings of 
anxiety or 
nervousness .625 .058 .006 .015 .166 -.026 .109 .080 -.013 -.113 .148 .011 
15. To slow 
down racing 
thoughts .614 -.057 .130 .026 -.017 -.013 .048 .058 -.080 .024 .180 .064 
19. To relax, 
loosen up, or 
unwind .579 .022 -.048 .115 .095 .130 .068 .036 .166 -.052 -.093 -.095 
5. To feel less 
irritable .571 -.008 .103 .087 -.043 -.008 -.027 .075 .035 .124 .115 .005 
14. To reducing 
feelings of fear .464 .005 .122 .057 .013 -.010 -.033 .052 -.008 .094 .301 .025 
 
 
 
Table 6 Continued 
25. To decrease 
restlessness .441 .011 .107 .087 -.098 -.161 .066 .001 .086 .188 .205 .113 
24. To feel like 
nothing can 
bother me .430 -.007 .110 .009 .021 .059 -.003 .035 .207 .105 .105 .024 
2. Conformity             
103. To not be 
the only one not 
doing it .125 .783 -.055 .044 -.060 .041 .058 -.010 .003 .009 -.072 -.053 
100. To satisfy 
social pressure 
to use .002 .760 .103 .089 .069 .015 -.016 .038 -.016 .001 -.016 -.062 
104. To be just 
like everybody 
else .001 .755 -.059 .017 .035 -.082 .017 -.083 .111 -.108 -.009 .137 
101. To follow 
what my friends 
are doing -.004 .751 -.060 .062 .094 .153 -.016 .064 -.028 -.093 .044 -.011 
102. To avoid 
being made fun 
of -.052 .651 .075 -.022 -.093 .100 -.063 .048 -.022 .087 .045 -.007 
105. To avoid 
being rejected .043 .639 .024 -.072 .040 .049 -.032 .031 -.031 .202 -.045 .033 
3. Effects of Other Substances 
111. To 
counteract the 
effects of 
another drug .033 .048 .745 .004 .094 .029 -.040 .056 -.007 .003 .009 .091 
 
 
 
Table 6 Continued 
112. To reduce 
the effects of, or 
“come down” 
off of another 
drug  .096 .043 .702 -.083 -.051 -.000 .050 .096 .102 -.030 -.014 .093 
108. To 
enhance the 
effects of 
another drug .007 -.057 .680 .097 .053 .058 .141 .058 .052 -.072 -.053 .070 
110. Because I 
am under the 
influence of 
another drug -.010 .005 .674 .076 .107 .180 .094 -.002 -.038 -.057 .020 .058 
109. To be able 
to use another 
drug for a 
longer period of 
time -.087 -.038 .642 .071 .139 .066 .015 -.010 .061 -.027 .053 .062 
106. To reduce 
the effects of 
another drug  .069 -.034 .610 .067 .013 .134 .002 .082 -.058 -.063 -.005 .051 
107. To help 
with the side 
effects of a 
medication .130 .058 .520 -.026 -.100 -.010 .067 .041 .066 .056 -.060 .122 
4. Relative Low Risk  
67. Because it 
has fewer side 
effects than 
other drugs .010 -.004 -.005 .907 -.047 .011 .010 .040 -.014 .045 .003 -.010 
 
 
Table 6 Continued 
66. Because it is 
not as bad for 
you as other 
drugs -.007 .009 -.058 .870 .014 -.006 .021 .049 -.063 -.030 .058 -.026 
68. Because it 
does not cause 
me as many 
problems as 
other drugs -.065 .034 -.011 .867 .004 -.026 .069 .001 .003 -.061 -.002 .010 
65. Because I 
can handle the 
high better than 
with some other 
drugs .024 -.042 .079 .807 -.076 -.010 .015 .013 .073 .060 .021 -.016 
64. To get high 
/ intoxicated 
with something 
I think is safer 
than other drugs .072 -.033 .063 .802 .017 .013 .033 -.059 .038 .001 -.048 -.022 
69. Because it is 
more socially 
acceptable than 
other drugs .013 .102 .012 .728 .076 -.003 -.087 -.041 -.004 .011 -.010 .152 
5. Positive Social Interactions 
46. To help me 
feel sociable or 
friendly  .109 -.016 .049 .007 .753 .014 .050 .042 .041 .012 .007 -.062 
 
 
 
 
Table 6 Continued 
44. To make 
social gathering 
and parties 
more fun .103 -.060 -.033 .072 .684 .075 -.081 .022 .254 -.093 -.060 .089 
41. To lose my 
inhibitions in 
social situations .013 -.005 .147 .069 .661 -.056 .064 .091 .010 -.065 .109 -.001 
45. To feel 
more confident 
and sure of 
myself around 
others .071 .064 .160 -.023 .653 -.007 .056 .073 .006 .055 .072 -.078 
48. To enjoy 
social 
interactions  .120 .008 -.025 .031 .639 .085 .045 .003 .162 .042 -.027 .027 
43. To have a 
reason/excuse 
to socialize  .016 .094 .125 .020 .635 -.015 -.023 .005 .070 .107 .026 .054 
54. To celebrate 
with others .036 -.047 -.165 .123 .591 .163 -.007 .078 .201 -.026 -.141 .063 
42. To feel 
accepted by 
others .016 .338 .030 -.011 .581 -.096 -.002 -.045 -.041 .079 .185 .038 
40. To make 
friends .032 .098 .065 .034 .562 .043 .063 .077 -.058 .128 .075 -.046 
47. To help me 
relate to others 
better -.004 .147 .125 .045 .536 -.094 .124 -.003 -.001 .291 .107 -.036 
 
 
 
Table 6 Continued 
55. To have a 
sense of 
belonging to a 
social group -.057 .317 -.009 .003 .507 .031 .050 .006 -.012 .215 .165 .057 
49. To 
communicate 
with others 
better .062 -.038 .019 .072 .502 -.041 .135 .067 .022 .336 .023 -.028 
52. To feel 
more intimate 
with, connected 
to, or closer to 
others .009 .017 .116 .059 .438 .104 .087 .065 .073 .266 .064 -.020 
6. Rebellion 
95. To break 
rules -.007 -.013 .001 -.010 -.000 .861 -.002 .009 -.036 .077 .072 .043 
96. To rebel 
against 
authority or 
society -.041 -.019 .137 -.015 -.057 .800 .008 .003 .073 .031 .015 -.012 
97. To do 
something risky 
or dangerous .032 -.004 .121 -.051 .050 .788 .093 -.018 .001 .010 .009 .015 
94. To do 
something 
illegal .064 .001 -.016 .034 -.026 .696 -.052 .035 .006 .043 -.011 .074 
 
 
 
 
Table 6 Continued 
99. To 
experience the 
thrill of doing 
something I’m 
not supposed to 
do .010 .135 .000 .051 -.003 .686 .075 .014 .051 -.034 .060 .036 
93. To do 
something 
socially 
unacceptable  -.008 .194 .036 .043 .007 .610 .084 .003 -.024 -.033 .046 .008 
7. Altered Perceptions / Experiential Processes 
60. To change 
my 
understanding 
of my 
perceptions 
(e.g., a spiritual 
awakening; 
special 
understanding 
of the universe; 
realizing the 
meaning in life) -.003 .010 .018 -.075 -.029 -.014 .897 .039 .033 .010 -.047 .064 
 
 
 
 
 
 
Table 6 Continued 
61. To 
experience a 
blending of 
senses (e.g., 
tasting colors; 
seeing music as 
colors or 
patterns) -.035 .041 .001 -.009 -.040 .035 .829 -.043 -.020 .100 .046 -.057 
58. To alter 
how I perceive 
my environment 
(e.g., hear 
music in greater 
detail or 
complexity; 
enhance or dull 
sensations; 
drown out 
distractions) .092 -.015 .035 .037 .056 -.053 .814 .031 .001 -.048 -.046 .004 
59. To cause me 
to perceive 
things that are 
not present (i.e., 
to hallucinate; 
to see patterns 
or distortions 
that are not 
actually 
present) -.022 -.021 .073 -.021 -.001 .054 .776 -.047 -.003 -.065 .005 .027 
 
 
 
Table 6 Continued 
62. To seek new 
experiences  -.026 -.029 -.014 .085 .070 .107 .775 .029 -.005 .022 -.012 .031 
57. To help me 
be more 
creative .075 -.068 .025 .028 -.041 -.137 .687 .144 .101 .004 -.007 .032 
63. To know 
what it’s like to 
be under the 
influence of 
these substances .044 -.001 -.081 .141 -.006 .089 .635 .008 .004 .007 .036 .012 
8. Performance / Arousal Enhancement 
80. To perform 
better on school 
(or 
occupational) 
work/tests -.011 .007 -.041 .038 .010 -.043 -.045 .930 -.016 -.004 -.009 .052 
77. To focus or 
pay attention .028 -.001 -.022 -.007 -.047 .023 .002 .898 .029 .006 .004 .023 
81. To study 
better .060 -.041 -.020 .025 -.007 .016 .003 .862 -.042 .031 -.048 .002 
78. To stay 
awake  -.114 .054 .140 -.074 .050 -.002 .093 .669 .015 -.068 .083 .028 
9. Increase Positive Affect 
30. To feel 
more joy or 
happiness  -.005 .035 .050 .060 -.051 -.091 .077 .025 .760 .044 .197 -.028 
39. To help me 
get into a good 
mood  .115 .020 -.043 .075 .029 .043 -.010 -.001 .709 .029 .065 .029 
37. To have fun .076 -.007 -.113 .085 .145 .149 .015 .010 .673 -.122 -.127 -.039 
 
 
Table 6 Continued 
34. To celebrate .054 -.008 -.046 .033 .137 .124 .049 -.041 .625 -.067 -.160 -.008 
32. To feel 
more pleasure .128 -.047 .149 .075 -.036 .014 .023 .036 .605 -.019 .118 -.024 
28. To feel 
more excited -.026 .074 .105 -.002 .085 -.052 .130 .100 .592 .025 -.036 -.047 
35. To feel 
content with life .051 .054 .079 -.020 -.032 -.037 .064 .061 .587 .213 .127 .091 
38. To feel alive -.104 -.029 .038 .013 .103 .083 .092 -.005 .578 .181 .148 .044 
29. To feel less 
bored .028 .003 .099 .071 .007 .054 .002 .076 .557 .099 .007 .003 
36. To feel 
euphoric or feel 
at peace .137 .002 .007 .104 -.051 .015 .215 .005 .501 -.027 .065 .116 
31. To feel 
more self-
confident or 
effective .057 .038 .091 -.063 .289 -.097 .064 .131 .375 .067 .142 -.008 
33. To improve 
my self-esteem -.021 .168 .087 -.060 .190 -.003 .079 .110 .353 .075 .213 -.055 
10. Manage Negative Social Interactions 
50. To avoid 
hurting 
someone’s 
feelings .022 .081 -.105 .028 .086 .076 .069 .020 .023 .773 -.040 .038 
51. To avoid or 
manage conflict 
with others .103 -.018 -.080 .005 .096 .093 .002 .085 .103 .665 -.038 .101 
11. Reduce Negative Affect 
9. To feel less 
ashamed -.024 .028 .047 .054 .020 .070 .033 .092 .049 .026 .732 -.070 
 
 
Table 6 Continued 
8. To reduce 
feelings of 
helplessness .193 -.029 -.080 .022 .055 .044 .037 .068 .014 -.044 .697 .089 
7. To reduce 
feeling of 
hopelessness .229 -.083 -.016 .055 .077 .002 .040 .019 .090 -.092 .637 .114 
10. To feel less 
guilty .042 .040 .042 .079 -.060 .142 -.021 .094 .087 .110 .588 .013 
12. To feel less 
lonely .343 .008 -.056 -.014 .112 .114 .069 -.016 .038 -.053 .455 .094 
2. To forget, 
escape, or avoid 
my memories .328 -.022 .002 -.010 .166 .093 -.005 .012 .065 -.108 .401 .080 
12. Substitution 
92. To get the 
same effects as 
something I’m 
prescribed when 
I run out of my 
prescription -.023 .007 .031 .020 -.019 .012 .062 -.014 -.041 -.014 .046 .908 
89. To get the 
same amount of 
the drug I think 
I need when my 
doctor won’t 
prescribe 
enough to me -.071 .026 .046 -.003 .021 .067 .013 .132 -.077 -.048 .018 .751 
 
 
 
 
Table 6 Continued 
90. To use a 
drug that is 
more powerful 
than one I have 
gotten used to -.007 -.013 .167 .076 -.054 .028 -.009 .041 .057 -.008 -.072 .622 
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12-Factor Model Factor Correlations 
The correlations among the rotated factors are presented in Table 7. The largest 
correlation was between Reduce Negative Affect and Reduce Anxiety/Unpleasant 
Arousal (r = .479) and the smallest correlation was between Relative Low Risk and 
Manage Negative Social Interactions (r = .055). The correlations among the factor scaled 
scores are presented in Table 8. We observed strong positive correlations between 
Reduce Anxiety/Unpleasant Arousal and Reduce Negative Affect (r = .757) and Increase 
Positive Affect (r = .663). This finding made sense given that symptoms of anxiety and 
affective disturbances are highly interrelated and are distressing to the point of feeling a 
need to increase positive affect. There was also a strong positive correlation between 
Positive Social Interactions and Increase Positive Affect (r = .675), which also made 
theoretical sense given how closely self-esteem and happiness are socially tied. The 
weakest correlations were observed in relationships with Conformity, specifically with 
Effects of Other Substances (r = .198), Altered Perceptions/Experiential Processes (r = 
.122), Performance/Arousal Enhancement (r = .145), and Substitution (r = .161). Lastly, 
we observed a weak relationship between Relative Low Risk and Manage Negative 
Social Interactions (r = .194). Indeed, none of these factors were hypothesized to be 
related.  
 
 
 
 
 
Table 7  
Factor Correlation Matrix 
Note: Factor 1 (Reduce Anxiety / Unpleasant Arousal); Factor 2 (Conformity); Factor 3 (Effects of Other Substances); Factor 4 (Relative Low Risk); Factor 5 (Positive Social Interactions); 
Factor 6 (Rebellion); Factor 7 (Altered Perceptions / Experiential Processes); Factor 8 (Performance / Arousal Enhancement); Factor 9 (Increase Positive Affect); Factor 10 (Manage Negative 
Social Interactions); Factor 11 (Reduce Negative Affect); Factor 12 (Substitution) 
 
 
 
 
 
 
 
Factor 1 2 3 4 5 6 7 8 9 10 11 12 
1 ---            
2 .121 ---           
3 .215 .118 ---          
4 .433 .155 .159 ---         
5 .311 .319 .200 .254 ---        
6 .202 .271 .250 .271 .201 ---       
7 .354 .085 .365 .374 .264 .238 ---      
8 .303 .106 .413 .206 .262 .197 .342 ---     
9 .434 .099 .211 .352 .435 .240 .422 .263 ---    
10 .151 .273 .123 .055 .258 .094 .182 .244 .174 ---   
11 .479 .159 .303 .162 .242 .119 .206 .293 .226 .217 ---  
12 .156 .113 .424 .244 .064 .274 .189 .327 .112 .113 .188 --- 
 
 
Table 8  
MUSQ Scale Score Correlation Matrix 
Factor 1 2 3 4 5 6 7 8 9 10 11 12 
1 ---            
2 .252*** ---           
3 .447*** .198*** ---          
4 .509*** .213*** .303*** ---         
5 .575*** .439*** .431*** .372*** ---        
6 .354*** .377*** .442*** .316*** .364*** ---       
7 .495*** .122* .479*** .416*** .425*** .332*** ---      
8 .399*** .145** .485*** .214*** .380*** .260*** .371*** ---     
9 .663*** .242*** .456*** .444*** .675*** .387*** .559*** .385*** ---    
10 .368*** .338*** .207*** .194*** .514*** .272*** .293*** .302*** .416*** ---   
11 .757*** .233*** .448*** .359*** .534*** .360*** .387*** .398*** .567*** .317*** ---  
12 .256*** .161** .557*** .283*** .203*** .370*** .273*** .395*** .236*** .219*** .307*** --- 
Note: Factor 1 (Reduce Anxiety / Unpleasant Arousal); Factor 2 (Conformity); Factor 3 (Effects of Other Substances); Factor 4 (Relative Low Risk); Factor 5 (Positive Social Interactions); 
Factor 6 (Rebellion); Factor 7 (Altered Perceptions / Experiential Processes); Factor 8 (Performance / Arousal Enhancement); Factor 9 (Increase Positive Affect); Factor 10 (Manage Negative 
Social Interactions); Factor 11 (Reduce Negative Affect); Factor 12 (Substitution) 
*p < .05; **p < .01; ***p < .0
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Hypothesis 2: Wanting, Liking, and Satisfaction Predicting Frequency of Use 
We conducted eight multiple regressions with participants’ mean wanting score 
and paired liking and satisfaction scale scores as independent variables and participants’ 
maximum frequency score for their most frequently used substance serving as the 
dependent variable. For example, the scale score for Factor 1 liking responses was 
analyzed with the scale score for Factor 1 satisfaction responses. We conducted 
regressions for liking and satisfaction scale scores for Factors 1, 4, 5, 7, 8, 9, 10, and 11 
to allow for adequate sample sizes. For the models, the sample size ranged from 56 to 85. 
All models were significant with a Bonferroni correction of p < .006 and accounted for 
15 to 42.8 percent of the variance in substance use frequency scores; however, contrary to 
our hypotheses, satisfaction and liking were not significant predictors of frequency of use 
in any of the models. At the individual variable level, wanting was a significant predictor 
of frequency of use in all models, such that greater intensity of wanting predicted more 
frequent substance use. Standardized betas for wanting ranged from .415 to .654 (See 
Table 9). 
Table 9  
 
Multiple Regression Analyses for Wanting, Liking, and Satisfaction Predicting Frequency 
of Use for Most Frequently Used Substance 
 
 
 
 
 
 
 n R2 B SE B β t p 
Model 1a 72 .255         .000* 
     (constant)     2.983 .837   3.566 .001* 
     Wanting     .524 .112 .495 4.677 .000* 
     MUSQL1     .266 .238 .175 1.115 .269 
     MUSQS1     -.081 .254 -.050 -.320 .750 
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Table 9 Continued 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Note: Liking and Satisfaction scale scores for: a Reduce Anxiety/Unpleasant Arousal; b Relative Low Risk; c Positive Social 
Interactions; d Altered Perceptions/Experiential Processes; e Performance/Arousal Enhancement; f Increase Positive Affect; g Manage 
Negative Social Interactions; h Reduce Negative Affect; * Significant with Bonferroni correction of p < .006 
 
 
Model 2b 81 .150         .001* 
     (constant)     2.619 .761   3.441 .001* 
     Wanting     .543 .136 .415 3.985 .000* 
     MUSQL4     .439 .461 .304 .952 .344 
     MUSQS4     -.323 .447 -.231 -.721 .473 
Model 3c 65 .394         .000* 
     (constant)     1.12 .821   1.363 .178 
     Wanting     .646 .120 .545 5.378 .000* 
     MUSQL5     .000 .264 .000 .001 .999 
     MUSQS5     .455 .310 .253 1.468 .147 
Model 4d 56 .270         .001* 
     (constant)     2.077 .802   2.589 .012* 
     Wanting     .518 .137 .452 3.791 .000* 
     MUSQL7     -.384 .453 -.312 -.848 .400 
     MUSQS7     .712 .456 .575 1.562 .124 
Model 5e 61 .270         .000* 
     (constant)     2.294 .816   2.81 .007* 
     Wanting     .665 .151 .502 4.412 .000* 
     MUSQL8     .030 .344 .022 .087 .931 
     MUSQS8     .204 .316 .160 .644 .522 
Model 6f 85 .309         .000* 
     (constant)     1.434 .837   1.713 .090 
     Wanting     .597 .112 .494 5.321 .000* 
     MUSQL9     -.006 .328 -.003 -.019 .985 
     MUSQS9     .461 .362 .233 1.274 .206 
Model 7g 64 .427         .000* 
     (constant)     2.32 .575   4.036 .000* 
     Wanting     .809 .122 .654 6.623 .000* 
     
MUSQL10 
    -.272 .224 -.222 -1.21 .231 
     
MUSQS10 
    .295 .212 .257 1.392 .169 
Model 8h 65 .428         .000* 
     (constant)     1.866 .626   2.982 .004* 
     Wanting     .719 .118 .614 6.111 .000* 
     
MUSQL11 
    .161 .158 .122 1.017 .313 
     
MUSQS11 
    .065 .179 .045 .361 .719 
 
102 
Hypothesis 3: Wanting, Liking, and Satisfaction Predicting Severity and Change  
We conducted 16 canonical correlation analyses to examine the extent to which 
frequency of use, wanting, liking, and satisfaction motive scores, as a set, were predictive 
of alcohol and cannabis severity and change variables, as a set. Again, we conducted 
separate analyses for paired liking and satisfaction motive scaled scores for Factors 1, 4, 
5, 7, 8, 9, 10, and 11 to allow for sufficiently large sample sizes and conducted these 
analyses separately for both alcohol and cannabis variables of interest (i.e., DSM-5 
severity, consequences/experiences from use, ideal use, stage of change, and RFQ). 
Therefore, frequency of use, wanting, liking, and satisfaction motive scores served as one 
variable set (referred to as “frequency and motivation scores”) and alcohol/cannabis 
variables of interest (referred to as “severity and change scores”) served as the second 
variable set.  Although we will interpret some findings here, it should be noted that our 
sample sizes for the analyses were substantially smaller than what is necessary for 
reliable interpretations. Stevens (1986) suggests at least 20 cases per variable to interpret 
the first salient function, while Barcikowski and Stevens (1975) suggest at least 40 cases 
per variable if more than one function is to be interpreted. Further, functions with 
canonical correlations at .7 or greater are likely reliable with smaller sample sizes (i.e., 
around n = 50; Stevens, 1986). Sample sizes for these analyses ranged from 30 to 54, 
with the majority of sample sizes in the 40s. As such, we only interpreted the first 
functions of the canonicals that consisted of canonical functions that accounted for ten 
percent or more of the variance (Stevens, 1996), function coefficients with absolute 
values of .35 or greater (Thompson, 1984) and functions with canonical correlations of at 
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least .7 (Stevens, 1986). The results of the canonical correlations described below are 
presented in Tables 10 through 24.  
 The first canonical correlation analysis examined the multivariate relationships 
between frequency and motivation scores for Factor 1 (Reduce Anxiety/Unpleasant 
Arousal) with alcohol severity and change variables (Table 10). Based on our criteria for 
the percentage of variance accounted for by the functions and magnitude of the canonical 
correlation, the first function was interpreted. Frequency and motivation scores accounted 
for 78.71% of the variance in severity and change scores (Rc = .89). Examination of 
salient function coefficients revealed a pattern where the combination of higher 
frequency of use and less satisfaction of the motive to reduce anxiety/unpleasant arousal 
predicted greater DSM-5 AUD severity.  
Table 10  
 
Canonical Correlation Analysis: Frequency of Use, Wanting, Liking, and Satisfaction for 
Reduce Anxiety / Unpleasant Arousal Motives Predicting Alcohol Use Severity and 
Change Variables 
 
 
 
 
 
 
 
 
 
 Function 1 Function 2 
Variable Coef.  Coef.   
Severity and Change Variables      
     DSM-5 AUD Severity .774  .791   
     Consequences/Experiences               
     from Use 
-.282  .851   
     Ideal Use .127  -.712   
     Stage of Change .283  -1.167   
     RFQ -.222  .845   
      
Rc  .887  .411  
Rc
2 (%)  78.71  16.88  
      
Covariates      
     Frequency of Use .688  -.805   
     Wanting  .344  .944   
     MUSQL1 .211  1.20   
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Table 10 Continued 
 
Note: n = 41 
 
The second canonical correlation analysis examined the multivariate relationships 
between frequency and motivation scores for Factor 4 (Relative Low Risk) with alcohol 
severity and change variables (Table 11). The first function accounted for 72.41% of the 
variance (Rc = .85). Salient function coefficients revealed a pattern where the 
combination of higher frequency of use, more craving, more liking that one uses alcohol 
because of its relative low risk, yet less satisfaction in the motive to use because one 
believes alcohol is a relatively low-risk substance strongly predicted greater DSM-5 
AUD severity.  
Table 11  
 
Canonical Correlation Analysis: Frequency of Use, Wanting, Liking, and Satisfaction for 
Relative Low Risk Motives Predicting Alcohol Use Severity and Change Variables 
 
 
 
 
 
 
 
 
 
 
Note: n = 54 
     MUSQS1 -.386  -.798   
 Function 1 Function 2 
Variable Coef.  Coef.  
Severity and Change Variables     
     DSM-5 AUD Severity 1.088  1.159  
     Consequences/Experiences               
     from Use 
-.079  .740  
     Ideal Use .020  .143  
     Stage of Change -.150  -.700  
     RFQ -.117  -.542  
     
Rc  .851  .410 
Rc
2 (%)  72.41  16.78 
     
Covariates     
     Frequency of Use .750  .215  
     Wanting  .369  -.275  
     MUSQL4 .446  2.263  
     MUSQS4 -.645  -1.479  
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 The third canonical correlation analysis examined the multivariate relationships 
between frequency and motivation scores for Factor 5 (Positive Social Interactions) with 
alcohol severity and change variables (Table 12). The first function accounted for 73.76% 
of the variance (Rc = .86). Salient function coefficients revealed a pattern where less 
frequent alcohol use predicted lower DSM-5 AUD severity.  
Table 12  
 
Canonical Correlation Analysis: Frequency of Use, Wanting, Liking, and Satisfaction for 
Positive Social Interactions Motives Predicting Alcohol Use Severity and Change 
Variables 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Note: n = 41 
The fourth canonical correlation analysis examined the multivariate relationships 
between frequency and motivation scores for Factor 7 (Altered Perceptions/Experiential 
Processes) with alcohol severity and change variables (Table 13). The first function 
accounted for 66.65% of the variance (Rc = .82). Salient function coefficients revealed a 
pattern where the combination of lower frequency of alcohol use, less cravings, and less 
 Function 1 Function 2 
Variable Coef.  Coef.   
Severity and Change Variables      
     DSM-5 AUD Severity -.915  .322   
     Consequences/Experiences               
     from Use 
.183  -.371   
     Ideal Use -.029  .680   
     Stage of Change -.019  .158   
     RFQ .126  -.999   
      
Rc   .859   .376  
Rc
2 (%)   73.76   14.14  
      
Covariates        
     Frequency of Use -.828  .892   
     Wanting  -.329  -1.187   
     MUSQL5 .017  -.547   
     MUSQS5 .136  .576   
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satisfaction of the motive to alter one’s perceptions and seek new experiences predicted 
lower DSM-5 AUD severity.  
Table 13  
 
Canonical Correlation Analysis: Frequency of Use, Wanting, Liking, and Satisfaction for 
Altered Perceptions/Experiential Processes Motives Predicting Alcohol Use Severity and 
Change Variables 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Note: n = 30 
The fifth canonical correlation analysis examined the multivariate relationships 
between frequency and motivation scores for Factor 8 (Performance/Arousal 
Enhancement) with alcohol severity and change variables (Table 14). The first three 
functions were interpreted, which accounted for 68.55% of the variance (Rc = .83). 
Salient function coefficients revealed a pattern where higher frequency of use predicted 
greater DSM-5 AUD severity.  
 
 
 Function 1 Function 2 
Variable Coef.  Coef.   
Severity and Change Variables      
     DSM-5 AUD Severity -1.01  .280   
     Consequences/Experiences               
     from Use 
-.104  -.391   
     Ideal Use -.139  .696   
     Stage of Change -.205  -.030   
     RFQ .057  -.789   
      
Rc  .816  .530  
Rc
2 (%)  66.65  28.04  
      
Covariates      
     Frequency of Use -.732  .784   
     Wanting  -.478  -.910   
     MUSQL7 .349  -.494   
     MUSQS7 -.368  .821   
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Table 14  
 
Canonical Correlation Analysis: Frequency of Use, Wanting, Liking, and Satisfaction for 
Performance/Arousal Enhancement Motives Predicting Alcohol Use Severity and Change 
Variables 
 
Note: n = 32 
The sixth canonical correlation analysis examined the multivariate relationships 
between frequency and motivation scores for Factor 9 (Increase Positive Affect) with 
alcohol severity and change variables (Table 15). The first function accounted for 72.72% 
of the variance (Rc = .85). Salient function coefficients revealed a pattern where the 
combination of higher frequency of alcohol use, more cravings, more liking that one uses 
to increase positive affect, but less actual achievement of increasing positive affect 
predicted greater DSM-5 AUD severity.  
 
 
 Function 1 Function 2 
Variable Coef.  Coef.   
Severity and Change Variables      
     DSM-5 AUD Severity 1.103  .428   
     Consequences/Experiences               
     from Use 
-.023  .680   
     Ideal Use .234  -.483   
     Stage of Change .167  -.742   
     RFQ -.243  .597   
      
Rc   .828   .494  
Rc
2 (%)   68.55   25.39  
      
Covariates        
     Frequency of Use .880  -.420   
     Wanting  .137  .465   
     MUSQL8 .265  1.400   
     MUSQS8 -.142  -1.738   
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Table 15  
 
Canonical Correlation Analysis: Frequency of Use, Wanting, Liking, and Satisfaction for 
Increase Positive Affect Motives Predicting Alcohol Use Severity and Change Variables 
 
 
 
 
 
 
 
 
 
\ 
 
 
 
 
 
 
Note: n = 49 
The seventh canonical correlation analysis examined the multivariate 
relationships between frequency and motivation scores for Factor 10 (Manage Negative 
Social Interactions) with alcohol severity and change variables (Table 16). The first 
function accounted for 64.10% of the variance (Rc = .80). Salient function coefficients 
revealed a pattern where the combination of higher frequency of alcohol use, more 
cravings, more liking that one uses to manage negative social interactions, but less actual 
achievement of managing negative social interactions predicted greater DSM-5 AUD 
severity.  
 
 
 Function 1 Function 2 
Variable Coef.  Coef.   
Severity and Change Variables      
     DSM-5 AUD Severity .919  -.026   
     Consequences/Experiences               
     from Use 
-.053  -.238   
     Ideal Use -.041  -.062   
     Stage of Change .072  -.498   
     RFQ -.077  .949   
      
Adequacy        
Rc  .853   .456  
Rc
2 (%)  72.72   20.81  
Adequacy       
      
Covariates       
     Frequency of Use .714  -.628   
     Wanting  .350  .406   
     MUSQL9     .483  1.09   
     MUSQS9  -.487  -1.760   
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Table 16  
 
Canonical Correlation Analysis: Frequency of Use, Wanting, Liking, and Satisfaction for 
Manage Negative Social Interactions Motives Predicting Alcohol Use Severity and 
Change Variables 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Note: n = 40 
The eighth canonical correlation analysis examined the multivariate relationships 
between frequency and motivation scores for Factor 11 (Reduce Negative Affect) with 
alcohol severity and change variables (Table 17). The first function accounted for 59.91% 
of the variance (Rc = .77). Salient function coefficients revealed a pattern where the 
combination of higher frequency of alcohol use and more cravings predicted greater 
DSM-5 AUD severity.  
 
 
 
 
 Function 1 Function 2 
Variable Coef.  Coef.   
Severity and Change Variables      
     DSM-5 AUD Severity .831  -.482   
     Consequences/Experiences               
     from Use 
-.237  -.060   
     Ideal Use -.162  -.340   
     Stage of Change -.038  -.100   
     RFQ -.058  .935   
      
Rc   .801   .422  
Rc
2 (%)   64.10   17.77  
      
Covariates        
     Frequency of Use .514  -.289   
     Wanting  .596  .272   
     MUSQL10 .397  1.541   
     MUSQS10 -.471  -.878   
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Table 17  
 
Canonical Correlation Analysis: Frequency of Use, Wanting, Liking, and Satisfaction for 
Reduce Negative Affect Motives Predicting Alcohol Use Severity and Change Variables 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Note: n = 41 
The ninth canonical correlation analysis examined the multivariate relationships 
between frequency and motivation scores for Factor 1 (Reduce Anxiety/Unpleasant 
Arousal) with cannabis severity and change variables (Table 18). The first function 
accounted for 44.06%, of the variance (Rc = .66). Salient function coefficients revealed a 
pattern where the combination of higher frequency of use and greater craving predicted a 
combination of greater DSM-5 CUD severity and less self-identified reasons to quit.  
 
 
 
 
 Function 1 Function 2 
Variable Coef.  Coef.   
Severity and Change Variables      
     DSM-5 AUD Severity 1.207  .544   
     Consequences/Experiences               
     from Use 
.146  .446   
     Ideal Use .091  .232   
     Stage of Change -.025  -.527   
     RFQ -.260  -.325   
      
Rc   .774   .648  
Rc
2 (%)   59.91   41.94  
      
Covariates        
     Frequency of Use .603  -.645   
     Wanting  .415  .209   
     MUSQL11 .207  .522   
     MUSQS11 .132  .484   
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Table 18  
 
Canonical Correlation Analysis: Frequency of Use, Wanting, Liking, and Satisfaction for 
Reduce Anxiety / Unpleasant Arousal Motives Predicting Cannabis Use Severity and 
Change Variables 
Note: n = 41 
 The tenth canonical correlation analysis examined the multivariate relationships 
between frequency and motivation scores for Factor 4 (Relative Low Risk) with cannabis 
severity and change variables (Table 19). The first function accounted for 52.03% of the 
variance (Rc = .72). Salient function coefficients revealed a pattern where the 
combination of higher frequency of use, more craving, more liking that one uses cannabis 
because of its relative low risk, yet less satisfaction in the motive to use because one 
believes cannabis is a relatively low-risk substance strongly predicted greater DSM-5 
CUD severity.  
 
 
 Function 1 Function 2  
Variable Coef.  Coef.    
       
Severity and Change Variables       
     DSM-5 CUD Severity 1.131  .073    
     Consequences/Experiences               
     from Use 
.176  -.730    
     Ideal Use -.283  .400    
     Stage of Change .047  -.543    
     RFQ -.665  .642    
         
Rc   .664   .527   
Rc
2 (%)   44.06   27.79   
         
Covariates         
     Frequency of Use .578  .471    
     Wanting  .717  -.435    
     MUSQL1 .024  -.188    
     MUSQS1 -.258  -.661    
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Table 19  
 
Canonical Correlation Analysis: Frequency of Use, Wanting, Liking, and Satisfaction for 
Relative Low Risk Motives Predicting Cannabis Use Severity and Change Variables 
Note: n = 34 
 The eleventh canonical correlation analysis examined the multivariate 
relationships between frequency and motivation scores for Factor 5 (Positive Social 
Interactions) with cannabis severity and change variables (Table 20). The first function 
accounted for 49.59% of the variance (Rc = .70). Salient function coefficients revealed a 
pattern where the combination of less craving and more satisfaction of the goal of 
positive social interactions through cannabis use predicted a combination of lower DSM-
5 CUD severity, more perceived positive consequences and experiences from use, and 
being lower on the Stages of Change.  
 
 
 
 Function 1 Function 2 
Variable Coef.  Coef.   
Severity and Change Variables      
     DSM-5 CUD Severity .989  -.740   
     Consequences/Experiences               
     from Use 
.271  -.639   
     Ideal Use -.057  -.221   
     Stage of Change .139  -.404   
     RFQ .085  .918   
        
Rc   .721   .528  
Rc
2 (%)   52.03   27.90  
        
Covariates        
     Frequency of Use .640  -.603   
     Wanting  .713  .599   
     MUSQL4 .386  -.361   
     MUSQS4 -.600  -.381   
 
113 
Table 20  
 
Canonical Correlation Analysis: Frequency of Use, Wanting, Liking, and Satisfaction for 
Positive Social Interactions Motives Predicting Cannabis Use Severity and Change 
Variables 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Note: n = 43 
The twelfth canonical correlation analysis examined the multivariate relationships 
between frequency and motivation scores for Factor 7 (Altered Perceptions/Experiential 
Processes) with cannabis severity and change variables (Table 21). The first function 
functions accounted for 46.62% (Rc = .68). Salient function coefficients revealed a 
pattern where the combination of more craving, less liking that one uses cannabis to alter 
their perceptions and seek new experiences, yet more satisfaction of this goal predicted a 
combination of greater DSM-5 CUD severity and more reasons to quit.  
 
 
 
 Function 1 Function 2 
Variable Coef.  Coef.   
Severity and Change Variables      
     DSM-5 CUD Severity -.739  .662   
     Consequences/Experiences               
     from Use 
.523  .629   
     Ideal Use -.318  -.505   
     Stage of Change -.478  -.210   
     RFQ -.014  -.343   
        
Rc   .704   .667  
Rc
2 (%)   49.59   44.46  
        
Covariates        
     Frequency of Use -.003  1.025   
     Wanting  -1.028  -.112   
     MUSQL5 -.347  -.120   
     MUSQS5 .549  -.182   
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Table 21  
 
Canonical Correlation Analysis: Frequency of Use, Wanting, Liking, and Satisfaction for 
Altered Perceptions/Experiential Processes Motives Predicting Cannabis Use Severity 
and Change Variables 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Note: n = 43 
 The thirteenth canonical correlation analysis examined the multivariate 
relationships between frequency and motivation scores for Factor 8 (Performance / 
Arousal Enhancement) with cannabis severity and change variables (Table 22). The first 
function accounted for 50.64% of the variance (Rc = .71). Salient function coefficients 
revealed a pattern where higher frequency of use predicted a combination of greater 
DSM-5 AUD severity and more perceived positive consequence and experiences from 
use.  
 
 
 
 Function 1 Function 2 
Variable Coef.  Coef.   
Severity and Change Variables      
     DSM-5 CUD Severity -.739  .662   
     Consequences/Experiences               
     from Use 
.523  .629   
     Ideal Use -.318  -.505   
     Stage of Change -.478  -.210   
     RFQ -.014  -.343   
        
Rc   .704   .667  
Rc
2 (%)   49.59   44.46  
        
Covariates        
     Frequency of Use -.003  1.025   
     Wanting  -1.028  -.112   
     MUSQL5 -.347  -.120   
     MUSQS5 .549  -.182   
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Table 22  
 
Canonical Correlation Analysis: Frequency of Use, Wanting, Liking, and Satisfaction for 
Performance/Arousal Enhancement Motives Predicting Cannabis Use Severity and 
Change Variables 
Note: n = 34 
The fourteenth canonical correlation analysis examining frequency and 
motivation scores for Factor 9 (Increase Positive Affect) with cannabis severity and 
change variables was uninterpretable due to a low sample size (n = 5). 
The fifteenth canonical correlation analysis examined the multivariate 
relationships between frequency and motivation scores for Factor 10 (Manage Negative 
Social Interactions) with cannabis severity and change variables (Table 23). The first 
function accounted for 56.51% of the variance (Rc = .75). Salient function coefficients 
revealed a pattern where the combination of higher frequency of cannabis use, more 
cravings, less liking that one uses to manage negative social interactions, but more actual 
achievement of managing negative social interactions predicted greater DSM-5 CUD 
 Function 1 Function 2 
Variable Coef.  Coef.   
Severity and Change Variables      
     DSM-5 CUD Severity 1.070  -.637   
     Consequences/Experiences               
     from Use 
.491  .552   
     Ideal Use -.127  -.617   
     Stage of Change .080  -.790   
     RFQ -.153  .407   
         
Rc   .712   .462  
Rc
2 (%)   50.64   21.32  
          
Covariates        
     Frequency of Use .875  .549   
     Wanting  .276  -.839   
     MUSQL8 .051  -.028   
     MUSQS8 -.349  .623   
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severity, more perceived positive consequences and experiences from use, wanting to use 
cannabis less, and being lower on the Stages of Change.  
Table 23  
 
Canonical Correlation Analysis: Frequency of Use, Wanting, Liking, and Satisfaction for 
Manage Negative Social Interactions Motives Predicting Cannabis Use Severity and 
Change Variables 
Note: n = 32 
Lastly, the sixteenth canonical correlation analysis examined the multivariate 
relationships between frequency and motivation scores for Factor 11 (Reduce Negative 
Affect) with cannabis severity and change variables (Table 24). The first function 
accounted for 69.22% of the variance (Rc = .83). Salient function coefficients revealed a 
pattern where the combination of higher frequency of cannabis use and more cravings 
predicted a combination of greater DSM-5 CUD severity, more perceived positive 
consequences and experiences from use, and less self-identified reasons to quit.  
 
 Function 1 Function 2 
Variable Coef.  Coef.   
Severity and Change Variables      
     DSM-5 CUD Severity .851  .557   
     Consequences/Experiences               
     from Use 
.486  -.705   
     Ideal Use -.552  .104   
     Stage of Change -.367  .540   
     RFQ -.305  -.326   
          
Rc   .752   .544  
Rc
2 (%)   56.51   29.55  
          
Covariates         
     Frequency of Use .562  -.462   
     Wanting  .373  .924   
     MUSQL10 -1.016  .367   
     MUSQS10 .907  -.585   
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Table 24  
 
Canonical Correlation Analysis: Frequency of Use, Wanting, Liking, and Satisfaction for 
Reduce Negative Affect Motives Predicting Cannabis Use Severity and Change Variables 
Note: n = 34 
Hypothesis 4: Incremental Validity Testing of Frequency, Liking, and Satisfaction 
Motive Measures 
We conducted 16 canonical correlation analyses to examine the extent to which 
frequency (of use for motive), liking, and satisfaction motive scores, as a set, were 
predictive of alcohol and cannabis severity and change variables, as a set. As before, we 
conducted separate analyses for Factors 1, 4, 5, 7, 8, 9, 10, and 11 to allow for sufficient 
sample sizes and conducted these analyses separately for both alcohol and cannabis 
variables of interest (i.e., DSM-5 severity, consequences/experiences from use, ideal use, 
stage of change, and RFQ). Therefore, frequency (of use for motive), wanting, liking, and 
satisfaction motive scores served as one variable set (referred to as “MUSQ scores”) and 
alcohol/cannabis variables of interest (referred to as “severity and change scores”) served 
 Function 1 Function 2 
Variable Coef.  Coef.   
Severity and Change Variables      
     DSM-5 CUD Severity .954  -.093   
     Consequences/Experiences               
     from Use 
.424  .017   
     Ideal Use -.158  -.453   
     Stage of Change .232  .122   
     RFQ -.418  -1.071   
          
Rc   .832   .620  
Rc
2 (%)   69.22   38.43  
          
Covariates        
     Frequency of Use .686  -.843   
     Wanting  .371  1.011   
     MUSQL11 .035  .585   
     MUSQS11 .114  -.349   
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as the second variable set. Sample sizes for these analyses ranged from 30 to 57, with the 
majority of sample sizes in the 40s. We utilized the same inclusion criteria used for 
hypothesis 3. Fourteen of the canonical correlation analyses were uninterpretable due to 
having canonical correlations below .7 (i.e., highest Rc = .646). As such, we interpreted 
only the first functions of two canonical correlation analyses. The results of all the 
canonical correlations are presented in Tables 25 through 39.  
We examined the multivariate relationships between MUSQ scores for Factor 11 
(Reduce Negative Affect) with alcohol severity and change variables (Table 31). The first 
function accounted for 50.19% of the variance (Rc = .71). Salient function coefficients 
revealed a pattern where the combination of higher frequency of alcohol use to reduce 
negative affect, less liking that one uses to reduce negative affect and less satisfaction of 
this goal through use predicted a combination of lower DSM-5 AUD severity, more 
perceived negative consequences and experiences from use, and more reasons to quit.  
We also examined the multivariate relationships between MUSQ scores for Factor 
8 (Enhance Performance/Arousal) with cannabis severity and change variables (Table 
36). The first function was interpreted, which accounted for 52.17 percent of the variance 
(Rc = .72). Salient function coefficients revealed a pattern where the combination of 
lower frequency of use to enhance one’s performance or arousal, less liking that one uses 
substances to achieve this goal, but greater satisfaction of this motive through cannabis 
use predicted a combination of greater DSM-5 CUD severity and more perceived positive 
consequences and experiences from cannabis use.  
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Table 25  
 
Canonical Correlation Analysis: Motive Frequency, Liking, and Satisfaction for Reduce 
Anxiety / Unpleasant Arousal Motives Predicting Alcohol Use Severity and Change 
Variables 
 
 
 
 
 
 
 
 
 
 
Note: n = 41 
 
 
 
 
 
 
 
 
 
 
         Function 1 
Variable Coef.  
Severity and Change Variables   
     DSM-5 AUD Severity  -.017  
     Consequences/Experiences               
     from Use 
.640  
     Ideal Use -.381  
     Stage of Change .125  
     RFQ -.697  
   
Rc  .626 
Rc
2 (%)  39.22 
   
MUSQ Factor 1   
     Frequency -1.22  
     Liking -.048  
     Satisfaction 1.25  
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Table 26  
 
Canonical Correlation Analysis: Motive Frequency, Liking, and Satisfaction for Relative 
Low Risk Motives Predicting Alcohol Use Severity and Change Variables 
Note: n = 5 
 
 
 
 
 
 
 
 
 
 
 
         Function 1   
Variable Coef.      
Severity and Change Variables       
     DSM-5 AUD Severity 1.12      
     Consequences/Experiences               
     from Use 
.888      
     Ideal Use .004      
     Stage of Change -.732      
     RFQ -.332      
       
Rc  .412     
Rc
2 (%)  16.97     
       
MUSQ Factor 4       
     Frequency -.361      
     Liking 2.55      
     Satisfaction -1.40      
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Table 27  
 
Canonical Correlation Analysis: Motive Frequency, Liking, and Satisfaction for Altered 
Perceptions / Experiential Processes Motives Predicting Alcohol Use Severity and 
Change Variables 
 
 
 
 
 
 
 
 
 
Note: n = 30 
 
 
 
 
 
 
 
 
 
 
      Function 1 
Variable Coef.  
Severity and Change Variables   
     DSM-5 AUD Severity -.065  
     Consequences/Experiences               
     from Use 
-.939  
     Ideal Use .795  
     Stage of Change -.243  
     RFQ -.178  
   
Rc  .524 
Rc
2 (%)  27.43 
   
MUSQ Factor 7   
     Frequency 1.23  
     Liking -.856  
     Satisfaction .312  
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Table 28  
 
Canonical Correlation Analysis: Motive Frequency, Liking, and Satisfaction for 
Performance / Arousal Enhancement Motives Predicting Alcohol Use Severity and 
Change Variables 
 
 
 
 
 
 
 
 
 
Note: n = 32 
 
 
 
 
 
 
 
 
 
 
      Function 1      Function 2 
Variable Coef.  Coef.   
Severity and Change Variables      
     DSM-5 AUD Severity .891  .854   
     Consequences/Experiences               
     from Use 
.746  .150   
     Ideal Use .015  1.04   
     Stage of Change -.556  .211   
     RFQ .559  -.558   
      
Rc  .492  .361  
Rc
2 (%)  24.20  13.04  
      
MUSQ Factor 8      
     Frequency -.008  1.19   
     Liking 1.92  -.306   
     Satisfaction -2.06  .034   
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Table 29  
 
Canonical Correlation Analysis: Motive Frequency, Liking, and Satisfaction for Increase 
Positive Affect Motives Predicting Alcohol Use Severity and Change Variables 
 
 
 
 
 
 
 
 
 
Note: n = 49 
 
 
 
 
 
 
 
 
 
 
 
      Function 1         Function 2 
Variable Coef.  Coef. 
Severity and Change Variables      
     DSM-5 AUD Severity .679  -.264   
     Consequences/Experiences               
     from Use 
-.554  .278   
     Ideal Use -.134  .469   
     Stage of Change -.747  .834   
     RFQ .373  .783   
      
Rc  .532  .357  
Rc
2 (%)  28.28  12.72  
      
MUSQ Factor 9      
     Frequency .791  -1.17   
     Liking .729  1.13   
     Satisfaction -1.69  -.655   
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Table 30  
 
Canonical Correlation Analysis: Motive Frequency, Liking, and Satisfaction for Manage 
Negative Social Interactions Motives Predicting Alcohol Use Severity and Change 
Variables 
 
 
 
 
 
 
 
 
 
Note: n = 40 
 
 
 
 
 
 
 
 
 
 
         Function 1         Function 2 
Variable Coef.  Coef.   
Severity and Change Variables      
     DSM-5 AUD Severity -.670  -.051   
     Consequences/Experiences               
     from Use 
-.669  -.648   
     Ideal Use -.255  -.313   
     Stage of Change .006  .276   
     RFQ .547  -.865   
      
Rc  .480  .335  
Rc
2 (%)  23.08  11.23  
      
MUSQ Factor 10      
     Frequency 1.19  .819   
     Liking .946  -.471   
     Satisfaction -1.55  -1.17   
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Table 31  
 
Canonical Correlation Analysis: Motive Frequency, Liking, and Satisfaction for Reduce 
Negative Affect Motives Predicting Alcohol Use Severity and Change Variables 
 
 
 
 
 
 
 
 
 
Note: n = 41 
 
 
 
 
 
 
 
 
 
 
 
         Function 1         Function 2 
Variable Coef.  Coef.   
Severity and Change Variables      
     DSM-5 AUD Severity -.921  -.736   
     Consequences/Experiences               
     from Use 
-.812  1.03   
     Ideal Use -.264  -.537   
     Stage of Change .034  .922   
     RFQ .416  .007   
      
Rc  .708  .366  
Rc
2 (%)  50.19  13.36  
      
MUSQ Factor 11      
     Frequency .551  -.972   
     Liking -.742  -.107   
     Satisfaction -.604  .147   
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Table 32  
 
Canonical Correlation Analysis: Motive Frequency, Liking, and Satisfaction for Reduce 
Anxiety / Unpleasant Arousal Motives Predicting Cannabis Use Severity and Change 
Variables 
 
 
 
 
 
 
 
 
 
Note: n = 41 
 
 
 
 
 
 
 
 
 
 
         Function 1 
Variable Coef.  
Severity and Change Variables   
     DSM-5 CUD Severity .124  
     Consequences/Experiences               
     from Use 
1.08  
     Ideal Use -.155  
     Stage of Change -.002  
     RFQ -.404  
   
Rc  .520 
Rc
2 (%)  27.05 
   
MUSQ Factor 1   
     Frequency .507  
     Liking -.320  
     Satisfaction .799  
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Table 33  
 
Canonical Correlation Analysis: Motive Frequency, Liking, and Satisfaction for Relative 
Low Risk Motives Predicting Cannabis Use Severity and Change Variables 
 
 
 
 
 
 
 
 
 
Note: n = 57 
 
 
 
 
 
 
 
 
 
 
 
         Function 1         Function 2 
Variable Coef.  Coef.   
Severity and Change Variables      
     DSM-5 CUD Severity .033  -.392   
     Consequences/Experiences               
     from Use 
.234  -.711   
     Ideal Use -1.19  -.134   
     Stage of Change -.762  .243   
     RFQ -.152  .406   
      
Rc  .492  .348  
Rc
2 (%)  24.21  12.10  
      
MUSQ Factor 4      
     Frequency 1.15  -1.16   
     Liking -3.10  .151   
     Satisfaction 1.87  .032   
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Table 34  
 
Canonical Correlation Analysis: Motive Frequency, Liking, and Satisfaction for Positive 
Social Interactions Motives Predicting Cannabis Use Severity and Change Variables 
 
 
 
 
 
 
 
 
 
Note: n = 34 
 
 
 
 
 
 
 
 
 
 
 
         Function 1      Function 2 
Variable Coef.  Coef.  
Severity and Change Variables     
     DSM-5 CUD Severity -.258  -.938  
     Consequences/Experiences               
     from Use 
.214  .450  
     Ideal Use .504  -.986  
     Stage of Change -.224  -.407  
     RFQ -.241  .305  
       
Rc  .473  .346 
Rc
2 (%)  22.37  11.96 
       
MUSQ Factor 5       
     Frequency -1.66  -.418  
     Liking 1.31  -.523  
     Satisfaction .447  1.72  
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Table 35  
 
Canonical Correlation Analysis: Motive Frequency, Liking, and Satisfaction for Altered 
Perceptions / Experiential Processes Motives Predicting Cannabis Use Severity and 
Change Variables 
 
 
 
 
 
 
 
 
 
Note: n = 38 
 
 
 
 
 
 
 
 
 
 
         Function 1      Function 2 
Variable Coef.  Coef.  
Severity and Change Variables     
     DSM-5 CUD Severity -.268  -1.05  
     Consequences/Experiences               
     from Use 
.493  -.711  
     Ideal Use .172  -.574  
     Stage of Change .598  -.037  
     RFQ -.410  -.058  
       
Rc  .624  .437 
Rc
2 (%)  39.00  19.08 
       
MUSQ Factor 7       
     Frequency -.300  .320  
     Liking 2.03  1.96  
     Satisfaction -.952  -2.77  
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Table 36  
 
Canonical Correlation Analysis: Motive Frequency, Liking, and Satisfaction for 
Performance / Arousal Enhancement Motives Predicting Cannabis Use Severity and 
Change Variables 
 
 
 
 
 
 
 
 
 
Note: n = 30 
 
 
 
 
 
 
 
 
 
 
         Function 1      Function 2 
Variable Coef.  Coef.  
Severity and Change Variables     
     DSM-5 CUD Severity .477  -.105  
     Consequences/Experiences               
     from Use 
.743  -.342  
     Ideal Use -.115  -.172  
     Stage of Change -.117  -1.18  
     RFQ .037  .269  
       
Rc  .722  .448 
Rc
2 (%)  52.17  20.05 
       
MUSQ Factor 8       
     Frequency -1.08  -.615  
     Liking -1.02  2.25  
     Satisfaction 1.51  -2.40  
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Table 37  
 
Canonical Correlation Analysis: Motive Frequency, Liking, and Satisfaction for Increase 
Positive Affect Motives Predicting Cannabis Use Severity and Change Variables 
 
 
 
 
 
 
 
 
 
Note: n = 45 
 
 
 
 
 
 
 
 
 
 
 
      Function 1 
Variable Coef.  
Severity and Change Variables   
     DSM-5 CUD Severity .961  
     Consequences/Experiences               
     from Use 
.128  
     Ideal Use -.020  
     Stage of Change .018  
     RFQ .024  
   
Rc  .468 
Rc
2 (%)  21.93 
   
MUSQ Factor 9   
     Frequency 1.65  
     Liking -1.41  
     Satisfaction -.117  
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Table 38  
 
Canonical Correlation Analysis: Motive Frequency, Liking, and Satisfaction for Manage 
Negative Social Interactions Motives Predicting Cannabis Use Severity and Change 
Variables 
 
 
 
 
 
 
 
 
 
Note: n = 33 
 
 
 
 
 
 
 
 
 
 
         Function 1      Function 2 
Variable Coef.  Coef.  
Severity and Change Variables     
     DSM-5 CUD Severity .321  -.078  
     Consequences/Experiences               
     from Use 
.497  -.383  
     Ideal Use -.476  .516  
     Stage of Change -.949  .037  
     RFQ -.429  -.005  
       
Rc  .648  .503 
Rc
2 (%)  41.99  25.30 
       
MUSQ Factor 10       
     Frequency -1.20  -1.18  
     Liking -.399  2.15  
     Satisfaction 1.93  -.920  
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Table 39  
 
Canonical Correlation Analysis: Motive Frequency, Liking, and Satisfaction for Reduce 
Negative Affect Motives Predicting Cannabis Use Severity and Change Variables 
 
 
 
 
 
 
 
 
 
Note: n = 35 
Hypothesis 5: Motives by Drug of Choice 
We conducted a MANOVA to determine whether salient motives (i.e., frequency 
of use for motives) significantly differed by one’s drug of choice. We examined only four 
of the six drug of choice classes due to inadequate sample sizes for some categories: 
alcohol (n = 207), cannabis (n = 82), stimulants (prescription, methamphetamine, 
cocaine; n = 16), and opioids (prescription, heroin; n = 32). The Box’s M test indicated 
the assumption of homogeneity of covariance matrices was violated; therefore, Pillai-
Bartlett Trace was used as the test statistic, M = 629.01, F(234, 9843.95) = 2.20, p < .001. 
The results of the omnibus test revealed significant motive differences between the drugs 
of choice, Pillai’s Trace = .70, F(36, 972) = 8.20, p < .001. 
      Function 1 
Variable Coef.  
Severity and Change Variables   
     DSM-5 CUD Severity -.767  
     Consequences/Experiences               
     from Use 
-.394  
     Ideal Use -.157  
     Stage of Change -.219  
     RFQ .642  
   
Rc  .600 
Rc
2 (%)  35.97 
   
MUSQ Factor 11   
     Frequency -.309  
     Liking -.237  
     Satisfaction -.653  
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The MANOVA was followed up with post-hoc ANOVA’s to determine where 
differences in motives varied by drug of choice (see Table 40 for all mean values). The 
results indicated that frequency of substance use for factors 2 (Conformity; F[3, 333] = 
.81, p = .49), 6 (Rebellion; F[3, 333] = 1.91, p = .13), and 10 (Manage Negative Social 
Interactions; F[3, 333] = 1.02, p = .38) did not significantly differ by one’s drug of 
choice. Because there were unequal sample sizes for individuals’ drugs of choice, we 
examined Hochberg’s GT2 Post Hoc comparisons for the remaining factors. For factor 1 
(Reduce Anxiety / Unpleasant Arousal; F[3, 333] = 14.48, p < .001), those who identified 
cannabis and opioids as their drug of choice used to reduce anxiety or unpleasant arousal 
significantly more frequently than those who identified alcohol as their drug of choice (p 
< .001). For factor 3 (Effects of Other Substances; F[3, 333] = 23.07, p < .001), those 
who reported cannabis (p < .01), stimulants (p < .001), and opioids (p < .001) as their 
drug of choice reported using to manage the effects of other substances significantly 
more frequently than those who reported alcohol as their drug of choice. Those with 
opioids as their drug of choice also used for this reason significantly more frequently than 
those with cannabis as their drug of choice (p < .001). For factor 4 (Relative Low Risk; 
F[3, 333] = 6.48, p < .001), those whose drug of choice was cannabis used because of 
perceived relative low risk significantly more frequently compared to those whose drug 
of choice was alcohol (p < .001). Although factor 5 (Positive Social Interactions) 
demonstrated a significant omnibus test, F[3, 333] = 3.38, p < .05, drug of choice means 
did not significantly differ for this motive for the post hoc analysis. For factor 7 (Altered 
Perceptions / Experiential Processes; F[3, 333] = 21.14, p < .001), those who identified 
cannabis (p < .001), stimulants, (p < .05) and opioids (p < .001) as their drug of choice 
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used to alter one’s perceptions or seek new experiences significantly more frequently 
compared to those who identified alcohol as their drug of choice. For factor 8 
(Performance / Arousal Enhancement; F[3, 333] = 18.02, p < .001), participants who 
reported stimulants and opioids as their drug of choice used to enhance their performance 
or level of arousal significantly more frequently than those who reported alcohol as their 
drug of choice (p < .001). Those whose drugs of choice were stimulants (p < .001) and 
opioids (p < .05) also used for these reasons significantly more frequently than those with 
cannabis as their drug of choice. Lastly, participants whose drug of choice was opioids 
used for this motive more frequently than those with a stimulant drug of choice (p < .05). 
For factor 9 (Increase Positive Affect; F[3, 333] = 16.08, p < .001), those who identified 
cannabis (p < .01), stimulants (p < .01), and opioids (p < .001) as their drug of choice all 
used to increase positive affect significantly more frequently than those identified alcohol 
as their drug of choice. Those with an opioid drug of choice also used more frequently 
than those with a cannabis drug of choice for this reason (p < .05). For factor 11 (Reduce 
Negative Affect; F[3, 333] = 14.13, p < .001), participants who reported cannabis (p < 
.05) and opioids (p < .001) as their drug of choice used to reduce negative affect 
significantly more frequently than those who reported alcohol as their drug of choice. 
Those with an opioid drug of choice also used more frequently than those with a cannabis 
drug of choice for this motive (p < .01). For factor 12 (Substitution; F[3, 333] = 19.67, p 
< .001), those who reported stimulants (p < .01) and opioids (p < .001) as their drug of 
choice used to substitute one substance for another significantly more frequently 
compared to those who reported alcohol as their drug of choice. In addition, those with 
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stimulant (p < .05) and opioid (p < .001) drugs of choice used to substitute another 
substance significantly more frequently than those with a cannabis drug of choice.  
Table 40  
Descriptive Statistics for Post-Hoc ANOVA Variables of Interest 
  M SD Min Max 
1. Reduce Anxiety / Unpleasant Arousal     
     Alcohol 2.26 1.16 1 6.00 
     Cannabis 2.94 1.29 1 6 
     Stimulants 2.85 .93 1.33 4.58 
     Opioids  3.53 1.24 1 5.75 
3. Effects of Other Substances     
     Alcohol 1.21 .55 1 4.14 
     Cannabis 1.55 .83 1 4.57 
     Stimulants 2.04 .90 1 4 
     Opioids  2.19 1.18 1 5.57 
4. Relative Low Risk      
     Alcohol 2.09 1.46 1 6 
     Cannabis 2.95 1.67 1 6 
     Stimulants 2.19 1.41 1 6 
     Opioids  2.43 1.39 1 5 
5. Positive Social Interactions     
     Alcohol 2.31 1.16 1 6 
     Cannabis 2.42 1.32 1 6 
     Stimulants 2.99 1.31 1 5.08 
     Opioids  2.88 1.04 1 5.23 
7. Altered Perceptions / Experiential 
Processes 
    
     Alcohol 1.54 .91 1 5.86 
     Cannabis 2.50 1.28 1 5.71 
     Stimulants 2.42 1.18 1 4.57 
     Opioids  2.53 1.46 1 6 
8. Performance / Arousal Enhancement     
     Alcohol 1.46 1.06 1 6 
     Cannabis 1.68 1.00 1 4.75 
     Stimulants 3.28 1.41 1 6 
     Opioids  2.29 1.19 1 5 
 
137 
Table 40 Continued 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
9. Increase Positive Affect     
     Alcohol 2.42 1.10 1 5.50 
     Cannabis 3.01 1.31 1 6 
     Stimulants 3.46 1.40 1 5.50 
     Opioids  3.74 1.25 1 5.42 
11. Reduce Negative Affect     
     Alcohol 1.81 1.10 1 6 
     Cannabis 2.24 1.26 1 5.67 
     Stimulants 2.38 1.27 1 5.67 
     Opioids  3.17 1.14 1 6 
12. Self-Medication     
     Alcohol 1.15 .56 1 5.33 
     Cannabis 1.23 .55 1 3.67 
     Stimulants 1.86 1.40 1 6 
     Opioids  2.14 1.42 1 5.67 
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 – DISCUSSION 
Studies of substance use motives have largely focused on a specific substance or a 
limited set of substances or motives. Further, substance use motivation measures have 
been limited by only measuring motives by the frequency at which one uses for a given 
reason. Motives are more complex and can be further explored by measuring additional 
facets of motivation. The current study aimed to advance the assessment of substance use 
motives by developing a comprehensive measure of motivations to use problematic 
substances and providing an initial psychometric analysis of the MUSQ. We created the 
MUSQ to tap into both a broader range of substances and motives to use and, further, 
measure additional facets of motivation in terms of wanting, liking, and motive 
satisfaction.  
Hypothesis 1: Factor Structure 
The MUSQ motive frequency items extend the previous literature by finding a 
more comprehensive factor structure. The factor analysis of the MUSQ parsed coping 
with negative affect into both coping with anxiety (Reduce Anxiety / Unpleasant 
Arousal), and coping with other negative affective states (Reduce Negative Affect), 
similar to the five-factor Drinking Motives Questionnaire (Grant, Stewart, O’Connor, 
Blackwell, & Conrod, 2007) and Clinical Substance Use Motives Questionnaire (Blevins, 
Lash, & Abrantes, 2018). We hypothesized that items related to arousal would load with 
affective items. Although this hypothesis was partially supported with an anxiety and 
arousal reduction factor, we found that reducing other negative affective states, affect 
enhancement (Increase Positive Affect), and arousal enhancement (Performance / 
Arousal Enhancement) loaded separately and comprised separate factors. Contrary to our 
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hypothesis, conformity and rebellion items did not load together, but rather loaded onto 
separate factors (i.e., Conformity and Rebellion). While conformity motive content has 
been seen in the majority of previously established measures, rebellion content was a 
relatively novel addition to the measurement of substance use motives. Rebellion content 
had appeared only as a dimension in a qualitative pilot study for the development of the 
Comprehensive Marijuana Motives Questionnaire (Lee, Neighbors, & Woods, 2007), but 
did not emerge as a factor when subjected to a factor analysis (Lee, Neighbors, 
Hendershot, & Grossbard, 2009). In addition, the valence of social interaction motives 
also loaded onto separate factors that captured both the drive to experience positive social 
interactions (Positive Social Interactions) and the motive to mitigate negative social 
interactions (Manage Negative Social Interactions). As expected, factors pertaining to 
managing the effects of other substances (Effects of Other Substances), using because of 
a substance’s perceived relative low risk (Relative Low Risk), altering one’s perceptions 
and experiential processes (Altered Perceptions / Experiential Processes), and substituting 
one substance for another (Substitution) appeared in our data. In addition, the frequency 
subscales of the MUSQ derived from these factors yielded excellent internal consistency, 
with inter-item correlations ranging from moderate to strong and coefficient alphas in the 
excellent range.  
There were three major limitations of this portion of the study. First, participants 
were asked to respond to motive frequency items regarding their overall substance use. 
Hypothetically, a participant who only used stimulants responded to all items in relation 
to their stimulant use, while a polysubstance user responded more broadly. Given that our 
sample was predominantly comprised of alcohol, cannabis, and prescription stimulant 
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users, salient motives were likely skewed towards relevance to these substances over 
others. Had the sample comprised a more even distribution of substances classes, it is 
quite possible that a Performance / Arousal Enhancement motive may not have emerged. 
Second, the MUSQ was presented to participants at the very end of a 50-minute survey 
with several other questionnaires preceding it. Thus, fatigue due to the duration of the 
survey was likely, which may have contributed to the frequency of missing responses to 
the second (motive liking) and third (motive satisfaction) corresponding questions to each 
motive. Finally, participants completed the survey without direct contact with the 
researcher (i.e., online), limiting their ability to seek clarification outside of emailing the 
principal investigator. Questions formatted for addressing frequency (e.g., “How often do 
you...?”) are common in research and are likely familiar and straightforward for the 
respondent. However, our inclusion of motive liking and satisfaction questions was 
novel. The study may have benefitted from in-person data collection to allow participants 
a greater opportunity for clarification. Indeed, some participants emailed the principal 
investigator seeking guidance for how to respond to the MUSQ for their overall current 
and past substance use, as wanting, motive frequency, liking, and satisfaction, and 
motives themselves, had changed over time as their substances and patterns of use 
changed. While the rationale for seeking responses in relation to current and past use was 
to widen the net of potential participants, this method may have muddied results given 
that these concerns may not have been well-defined for the participants. Future studies 
would find value from a psychometric and participant perspective in seeking responses to 
the MUSQ in relation to current use. Further, completion of the MUSQ should be in 
reference to a single substance class and polysubstance users should complete a MUSQ 
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per problem substance (e.g., once for alcohol, once for stimulants). One is not diagnosed 
with an overall SUD; rather, specific SUDs are diagnosed and, at times, are observed at 
different severities (e.g., severe Alcohol Use Disorder with a mild Cannabis Use 
Disorder). The Incentive-Sensitization Theory would suggest wanting and liking should 
also vary in relation to the SUD severity. It appears the other facets of motivation we 
attempted to capture (i.e., motive frequency and satisfaction) would likely vary by the 
severities or absence of specific SUDs too.  
 Although we were unable to conduct factor analyses of the motive liking and 
satisfaction items due to low response rates, we addressed the subsequent research 
questions of MUSQ validity by creating liking and satisfaction mean scale scores based 
on the final motive frequency factor structure. Nevertheless, sample sizes for many of the 
subscales were insufficient for statistical analysis. As such, validity analyses were 
conducted only for the following scales: Reduce Anxiety / Unpleasant Arousal, Relative 
Low Risk, Positive Social Interactions, Altered Perceptions / Experiential Processes, 
Performance / Arousal Enhancement, Increase Positive Affect, Manage Negative Social 
Interactions, and Reduce Negative Affect. 
Hypothesis 2: Wanting, Liking, and Satisfaction Measures 
 Liking and satisfaction did not predict participants’ frequency of substance use. 
Rather, greater wanting, or craving, of substances consistently predicted higher frequency 
of use. This finding is somewhat in line with the Incentive-Sensitization Theory (IST), 
given that it posits wanting is the most salient drive to use. Further, IST suggests wanting 
must increase as addiction severity increases, but liking may be either invariable or 
demonstrate a decrease as addiction worsens (Berridge & Robinson, 2017). Given that 
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the theory does not suggest a consistent pattern for liking as addiction severity increases, 
nor does it equate addiction severity to higher frequency of use, per se, our results make 
sense. Further, IST discusses liking in terms of liking the effects of the substance, not 
necessarily liking that one uses the substance to serve a higher function (e.g., achieve a 
specific motive). Satisfaction of a motive via substance use, moreover, was and still is a 
hypothesized facet of substance use motivation; however, its theoretical soundness may 
be more in line with the theory backing Motivational Interviewing than IST. The degree 
to which a motive is satisfied via substance use may not predict substance use frequency, 
but it is likely still very relevant as a point of discussion in promoting change talk. This 
prediction should not be abandoned but should be analyzed with greater precision in 
future studies. A limitation here was the confounding measurement of these variables in 
relation to particular substances. Participants responded to wanting, liking, and 
satisfaction items in regard to their overall substance use, but the dependent variable was 
the frequency of their most frequently used substance. Thus, a lack of significant findings 
in this area should not be construed as disconfirming evidence for the theory. Future 
studies should examine this relationship in regard to a single substance (e.g., alcohol) or 
class of substances (e.g., opioids) for greater clarity.  
Hypotheses 3 and 4: Incremental Validity Testing of the MUSQ 
 Frequency of substance use has always been a strong predictor of severity and 
problem variables. In addition, existing substance use motive questionnaires have 
consistently found that measuring motives in terms of frequency of use for given motives 
predicts substance use severity and related problems. We attempted to test the 
incremental validity of the scores from the factor-based subscales of the MUSQ via 
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canonical correlations. Our analyses for hypotheses 3 and 4 yielded sample sizes ranging 
from 30 to 57, with the majority of sample sizes in the 40s. For the first functions, 
canonical correlations for hypothesis 3 ranged from .664 to .887, while canonical 
correlations for the first functions in hypothesis 4 ranged from .412 to .722. As such, our 
inconsistent and, at times, confusing results should be interpreted with utmost caution. As 
an example, and as further support for the limitations of subsequent functions, we saw 
incompatible results for the first canonical correlation for hypothesis 3 (see Table 11). 
The first function demonstrated higher frequency of alcohol use predicted greater DSM-5 
AUD severity, while the second function suggested lower frequency of alcohol use 
predicted greater DSM-5 AUD severity. With a canonical correlation of .411 for the 
second function and a small sample (n = 41), the results for the second function are likely 
spurious.  
We expected higher frequency of substance use and higher motive frequency 
would predict severity and change variables but, in addition to these predictors in a 
variable set, we expected wanting, liking, and satisfaction to yield additive predictability 
of these variables. Indeed, in the overwhelming majority of canonical correlation 
analyses for hypothesis 3, we saw the first function was consistently characterized by 
higher frequency of substance use predicting greater DSM-5 alcohol and cannabis use 
disorder severities. These correlations were consistently around .7 or greater, supporting 
the validity of this conclusion. When wanting was a significant predictor, it always 
predicted greater DSM-5 alcohol and cannabis use disorder severity. When liking was a 
significant predictor, it varied in relation to DSM-5 alcohol and cannabis use disorder 
severity depending on the motive addressed. This finding mirrors IST, supporting the 
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inconsistent patterns of liking as severity increases. When satisfaction was a significant 
predictor, six of the first functions demonstrated less satisfaction of a given motive via 
use predicted greater DSM-5 alcohol and cannabis use disorder severity, whereas three of 
the first functions demonstrated more satisfaction predicted greater DSM-5 severity. All 
other significant problem and change variables were inconsistently predicted, and thus do 
not warrant interpretation.  
For hypothesis 4, two of the first functions in the canonical correlations reached a 
Rc at or above .7 and were interpretable despite our small sample sizes. The first function 
of the canonical correlation examining motive frequency, liking, and satisfaction for the 
Reduce Negative Affect factor predicting alcohol use severity and change variables 
suggested lower frequency of substance use to reduce negative affective states, more 
liking that one uses substances to reduce their negative affect, and more satisfaction of 
this goal via use predicted a combination of greater AUD severity, more perceived 
positive consequences and experiences from alcohol use, and having less reasons to quit 
using alcohol. Two comments should be made regarding this pattern. First, as mentioned 
before, participants responded to the MUSQ for their overall substance use, while the 
severity and change variable set in this analysis pertained only to participants’ alcohol 
use. Assumptions cannot be made that this MUSQ pattern relates solely to alcohol use – 
it can only be said that this pattern for substance use in general predicts these alcohol-
related problems and personal perceptions regarding alcohol use. Second, although lower 
frequency of overall substance use to reduce negative affect predicted greater AUD 
severity, this lower frequency may be explained by participants’ averaging their 
frequency of use for this motive across multiple substances. If, for example, a participant 
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uses stimulants, hallucinogens, and benzodiazepines often but used these substances 
infrequently to reduce negative affect, while they used alcohol more frequently to achieve 
this motive, they may have given the frequency item a lower overall rating.  
The first function of the canonical correlation examining motive frequency, liking, 
and satisfaction for the Performance / Arousal Enhancement factor predicting cannabis 
use severity and change variables suggested lower frequency of overall substance use to 
enhance one’s performance or arousal, less liking that one uses to achieve this goal, but 
more satisfaction of this goal via use predicted a combination of greater DSM-5 CUD 
severity and more perceived positive consequences and experiences from cannabis use. 
Given the Performance / Arousal Enhancement factor likely emerged from the data from 
stimulant users, the substantially low sample size in the analysis given the number of 
variables in the sets, and the MUSQ addressing overall use as opposed to cannabis use, 
these results may not be replicable or generalizable.  
Hypothesis 5: Motives by Drug of Choice 
 Finally, we aimed to determine whether salient motives differed by participants’ 
first drug of choice. We had sufficient power to detect differences in motives for those 
who identified alcohol, cannabis, or opioids as their drug of choice; however, 
interpretations of differences in salient motives in comparisons with those who identified 
stimulants as their drug of choice should be interpreted with caution, as we needed at 
least eight more participants in this group to detect a large effect (G*Power; Erdfelder, 
Faul, & Buchner, 1996). Further, we conducted follow-up ANOVA’s to better answer the 
research question. With this, however, an increase in the probability of Type I error 
cannot be ruled out. Regardless, the majority of the results made theoretical sense. For 
 
146 
example, those with a cannabis drug of choice used more often because of perceived 
relative low risk compared to those with an alcohol drug of choice. Cannabis lacks the 
severe withdrawal effects, blackouts, and increased likelihood of aggression (Pihl, 
Peterson, & Lau, 1993) and death by intoxication (Hall, Room, & Bondy, 1994) seen 
with alcohol intoxication. Other results, however, were inconsistent with what one would 
expect. For example, our results suggested those with an opioid drug of choice reported 
using substances to enhance their performance or arousal more often than those with a 
stimulant drug of choice. A consistent limitation seen in this study and demonstrated here 
is that participants did not respond to the motive items in relation to specific substances, 
nor did they respond in reference to their first drug of choice. We also asked participants 
to identify their top three drugs of choice and could not assume any particular distance 
from their first, second, or third drug of choice in terms of personal salience. A 
participant may have indicated cannabis was their first drug of choice, and therefore 
cannabis was considered in the analysis, but identified alcohol as their second drug of 
choice and used alcohol much more frequently and, as such, responded to motive items 
mostly in terms of their alcohol use.  
Strengths, Limitations, and Future Directions 
 The MUSQ extends the measurement of motivations for substance use by 
capturing other facets of motivation in addition to frequency of use for a given motive. 
With the MUSQ, one can assess not only how often one uses substances for a particular 
reason, but the degree to which an individual likes that they use substances as a means to 
achieve a goal and the degree to which a goal is actually accomplished via use. If 
anything, this measure can be used as a point of MI discourse to establish discrepancy 
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between wanting to change and not change one’s substance-using behavior. For example, 
a clinician could direct a client to a pattern where they are using substances frequently to 
reduce feelings of loneliness, despite still feeling lonely or wishing they could cope with 
loneliness through other means. The MUSQ also captures a wider breadth of motivations 
to use and more nuanced motivations compared to what is seen in existing substance use 
motivation measures. Rarely do we see motives related to using a substance to substitute 
another, to rebel, or to manage negative social interactions in the literature. Further, 
motives related to using because of perceived relative low risk have appeared 
sporadically in the substance use motives literature but have never captured all of the 
facets of relative low risk at once (i.e., in terms of safety, health, legality, tolerance, and 
social acceptability).  
Overall, the added motive content in the MUSQ showed some evidence for 
incremental validity, though the results are limited by small effects and small sample 
sizes. Future studies would benefit from collecting data from individuals with more 
substance use history beyond alcohol and cannabis. Given the length of the questionnaire, 
the MUSQ should not be combined with too many additional measures in a given study 
in order to protect against fatigue as a factor in attrition or missing responses. In 
administering the MUSQ, responses should be collected separately for motives by 
substance class and responses for polysubstance users should be compared. Finally, the 
MUSQ should be responded to based solely on current substance use.  
 The MUSQ requires future psychometric studies utilizing the aforementioned 
recommendations. The MUSQ should be subjected to invariance testing by drug classes 
to determine whether the factor structure holds across substances. If this is not the case, 
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the MUSQ may not be useful as a general substance use motives measure, in which case 
it would be important to assess motives for different substances separately.  Incremental 
validity testing should be re-analyzed by substance class with a larger sample that 
includes a wider array of substances than the three that were predominant in the current 
study. Importantly, future studies may benefit from utilizing existing substance use 
problem and change measures with strong psychometric properties in order to provide 
more evidence for the validity of scores from the MUSC. For example, SUD severity 
should be measured utilizing a gold-standard measure (e.g., the Structured Clinical 
Interview for DSM-5 – Research Version [SCID-5-RV]; First, Williams, Karg, Spitzer, 
2015) and individuals’ statuses on the Stages of Change should be measured with the 
Stages of Change Questionnaire (McConnaughy, Prochaska, & Velicer, 1983).
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APPENDIX A – IRB Approval Letter 
 
 
APPENDIX B – Frequency of Use 
The following are commonly used substances. Please first indicate your use status (never used, have used but no longer 
use, or currently use). Then, indicate your typical use pattern for each of the following substances. If you have used a 
substance, but no longer use, please indicate what your typical use pattern was before you quit 
 
 
 
NEVER 
USED 
HAVE 
USED BUT 
NO 
LONGER 
USE 
CURRENTLY 
USE 
LESS 
THAN 
ONCE 
PER 
YEAR 
 
1-6 
TIMES 
PER 
YEAR 
1-4 
TIMES 
PER 
MONTH 
1-3 
TIMES 
PER 
WEEK 
ALMOST 
EVERY 
DAY 
 
EVERY 
DAY 
MULTIPLE 
TIMES PER 
DAY 
ALCOHOL                     
CANNABIS (MARIJUANA, HASH, HASH OIL)                     
PRESCRIPTION STIMULANTS (E.G., ADDERALL, RITALIN)                     
PRESCRIPTION OPIOIDS (E.G., HYDROCODONE, VICODIN, 
OXYCONTIN, PERCOCET, MORPHINE, CODEINE)                     
BENZODIAZEPINES (E.G., XANAX, KLONOPIN, VALIUM, 
ATIVAN, HALCION, RESTORIL)                     
HEROIN                     
COCAINE 
                    
METHAMPHETAMINE 
                    
ECSTASY/MDMA/MOLLY                     
HALLUCINOGENS (E.G., LSD, MUSHROOMS, SALVIA, 
PEYOTE/MESCALINE, DMT, AYAHUASCA) OR OTHER 
HALLUCINOGENS (E.G., 2-CE) 
                    
DISSOCIATIVES (E.G., KETAMINE, DXM, PCP)                     
PRESCRIPTION SLEEP AIDS (E.G., LUNESTA, AMBIEN, 
SONATA)                     
SYNTHETIC CANNABINOIDS (E.G., K2, SPICE)                     
SYNTHETIC CATHINONES (E.G., BATH SALTS)                     
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APPENDIX C – Use Related Questions 
 
Of the following, which substance do you consider to be your drug of choice? If you 
no longer use substances, indicate which substance was your drug of choice in the 
past.  
 Alcohol 
 Cannabis 
 Prescription Stimulants 
 Prescription Opioids 
 Benzodiazepines 
 Cocaine 
 Methamphetamine 
 Ecstasy/MDMA/Molly 
 Hallucinogens 
 Dissociatives 
 Prescription Sleep Aids 
 Synthetic Cannabinoids 
 Synthetic Cathinones  
______________________________________________________________________ 
In general, how would you describe your experiences while you are (were) 
intoxicated / high on ______? 
 
Always 
negative 
Mostly 
negative 
More 
negative 
than 
positive 
About 
equally 
More 
positive 
than 
negative 
Mostly 
negative 
Always 
positive 
1 2 3 4 5 6 7 
 
In general, how would you describe your consequences or outcomes of using _____ ? 
  
Always 
negative 
Mostly 
negative 
More 
negative 
than 
positive 
About 
equally  
More 
positive 
than 
negative  
Mostly 
positive 
Always 
positive 
1 2 3 4 5 6 7 
 
In what ways have you used _____? (check all that apply) 
 I swallow it / eat it / drink it 
 I apply it to my tongue / put it under my tongue 
 I smoke it (traditionally) 
 I smoke it (vapor) 
 I ingest it intranasally (through my nose) 
 I inject it 
 I use a patch on my skin  
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 Other _______(specify) 
Approximately how long have you been using ___? 
 I don’t use this substance anymore 
 Less than a month 
 A month 
 A few months (2-3) 
 Several months (4-11) 
 1 year 
 2 years 
 3 years 
 4 years 
 5 years 
 6 years 
 7 years 
 8 years 
 9 years 
 10 years 
 more than 10 years 
Approximately how long did you use ___ before you quit? 
 Less than a month 
 A month 
 A few months (2-3) 
 Several months (4-11) 
 1 year 
 2 years 
 3 years 
 4 years 
 5 years 
 6 years 
 7 years 
 8 years 
 9 years 
 10 years 
 more than 10 years 
How old were you when you first used _____? 
*enter whole number 
How did you first ever hear about ______? 
 Parents 
 Siblings 
 Other family 
 Friends or others from school or college  
 Friends or others from work 
 Friends or others from other groups (e.g., clubs, organizations, sports)  
 
153 
 Friends I met through drug use  
 A drug dealer 
 A doctor 
 TV / Movies / Commercials / Advertisements  
 Music 
 Don’t remember 
When you first saw ___ in real life, who were you with? (Check all that apply) 
 Parents 
 Siblings 
 Other family 
 Friends or others from school or college  
 Friends or others from work 
 Friends or others from other groups (e.g., clubs, organizations, sports)  
 Friends I met through drug use  
 A drug dealer 
 A doctor 
 By myself 
 Don’t remember 
When you first used ____, who were you with? (Check all that apply) 
 Parents 
 Siblings 
 Other family 
 Friends or others from school or college  
 Friends or others from work 
 Friends or others from other groups (e.g., clubs, organizations, sports)  
 Friends I met through drug use  
 A drug dealer 
 A doctor 
 By myself 
 Don’t remember 
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APPENDIX D – Exposure to Substance 
How often do (did) you acquire _____ from… 
 NEVER RARELY OCCASIONALLY SOMETIMES OFTEN ALMOST 
ALWAYS 
ALWAYS 
PARENTS 
 
 
1 
 
2 
 
3 
 
4 
 
5 
 
6 
 
7 
SIBLINGS 
 
 
1 
 
2 
 
3 
 
4 
 
5 
 
6 
 
7 
OTHER FAMILY 
 
 
1 
 
2 
 
3 
 
4 
 
5 
 
6 
 
7 
FRIENDS OR 
OTHERS FROM 
SCHOOL OR 
COLLEGE 
 
 
1 
 
2 
 
3 
 
4 
 
5 
 
6 
 
7 
FRIENDS OR 
OTHERS FROM 
WORK 
 
 
1 
 
2 
 
3 
 
4 
 
5 
 
6 
 
7 
FRIENDS OR 
OTHERS FROM 
OTHER GROUPS 
(E.G., CLUBS, 
ORGANIZATIONS, 
SPORTS) 
 
 
1 
 
2 
 
3 
 
4 
 
5 
 
6 
 
7 
FRIENDS I MET 
THROUGH DRUG 
USE 
 
 
1 
 
2 
 
3 
 
4 
 
5 
 
6 
 
7 
A DRUG DEALER 
 
 
1 
 
2 
 
3 
 
4 
 
5 
 
6 
 
7 
A DOCTOR 
 
 
1 
 
2 
 
3 
 
4 
 
5 
 
6 
 
7 
BUYING IT AT A 
STORE 
 
 
1 
 
2 
 
3 
 
4 
 
5 
 
6 
 
7 
TAKING OR 
STEALING IT 
FROM A STORE 
 
 
1 
 
2 
 
3 
 
4 
 
5 
 
6 
 
7 
BUYING IT ON 
THE INTERNET 
 
 
1 
 
2 
 
3 
 
4 
 
5 
 
6 
 
7 
A PARTY 
 
 
1 
 
2 
 
3 
 
4 
 
5 
 
6 
 
7 
A BAR 
 
1 
 
2 
 
3 
 
4 
 
5 
 
6 
 
7 
TAKING OR 
STEALING IT 
FROM MY HOME 
 
 
1 
 
2 
 
3 
 
4 
 
5 
 
6 
 
7 
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When you use(d) ___, who do(did) you use with? 
 
  
TAKING OR 
STEALING IT 
FROM OTHERS’ 
HOMES 
 
 
1 
 
2 
 
3 
 
4 
 
5 
 
6 
 
7 
MAKING IT OR 
GROWING IT 
 
 
1 
 
2 
 
3 
 
4 
 
5 
 
6 
 
7 
 
NEVER RARELY OCCASIONALLY SOMETIMES OFTEN 
ALMOST 
ALWAYS ALWAYS 
PARENTS 
 
 
1 
 
2 
 
3 
 
4 
 
5 
 
6 
 
7 
SIBLINGS 
 
 
1 
 
2 
 
3 
 
4 
 
5 
 
6 
 
7 
OTHER FAMILY 
 
 
1 
 
2 
 
3 
 
4 
 
5 
 
6 
 
7 
FRIENDS OR 
OTHERS FROM 
SCHOOL OR 
COLLEGE 
 
 
1 
 
2 
 
3 
 
4 
 
5 
 
6 
 
7 
FRIENDS OR 
OTHERS FROM 
WORK 
 
 
1 
 
2 
 
3 
 
4 
 
5 
 
6 
 
7 
FRIENDS OR 
OTHERS FROM 
OTHER GROUPS 
(E.G., CLUBS, 
ORGANIZATIONS, 
SPORTS) 
 
 
1 
 
2 
 
3 
 
4 
 
5 
 
6 
 
7 
FRIENDS I MET 
THROUGH DRUG 
USE 
 
 
1 
 
2 
 
3 
 
4 
 
5 
 
6 
 
7 
FRIENDS OR 
OTHERS I MET 
AT REHAB, DRUG 
TREATMENT, OR 
THROUGH 
RECOVERY 
GROUPS (E.G., 
ALCOHOLICS 
ANONYMOUS) 
 
 
1 
 
2 
 
3 
 
4 
 
5 
 
6 
 
7 
A DRUG DEALER  
1 
 
2 
 
3 
 
4 
 
5 
 
6 
 
7 
BY MYSELF 
 
 
1 
 
2 
 
3 
 
4 
 
5 
 
6 
 
7 
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APPENDIX E – Treatment History and Change Status 
Ideally, how much ___ do you wish to use? 
Completely 
quit using 
Use a lot 
less 
Use a 
little less  
Use the 
same  
Use a 
little more 
Use a lot 
more 
Use as 
much as 
possible 
1 2 3 4 5 6 7 
 
Which of the following best describes your current state regarding continuing to use 
this drug? (Check one) 
 I have not quit or reduced use, and do not intend to 
 I have not quit or reduced use, but I am thinking about quitting or reducing my 
use 
 I have not quit or reduced use, but I know I should quit or reduce my use 
 I should quit or reduce use, but I do not want to 
 I want to quit or reduce use, but I am not ready or able to 
 I have thought of some plans to quit or reduce use, but I have not taken action 
 I’ve successfully quit or reduced use for at least 3 months 
 I’ve successfully quit or reduced use for up to 6 months 
 I’ve successfully quit or reduced use for 6 months to a year 
 I’ve successfully quit or reduced use for 1 to 2 years 
 I’ve successfully quit or reduced use for more than 2 years 
Have you ever received treatment for using this substance? 
 Never 
 Once 
 Twice 
 Three times 
 More than three times 
Are you receiving treatment for using this substance now? 
 Yes 
 No 
Please indicate the degree to which you found your substance use treatment type 
helpful. If you have not participated in a specific type of treatment, check “not 
applicable.”  
 
1. Informal or non-medical treatment outside of standard mental or medical health 
 Not applicable 
 
1                      2                     3                   4                     5                 6 
   Not at all        Minimally        A little       Moderately       Strongly     Extremely 
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2. AA/NA/CA or another 12-step group 
 Not applicable 
 
1                      2                     3                   4                     5                 6 
   Not at all        Minimally        A little       Moderately       Strongly     Extremely 
 
3. Detoxification treatment 
 Not applicable 
 
1                      2                     3                   4                     5                 6 
   Not at all        Minimally        A little       Moderately       Strongly     Extremely 
 
4. Outpatient treatment 
 Not applicable 
 
1                      2                     3                   4                     5                 6 
   Not at all        Minimally        A little       Moderately       Strongly     Extremely 
 
5.  Inpatient residential treatment 
 Not applicable 
 
1                      2                     3                   4                     5                 6 
   Not at all        Minimally        A little       Moderately       Strongly     Extremely 
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APPENDIX F – Substance Use Disorder Diagnostic Criteria 
Given the amount of substance use you’ve reported, estimate the degree to which 
the following items apply to you. If you reported no use, indicate “Not at all true of 
me.” 
 
1. I use the substance(s) in larger amounts or over a longer period than was originally 
intended. 
Not at all 
true of me 
Minimally true of 
me 
A little true of 
me 
Moderately 
true of me 
Very much 
true of me 
Completely 
true of me 
1 2 3 4 5 6 
2. I have a persistent desire to cut down or regulate my substance use, or, I have had 
multiple unsuccessful efforts to decrease or discontinue use. 
Not at all 
true of me 
Minimally true of 
me 
A little true of 
me 
Moderately 
true of me 
Very much 
true of me 
Completely 
true of me 
1 2 3 4 5 6 
3. I spend a great deal of time obtaining the substance(s), using the substance(s), or 
recovering from the effects of use. 
Not at all 
true of me 
Minimally true of 
me 
A little true of 
me 
Moderately 
true of me 
Very much 
true of me 
Completely 
true of me 
1 2 3 4 5 6 
4. I have substance cravings, or times in which I have such strong urges to use that I cannot 
think of anything else. 
Not at all 
true of me 
Minimally true of 
me 
A little true of 
me 
Moderately 
true of me 
Very much 
true of me 
Completely 
true of me 
1 2 3 4 5 6 
5. I fail to fulfill my obligations at work, school, or home because of my substance use. 
Not at all 
true of me 
Minimally true of 
me 
A little true of 
me 
Moderately 
true of me 
Very much 
true of me 
Completely 
true of me 
1 2 3 4 5 6 
6. I continue to use the substance(s) despite having persistent and/or recurrent social or 
interpersonal problems that are caused or worsened by the effects of substance use. 
Not at all 
true of me 
Minimally true of 
me 
A little true of 
me 
Moderately 
true of me 
Very much 
true of me 
Completely 
true of me 
1 2 3 4 5 6 
7. I have given up or reduced important social, occupational, educational, or recreational 
activities because of substance use. 
Not at all 
true of me 
Minimally true of 
me 
A little true of 
me 
Moderately 
true of me 
Very much 
true of me 
Completely 
true of me 
1 2 3 4 5 6 
8. I use the substance(s) in situations in which it is physically hazardous (e.g., driving while 
intoxicated, using with strangers or in unfamiliar/high-crime neighborhoods). 
Not at all 
true of me 
Minimally true of 
me 
A little true of 
me 
Moderately 
true of me 
Very much 
true of me 
Completely 
true of me 
1 2 3 4 5 6 
9. I continue to use despite knowing that I have a persistent or recurrent physical (e.g., 
difficulty breathing; liver failure; tooth decay) or psychological problem (e.g., depression; 
memory loss) that is likely caused or worsened by substance use. 
Not at all 
true of me 
Minimally true of 
me 
A little true of 
me 
Moderately 
true of me 
Very much 
true of me 
Completely 
true of me 
1 2 3 4 5 6 
10. I have noticed that I need a greater amount of the substance(s) to get the desired effect, 
or, have noticed a reduced effect when the usual amount is consumed. 
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Not at all 
true of me 
Minimally true of 
me 
A little true of 
me 
Moderately 
true of me 
Very much 
true of me 
Completely 
true of me 
1 2 3 4 5 6 
11. I experience withdrawal symptoms (e.g., irritability, nausea, shakiness, etc.) if I do not have 
the substance(s) in my system, so I consume the substance(s) to relieve the symptoms. 
Not at all 
true of me 
Minimally true of 
me 
A little true of 
me 
Moderately 
true of me 
Very much 
true of me 
Completely 
true of me 
1 2 3 4 5 6 
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APPENDIX G – Reasons for Quitting (Revised) 
The following are common reasons why people choose to quit or reduce their 
substance use. Please indicate the degree to which you want to quit or reduce use for 
each reason. If you have already quit or reduced your use, indicate the degree to 
which each reason was relevant to you in your transition. 
 
 
I want to quit or reduce my use 
of_.... 
 
Not at all 
A little 
bit 
 
Moderately 
Quite a 
bit 
Very 
much 
1. To show myself that I can quit if 
I want to 
1 2 3 4 5 
2. Because I will like myself better 
if I quit 
1 2 3 4 5 
3. Because I won’t have to leave 
social functions or other 
people’s houses to use 
1 2 3 4 5 
4. So that I can feel in control of 
my life 
1 2 3 4 5 
5. Because my family and friends 
will stop nagging me if I quit 
1 2 3 4 5 
6. To get praise from people I’m 
close to 
1 2 3 4 5 
7. Because using this substance 
does not fit in with my self-
image 
1 2 3 4 5 
8. Because using is socially 
unacceptable 
1 2 3 4 5 
9. Because someone has told me to 
quit or else 
1 2 3 4 5 
10. Because I will receive a special 
gift if I quit 
1 2 3 4 5 
11. Because of potential health 
problems 
1 2 3 4 5 
12. Because people I am close to 
will be upset if I don’t quit 
1 2 3 4 5 
13. So that I can get more things 
done 
1 2 3 4 5 
14. Because I have noticed that 
using this drug is hurting my 
health 
1 2 3 4 5 
15. Because I want to save the 
money I spend on this drug 
1 2 3 4 5 
16. To prove that I am not addicted 1 2 3 4 5 
17. Because there is a drug-testing 
policy at work, school, or 
another organization I am in 
1 2 3 4 5 
18. Because I know others with 
health problems caused by this 
drug 
1 2 3 4 5 
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19. Because I am concerned that 
using this drug will shorten my 
life 
1 2 3 4 5 
20. Because of legal problems 
related to using this drug 
1 2 3 4 5 
21. Because I don’t want to set a bad 
example for children 
1 2 3 4 5 
22. Because I want to have more 
energy 
1 2 3 4 5 
23. So that my hair, clothes, or home 
wont smell like the drug   
1 2 3 4 5 
24. So that I won’t ruin clothes or 
furniture by spilling or burning 
holes 
1 2 3 4 5 
25. Because my memory will 
improve 
1 2 3 4 5 
26. So that I will be able to think 
more clearly 
1 2 3 4 5 
27. So that I don’t go on to use 
harder drugs 
1 2 3 4 5 
28. Because using is making my 
other mental health problems 
worse 
1 2 3 4 5 
29. So that I don’t hurt or endanger 
someone 
1 2 3 4 5 
30. Because I am embarrassed about 
how this reflect on me or my 
family 
1 2 3 4 5 
31. Because I am embarrassed or 
ashamed about things I have 
done because of using 1 2 3 4 5 
32. To perform better in school or at 
work 
1 2 3 4 5 
33. Because I am tired of craving 
this drug 
1 2 3 4 5 
 
 
APPENDIX H – Motivations for Using Substances Questionnaire (MUSQ) 
Craving 
Sometimes thinking about a drug you use, or used to use, can make you crave it. Other times, seeing people you have used 
with, being in places where you have used, or encountering objects (e.g., bongs, pipes, bottle openers, syringes, spoons) or 
media (e.g., songs, motives, TV shows) that remind you of using can make you crave a drug. Craving can feel like being 
compelled to use, feeling that you cannot control your behavior, and/or finding yourself preoccupied with thinking about the 
drug. Please rate the degree to which you crave drugs you use. If you no longer use alcohol and/or drugs, rate the 
following items for your craving level before you quit using. 
 
When you think about alcohol and/or drugs how intense are your cravings? 
1                      2                     3                   4                     5                 6 
Not at all        Minimally        A little       Moderately       Strongly     Extremely 
 
When you encounter a reminder about alcohol and/or drugs (e.g., people, places, things) how intense are your 
cravings? 
1                      2                     3                   4                     5                 6 
Not at all        Minimally        A little       Moderately       Strongly     Extremely 
 
 
Frequency, Liking, and Satisfaction 
 
Rate the following reasons or motives for your use of alcohol and/or drugs on: 
a) How frequently you use alcohol and/or drugs for that reason or motive; 
b) How much you like using alcohol and/or drugs for that reason or motive; and 
c) How much that reason or motive is satisfied when you use alcohol and/or drugs 
 
If this motive or reason does not apply to your use of alcohol and/or drugs indicate I don’t use for this reason. 
If you no longer use alcohol and/or drugs, rate the items for your use pattern before you quit using.  
 
 
 
Before each set of items, indicate which drugs you use for this set of reasons. (Check all that apply) 
 Alcohol 
 Cannabis  
 Synthetic Cannabinoids  
 Cocaine  
 Methamphetamine 
 Prescription Stimulants 
 Heroin 
 Prescription Opioids 
 Benzodiazepines 
 Prescription Sleep Aids 
 Hallucinogens  
 Dissociatives 
 MDMA/Molly/Ecstasy 
 Synthetic Cathinones 
 
Reasons or Motives to Use a Drug Frequency, Liking, Satisfaction 
To Reduce Negative Feelings  
1. To avoid or blot out my emotions A) FREQUENTLY 
1               2               3               4               5               6 
      Never             Rarely        Occasionally      Often      Almost Always     
Always 
2. To forget, escape, or avoid my memories B) LIKE  
1               2               3               4               5               6 
    Not at all        Minimally         A little      Moderately      Strongly      
Extremely 
3. To forget, escape, or avoid my problems C) SATISFIED                                 
        1               2               3               4               5               6 
    Not at all        Minimally         A little      Moderately      Strongly      
Extremely 
 
 
4. To reduce feelings of sadness or depression  
5. To reduce feeling irritable  
6. To reduce feelings of anger or frustration 
7. To reduce feelings of hopelessness 
8. To reduce feelings of helplessness 
9. To feel less ashamed 
10. To feel less guilty 
11. To reduce feelings of anxiety or nervousness 
12. To feel less lonely  
13. To stop worrying  
14. To reduce feelings of fear  
15. To slow down racing thoughts  
16. To feel more in control of my life   
17. To reduce feelings of inhibition  
18. To calm down   
19. To relax, loosen up, or unwind  
20. To feel less on edge  
21. To reduce unpleasant physical sensations  
22. To reduce stress  
23. To release tension  
24. To feel like nothing can bother me   
25. To decrease restlessness  
To Increase Positive Feelings  
26. To perk up or become alert   
27. To feel like I have energy  
28. To increase excitement  
29. To reduce boredom  
30. To increase joy or happiness  
31. To increase feelings of self-confidence or effectiveness  
 
 
32. To increase pleasure   
33. To increase my self-esteem  
34. To celebrate  
35. To feel content with life  
36. To increase euphoria or feelings of peacefulness  
37. To have fun  
38. To feel alive  
39. To help me get into a good mood  
Social Enhancement  
40. To make friends   
41. To lose inhibitions when in social situations  
42. To feel accepted by others  
43. To have a reason/excuse to socialize  
44. To make social gatherings and parties more fun  
45. To feel more confident and sure of myself around others  
46. To help me feel sociable   
47. To help me relate to others better  
48. To enjoy social interactions  
49. To communicate with others better  
50. To avoid hurting someone’s feelings  
51. To avoid or manage conflict with others  
52. To feel more intimate with, connected to, or closer to others  
53. To enhance my social status, or be perceived as “cool” by others  
54. To celebrate with others  
55. To have a sense of belonging to a social group  
56. To help me express myself to others  
Mind Expansion/Creativity/New Experiences  
57. To help me be more creative  
58. To alter how I perceive my environment (e.g., hear music in greater 
detail or complexity; enhance or dull sensations; drown out 
distractions) 
 
 
 
59. To cause me to perceive things that are not present (i.e., to 
hallucinate; to see patterns or distortions that are not actually 
present) 
 
60. To change my understanding of my perceptions (e.g., a spiritual 
awakening; special understanding of the universe; realizing 
meaning in life) 
 
61. To experience a blending of senses (e.g., tasting colors; seeing 
music as colors or patterns) 
 
62. To seek new experiences  
63. To know what it is like to be high/intoxicated with this substance   
Safer than Other Drugs  
64. To get high/intoxicated with something I think is safer than other 
drugs 
 
65. Because I can handle the high better than with some other drugs   
66. Because it is not as bad for you as other drugs  
67. Because it has fewer side effects than other drugs   
68. Because it does not cause me as many problems as other drugs  
69. Because it is socially more acceptable than other drugs  
70. Because it’s easier to hide my use from others than for other drugs  
71. Because I can use it legally   
72. Because I can get high without screening positive on a drug test   
73. Because it has greater purity than other drugs  
74. Because it is prescribed to me by a doctor   
Improving Function/Reducing Pain or Illness  
75. To reduce physical pain  
76. To sleep  
77. To focus or pay attention  
78. To stay awake  
79. To enhance sex or sexual experiences  
80. To perform better on school (or occupational) work/tests  
81. To study better  
 
 
82. To enhance or facilitate physical (or sport) performance  
83. To decrease my appetite (eat less)  
84. To increase my appetite (eat more)  
85. To black out or to blot out awareness  
86. To reduce hallucinations or paranoia  
87. To avoid drug or alcohol withdrawal symptoms (e.g., shakiness, 
sickness, sweating, restlessness) 
 
Using in Place of Another Drug  
88. To have something to use when my preferred substance is not 
available 
 
89. To get the amount of the drug I think I need when my doctor won’t 
prescribe enough to me 
 
90. To use a drug that is more powerful than one I have gotten used to   
91.  To help me stop or decrease my use of another drug   
92. To get the same effects as something I’m prescribed when I run out 
of the prescription 
 
Defying Norms/Risky Behavior versus Social Conformity  
93. To do something socially unacceptable   
94. To do something illegal   
95. To break rules  
96. To rebel against authority or society  
97. To do something risky or dangerous  
98. To be different  
99. To experience the thrill of doing something I’m not supposed to do  
100. To satisfy social pressure or harassment to use  
101. To follow what my friends are doing  
102. To avoid being made fun of  
103. To not be the only one not doing it   
104. To be just like everybody else  
105. To avoid being rejected  
 
 
Altering the Effects of Drugs  
106. To reduce the effects of another drug  
107. To help with the side effects of a medication  
108. To enhance the effects of another drug  
109. To be able to use another drug for a longer period of time  
110. Because I am under the influence of another drug  
111. To counteract the effects of another drug   
112. To ‘come down’ off of another drug  
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